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ABSTRACT

M inimally and non-invasive glucose sensing techniques are instrumental in
improving the quality o f life o f diabetics, point-of-care testing, critical care monitoring,
development o f new anti-diabetic drugs or therapeutic compounds, and the study o f basic
physiology. The overall goal o f this project was to build a fluorescent glucose sensor by
incorporating relevant sensing chemistry within microcapsules. The specific aims for this
research were to study various processes used for the fabrication o f micro-containers, the
use o f these for encapsulation purposes, and the application o f the encapsulated system
towards glucose sensing. The following is a brief description highlighting the key areas
o f the research.
Different materials

such

as polystyrene

sulfonate

(PSS), polyallylamine

hydrochloride (PAH), polydiallyldimethyl ammonium chloride (PDDA), chitosan (CHT),
and polyvinyl sufate (PVS) were used to construct the capsule walls. Fluorescence
recovery after photobleaching (FRAP) was used to study the effect o f capsule wall
architecture on the permeability o f capsules to FITC labeled GOx (FITC-GOx). Long
term stability and activity studies proved that (PVS/CHT} 2 -{PSS/PAH } 2 capsules were
the most stable and showed minimal leaching (79% o f enzyme retained) and the activity
o f the encapsulated enzyme did not change significantly over four weeks. Hence, they
were selected for demonstration o f glucose sensing. Fluorescence sensors for glucose
using pH-sensitive Pyrene 8 -hydroxy-1,4,6,-trisulfonylchloride (HPTS), which facilitates

iii
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ratiometric monitoring o f pH changes, was used to label GOx (HPTS-GOx), and
encapsulated in these capsules. Changes in glucose concentration were monitored as a
function o f the pH changes during glucose consumption by GOx, and the sensors showed
a linear response to sequential additions o f glucose in the physiological region o f interest
(0mM-30mM).
In summary, the ideas, techniques and discussion o f the results presented in this
dissertation are a significant contribution to the science o f enzyme encapsulation. The
preliminary data demonstrating glucose sensing using a labeled pH-sensitive dye is an
important contribution to this application. Some o f the novel techniques presented here
serve as a foundation for future application o f these to other areas. The experimental
techniques and methods o f characterization described in this dissertation can serve as a
comprehensive guide to researchers involved in similar study.
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CHAPTER 1

INTRODUCTION

Figure 1. Cover page: Fantastic Voyage, by Isaac Asimov

What was only a figment of the imagination of American author and biochemist
Issac Asimov has become today’s quest for understanding our macroscale world with
microscale innovations. Though living beings have yet not been shrunk and injected into
the body as was envisaged by Asimov, there have been Promethean strides made in the
field of micro- and nano-technology. Scientists and researchers are developing artificial
cells that can replace damaged cells in the body, and miniaturized sensors have been
injected into cells to monitor cellular events. Nanorobots—which were earlier dismissed

1
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as mythical monsters are now being considered for diverse applications from
mouthwashes to skin disease cures to medical nanodevices that can augment the human
immune system and nibble away atherosclerotic plaques. The concept o f tattooing,
viewed as a form o f body art, fashion, and rebellion is now also being used by researchers
for embedding smart sensors for monitoring vital analytes in the body.
Dr. Gregory Fahy o f the American Red Cross aptly said in the paper
“Nanotechnology in Medicine” presented at the U.S. Pharmacopeial Convention in fall
1992. “Living organisms are naturally-existing, fabulously complex systems o f molecular
nanotechnology. ” W ith that in mind, it seems that the development o f micro- and
nanoscale sensors and actuators might prove to be instrumental in curing the human body
o f its various ills. Among the various devices that are in great demand both in terms o f
improvement o f the quality o f life o f patients, as well as in terms o f scientific challenge,
is an ongoing quest for the “ideal” glucose sensor. Sensing glucose is imperative in a
wide spectrum o f applications ranging from food industry to personal management o f
diabetes. Many systems have been developed for ex vivo analysis o f glucose; however,
there is still a need for development o f a reliable, implantable or minimally implantable
glucose sensor for in vivo monitoring o f physiological levels o f glucose. Such a sensor
needs to satisfy a number o f stringent criteria, such as selectivity, linear range, and
response time, biocompatibility, storage and operational stability at body temperature,
reversibility o f signal, and reproducibility o f sensor fabrication, which current endeavors
have not been able to completely satisfy1.
Advances in the micro- and nano-fabrication industries together with rapid
progress in the photonics industry have created a tremendous potential for development
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o f portable, minimally invasive sensors for monitoring a wide spectrum o f micronutrients
and analytes in the body2, especially the market driven demand in the glucose sensing
industry for in vivo glucose monitoring o f diabetic patients. Self-monitoring o f blood
glucose (SMBG) is the bedrock o f successful diabetes management. It has the potential to
improve the quality o f life o f millions o f diabetics all over the world essentially by
ameliorating the pain associated with the traditional finger prick method, and by
developing a continuous and reliable in-vivo glucose monitoring system that would help
the patient to optimize insulin therapy and metabolic control3. This method would also
prevent the dangers associated with acute metabolic deterioration, such as hypo and
hyperglycemia.
There have been several minimally invasive and non-invasive techniques
developed for continuous monitoring o f blood glucose. Implantable subcutaneous glucose
sensors and subcutaneous interstitial fluid sampling by microdialysis are examples o f
techniques based on analysis o f interstitial fluid. Electrodes developed for this purpose
and which are inserted into the subcutaneous tissue cannot be used for long periods o f
time in humans due to fouling o f the electrode, which results in drift o f signal, and hence
a loss o f glucose sensitivity. The microdialysis methods have a significant time lag
associated with the process o f measurement, which can vary between 5 and 45 minutes4.
Transdermal glucose monitoring systems and optical glucose sensors have also been
developed.

M ost non-invasive approaches use optical techniques the basic principle

being measurement o f the properties o f light reflected from the skin, either as a result o f
direct interaction with glucose using spectroscopic techniques, or due to indirect effects
by changes in the physical properties o f the skin (scattering). The non-invasive
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techniques suffer from insufficient precision4. Implantable glucose sensors have the
obvious major applications in diabetic self-monitoring, but other applications include
critical care monitoring and the study o f basic physiology. As an example o f the latter,
real-time monitoring o f neurochemical dynamics, including glucose and lactate, is
important to understanding neural processing, cell biology, and drug activity. To date,
some minimally invasive methods have been developed for sensing blood glucose
concentrations, but all o f the accurate devices on the market still require extraction o f
blood samples. Fully-implanatable systems with wireless communication are an ideal
solution; however, while many such devices are under development, the stability o f
enzyme-electrochemical systems remains a difficult obstacle to overcome. Sensors based
on optical measurements are an attractive alternative, as they m ay be analyzed
spectroscopically.
Among the various non-invasive glucose biosensors reported in literature, several
optical techniques have been cited, such as, near-infrared spectroscopy5, polarimetry6,
Raman spectroscopy5, and fluorescence spectroscopy7. Optical sensors are generally
advantageous in terms o f minimal analyte consumption and can potentially be used to
monitor real-time events. Fluorescence sensors provide a non-invasive method o f
detection o f analytes, which is fast, reagentless, and versatile1. However, if the
fluorescent dyes are directly introduced into the body, their location cannot be controlled.
Moreover, there can be problems o f cytotoxicity and compartmentalization o f the
indicators in organelles. Hence, encapsulation o f the sensor chemistry is vital in order to
overcome all these drawbacks. A number o f fiber-optic sensors for sensing various
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analytes (oxygen8, carbon dioxide9, glucose10 and N A D H 11) have been developed;
however, the measurement technique is invasive.
The study o f enzyme encapsulation has been o f significant interest both from the
standpoint o f academic research as well as in several industrial applications12. The
prim ary objective behind encapsulation o f enzymes is to use a semi-permeable support
matrix to entrap the enzyme, prevent its leaching out o f the matrix, while allowing
exchange o f analytes, products, and co-factors between the encapsulated enzyme and the
surroundings13. Various methods o f encapsulation in micro and nanoparticles have been
developed for applications in pharmaceutics, cosmetics, agriculture and biosensors,
among

others14,15,16,

liposomes17,

microspheres

prepared

by

microemulsion

techniques18’19, and silica matrices 20 are among the various carrier systems used for
various chemicals, drugs and biomacromolecules. Medical applications o f such microand nanocontainters include using them as protective shells for cell and tissue
encapsulation or as carriers for drug-delivery. Some o f these techniques suffer from the
lack o f homogeneity o f particles, and lack o f repeatability in terms o f the quantity
encapsulated within and between batches. In the field o f fluorescence biosensing, analyte
specificity is achieved by co-encapsulation o f indicator and reference dyes and various
receptor systems, such as synthetic receptors (i.e. boronic acid derivatives21’22’23),
naturally occurring (i.e. enzyme glucose oxidase (GOx)24’25’26, lectin27’28’29 Concanavalin
A, sugar binding proteins) and genetically engineered binding proteins 30,31 (i.e. glucose
binding protein, GBP).
Recently, encapsulating polymeric microcapsules with specialized multilayer
compositions and controllable wall properties has been proposed32,33,34. Layer-by-Layer
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(LbL) self assembly has proved to be a versatile method by which both planar thin film
architectures and hollow core shells can be produced35,36,37. This method is advantageous
due to the ease and repeatability o f the fabrication process, and because it does not
require sophisticated and expensive equipment. Various templates have been used to
fabricate microcapsules with different sizes and wall architectures. Among the various
templates that have been used for fabrication o f microcontainers are silica, polymeric
particles like polystyrene and melamine formaldehyde (MF)38,39,40, metal particles41,
biological cells42,43, and inorganic crystals44. Using micro/nanocapsules made by LbL
methods, several methods o f encapsulation have been developed. These methods include
encapsulation o f both biomolecular and non-biomolecular materials.
To date, there have been no reports o f the use o f pH sensitive ratiometric dyes
encapsulated using micro/nanoscale carriers, for the measurement o f glucose. Pyrene 8 hydroxy-1,4,6-trisulfonylchloride (HPTS), is a pH indicator dye that has been used by
several groups to demonstrate pH sensitivity in thin films45,46,47. It has numerous
advantages such as large Stokes shifts, high quantum yield, high absorbance, excellent
photostability, and lack o f toxicity45.
The fundamental aim o f this dissertation was to develop a glucose sensor based
on sensing pH changes associated with oxidation o f glucose by glucose oxidase to
indicate changes in glucose concentration. With this goal aim in mind, two specific aims
were identified. A im l, various enzyme encapsulation techniques were studied and
compared with the purpose o f identifying the best method (percentage encapsulation
efficiency, activity, and stability) for the encapsulation o f GOx. In the process o f
developing methods o f encapsulation for GOx a novel method o f encapsulation o f HRP
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was discovered. This method involved fabrication o f a charged matrix o f acrylic acid
inside the hollow capsule volume. The method is rather simple and can be extended to
encapsulation o f macromolecules with slightly basic isoelectric points (pi). A short study
o f the effect o f encapsulation parameters on the encapsulation efficiency and stability o f
the encapsulated enzyme was performed48. Aim2, based on comparison o f the relative
merits o f the various methods o f encapsulation in specific aim 1 , a method was selected
and used to encapsulate HPTS-GOx. The effect o f labeling on the pH sensitivity o f the
dye was studied and compared with the response o f the free dye. The glucose sensitivity
o f the dye was studied in solution and after encapsulation, both in DI water and in PBS
buffer.
A novel method o f sensing glucose has been demonstrated. The marriage o f
fluorescence spectroscopy and nanotechnology has produced glucose sensors which can
potentially be used to monitor glucose changes in the body as a function o f changes in
pH. To date, there has been no reported research on glucose sensors based on translation
of pH changes into changes in glucose concentration. Sensors were fabricated by
encapsulating glucose oxidase (GOx), labeled w ith a pH sensitive fluorophore pyrene 8 hydroxy-1,4,6-trisulfonylchloride (HPTS) in microcapsules. The microcapsules were
fabricated using LbL assembly o f generic polyelectrolytes and chitosan on an MF
template. The glucose sensitivity o f the encapsulated chemistry was demonstrated. The
conceptual schema o f sensor fabrication and desired optical response is shown in Figure
2. From the figure it can be seen that increasing glucose concentrations causes an
increase in excitation ratio o f HPTS, which is labeled to glucose oxidase. The principal
advantage o f this method has been the simplicity o f the encapsulation procedure, as well
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as the lack o f a need for an additional reference indicator due to the inherent ratiometric
nature o f HPTS.
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Figure 2. Schema o f sensor fabrication and optical response

The following chapters o f this dissertation describe the background, experimental
theory and methods, materials and techniques, results and conclusions o f the work done
to fulfill the aforementioned specific aims. Chapter II is an overview o f the literature and
background pertaining to glucose regulation in the body, previous and current research in
non-invasive and minimally Invasive, transdermai, fluorescence glucose sensing
techniques; skin optics and the concept o f smart tattoos have also been reviewed.
Chapter III gives details o f the chemical techniques (cross-linking, labeling reactions),
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the optical imaging and spectroscopic techniques used for measurements and the surface
characterization techniques used to achieve the aims o f the project. The materials and
methods used to perform the experiments have been described in Chapter IV. Chapter V
describes the experimental results with a detailed discussion o f the outcomes and the
rationale behind them. Finally, the conclusions derived from the work have been
described in Chapter VI.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

CHAPTER II

LITERATURE REVIEW

This chapter describes a wide range o f topics related to glucose regulation in the
body, diabetes mellitus and its treatment options and the need for continuous glucose
monitoring. Current research in implantable, non-invasive and minimally invasive,
transdermal, fluorescence glucose sensing techniques, skin optics and the concept o f
smart tattoos have been reviewed. Further, it deals with layer-by-layer (LbL) assembly
and various encapsulation techniques using this technique.

2.1 Physiology of Glucose Metabolism
2.1.1 Anatomy of the Pancreas
The pancreas (Figure 3), a large compound gland with an internal structure
similar to that o f the salivary glands, lies parallel to and beneath the stomach. It is mainly
composed o f two main types o f tissues: the acini, which secrete digestive juices into the
duodenum; and the islets o f Langerhans, which secrete insulin and glucagon directly into
the blood. The human pancreas has one to two million islets o f Langerhans organized
around small capillaries into which its cells secrete their hormones. The islets contain
three major types o f cells: alpha cells, which secrete glucagons; the beta cells, which
secrete insulin; and the gamma cells, which secrete somatostatin. The close interrelations

10
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among these cells types in the islets o f Langerhans allow direct control secretion o f some
o f the hormones by the other hormones; i.e., insulin inhibits glucagon secretion, and
somatostatin inhibits the secretion o f both insulin and glucagon49.

Stomach
sto m a c h

Large Intestine

pm

Small Intestine

duodenum

Capillaries

Figure 3. The pancreas—an important organ for insulin regulation o f the body.
(Source: www.nlm.nih.gov/.../ ency/imagepages/8883.htm, www.nurseminerva.co.uk/
p ancreat.htm,cal.man.ac.uk/.../ 2000/mnby71c2/pancreas.htm)
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2.1.2 Effect of Various Enzymes on
Glucose. Fat and Protein
Metabolism
Though insulin secretion has been associated with energy abundance, i.e. with
consumption o f foods rich in carbohydrates and proteins, it has also been found to affect
fat and protein metabolism almost as much as carbohydrate metabolism. The secretion o f
insulin in great quantities is especially true for excess carbohydrate consumption and is
less for proteins and only slightly for fats.
Excess carbohydrates are stored as glycogen, mainly in the liver and muscles. Fat
storage takes place in the adipose tissue; insulin causes all excess carbohydrates that
cannot be stored as glycogen in the liver and muscles to be converted into fat. In the case
o f proteins, insulin promotes amino acid uptake by cells and their conversion into protein.
Insulin also inhibits the breakdown o f the proteins that are already in the cells.
Mainly, four hormones play an important role in switching between carbohydrate
and lipid metabolism. The growth hormone from the anterior pituitary gland, cortisol
from the adrenal cortex, epinephrine from the adrenal medulla, and glucagon from the
alpha cells o f the islets o f Langerhans. Growth hormone and cortisol are secreted in
response to hypoglycemia and inhibit cellular utilization o f glucose while promoting fat
utilization. Epinephrine has both lipolytic effects increasing the fatty acids in the blood
and glucogenolytic effects increasing glucose concentration o f blood, but mostly the
former. The effect o f epinephrine is particularly important during periods o f stress, such
as exercise, anxiety, and circulatory shock.
Glucagon encourages gluoneogenesis during periods o f hypoglycemia by
activating several enzymes that promote amino acid uptake by the liver and their
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conversion into glucose. It also promotes glycogenolysis, which entails the breakdown o f
glycogen in the liver into glucose and its release as glucose into the blood.

Diabetes Mellitus

2.2

Type I and Type II diabetes account for 99.9% o f all prevalence o f diabetes and
affect about 135 million people worldwide. Type I diabetes results from a chronic
autoimmune destruction o f the pancreatic /3-cells and usually starts from childhood or
early adulthood (<35yrs). Type II diabetes results when organs become insensitive to the
action o f insulin and/or the production o f insulin by the beta cells is insufficient
(dysfunction o f /3 cells). Heredity plays a vital role in diabetes, both Type I and Type II49.

2.2.1 Pathophysiology of Diabetes Mellitus
Diabetes Mellitus is characterized by the following consequences o f lack o f
insulin: increase in blood glucose concentration up to 300-1200mg/dl (16mM-66mM)
and increased fat immobilization from fat deposit areas, causing abnormal fat metabolism
and deposition o f cholesterol in arterial walls leading to atherosclerosis and protein
depletion in the tissues o f the body49.
When blood glucose concentration rises above 180mg/ml (blood threshold), a
significant portion o f this glucose entering the kidney tubules in the glomerular filtrate
cannot be reabsorbed and hence spills into the urine. This leads to osmotic diuresis, or the
increased loss o f water in urine due to osmotic effect o f glucose decreasing tubular
reabsorption o f fluid. It also leads dehydration o f cells. Extracellular and intracellular
dehydration can lead to circulatory shock.

Increased fat metabolism can also lead to

acidosis and hence coma and eventually death. Polyuria (excessive elimination o f urine),
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polydipsia (excessive drinking o f water), polyphagia (lack o f energy), weight loss and
asthenia (lack o f energy) are the earliest signs o f diabetes.
A t elevated levels o f glucose (>5mM), glycosylation o f proteins (hemoglobin,
collagen etc.) takes place due to reaction o f glucose (without enzyme catalysis) with
proteins. This can result in tissue damage and failure o f vital organs such as the kidneys,
which is a long-term complication o f diabetes50.

2.2.2 Treatment of Diabetes Mellitus
For type II diabetes, a diet, oral hypoglycemic agents and/or the administration o f
insulin is required and sufficient to regulate the blood glucose concentration. In addition
to increasing glucose levels in the blood, there are also other concerns in type II diabetes.
The emphasis in the treatment o f type II diabetes is on the reduction o f chronic
hyperglycemia and the long-term degenerative conditions that are associated with i t 49.
Type I diabetes is associated with absolute insulin deficiency. Hence, treatment
specifically involves insulin injections in the subcutaneous tissues o f arms, legs or
abdomen (IDDM). An intensive regimen o f short-acting insulin before meals, followed
by an additional injection o f intermediate-acting insulin before bedtime are required to
mimic the normal insulin profile in blood and assists in improvement o f the metabolic
profile o f the patient. The patient needs to check his/her blood glucose regularly,
currently by using a finger-prick method, and adjust the insulin dosage accordingly.
Continuous monitoring can help achieve even better glucose regulation. Insulin delivery
using implantable pumps to the peritoneal cavity can further improve metabolic control
for type I patients who are difficult to regulate.
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A combination o f insulin injections and frequent self-monitoring o f blood glucose
(SMBG) have improved metabolic control in type I patients; normoglycemia is difficult
to achieve because subcutaneous insulin injections cannot mimic non-diabetic insulin
secretion patterns. For example, high concentrations o f peripheral insulin are needed to
achieve sufficient insulin concentrations in the portal vein to slow down the production o f
glucose by the liver. Also, short-acting insulin is resorbed much more slowly than insulin
secreted by the beta cells, and there is no feedback control for adjusting the insulin
delivery rates according to the prevailing glucose level.
Yet another approach to improve metabolic control o f type I diabetic patients is
transplantation o f pancreas or isolated islets o f Langerhans51,52’53 The first transplantation
o f pancreas was done in 1967. By the 1970s, due to significant improvement o f the
surgical technique and better control o f immunosuppression and infection post
transplantation,

the

success

rate

o f transplantations

transplantations

o f the pancreas are

carried

greatly

improved.

Today,

out in combination with kidney

transplantation; this procedure has a success rate o f 75%. However, it still remains to be
seen if majority o f the type I diabetic patients will benefit from this procedure; patients
have to be on immunosuppression for the rest o f their lives. There is also a paucity o f
suitable donors. Hence, the American Diabetes Association (ADA) has proposed that
transplantation o f pancreas be considered the appropriate therapy only for type I diabetic
patients with end-stage renal disease who have to plan a kidney transplant or as an
alternative therapy for patients who have a history o f frequent acute and severe metabolic
complications.
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The success rate o f islet-transplantation is only 10% as opposed to 75% for the
combined pancreas-kidney transplantation. This rate results from the rejection o f the
transplanted islets due to the immuno response o f the acceptor site. Also, non-specific
inflammatory responses occurring at the time o f implantation may alter islet function.
The normal procedure for islet transplantation involves isolation o f islet tissue by
collagenase digestion o f the pancreatic donor tissue, then purification o f the tissue
followed by injection o f a sufficient mass o f islet tissue into the hepatic parenchyma via
injection through the portal vein. This procedure requires the use o f a large quantity o f
immunosuppressant; an alternative is to use islets encapsulated in a porous material that
is permeable for insulin and glucose but impermeable to leukocytes. Also, encapsulated
animal islets can be considered as a solution to shortage o f donor islets from humans.
However, though encapsulation makes the cells less vulnerable to immune response, it
does alter the reaction dynamics o f the islets resulting in delayed insulin secretion. This
alteration results from the elongation o f the diffusion pathway to the encapsulated cells
since they are not directly provided by blood capillaries. A potential solution to this
problem is the use o f a solid support for the encapsulated cells that can be placed in the
peritoneal cavity. This placement will hasten the accommodation o f the implant with
blood capillaries and thus reduce the diffusion pathway.

2.2.3 Need for Continuous Glucose-Monitoring
Systems (Glucose Sensors) and Glucose
Measurements in the Interstitial
Fluid (ISF)
The ultimate goal o f glucose regulation regimens should be preferably to achieve
the same degree o f regulation o f blood glucose concentrations as non-diabetics. A new
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milestone in insulin therapy has been achieved by the development o f self-monitoring
devices. A combination o f self-monitoring o f glucose and an intensified insulin regimen
has proved effective in managing the occurrence o f hyperglycemic events. However, the
same cannot be said about hypoglycemia. It has been found that the incidence o f
occurrence o f hypoglycemia increases with tightly metabolic controlled patients.
Hypoglycemic attacks are unpleasant and can lead to loss o f consciousness. Though
hypoglycemia is not restricted to nocturnal attacks, they are especially dangerous because
the patient is asleep and hence unaware o f the low blood glucose levels. A major focus
o f interest for diabetologists is the “hypoglycemia unawareness syndrome” which is
characterized by the occurrence o f sudden and unpredictable hypoglycemia without clear
warning symptoms.
A major drawback o f self-monitoring is the simple fact that current methods are
discontinuous. Most patients are deterred from making multiple measurements because o f
the pain and boredom associated with the procedure and simple dislike because the
patient is forced to confront the disease everytime he/she makes a measurement. Only
highly motivated patients measure their blood glucose more than six times a day, and this
is a miniscule fraction o f the total number o f diabetics. Hence, a continuous glucose
monitoring system would prove to be a boon for diabetics in order to better control
hypoglycemic events. A major factor in the regulation o f blood glucose is the delay time
between the actual change in blood glucose concentration and the glucose measurement;
this delay should be minimized. In a healthy person, a complex series o f events involving
gut hormones and neural factors lead to anticipatory insulin secretion, prior to insulin
secretion from a rising blood glucose level. Hence, a more realistic design for continuous
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monitoring would be a closed-loop glucose sensor for operation in the “non-meal” or
basal periods, with additional insulin delivered at or just prior to the start o f a meal.
Though glucose monitoring had been confined mainly to measurement o f blood
glucose for historical reasons, there are obvious risks involved in inserting a glucose
sensor in the intravasal compartment for prolonged time periods such as embolism,
thrombosis, and septicemia. Hence, currently several methods involve placing the sensor
in the extravascular spaces or the interstitial fluid (ISF). M inimally invasive sensors
measure glucose levels in the ISF (Figure 4), and non-invasive ones measure a composite
o f glucose levels in the intracellular, interstitial, and intravascular compartments54.

arterial

sensor

capillar

venous

Interstitial

°

Fat/muscl

ceii y

Figure 4. A glucose electrode inserted in the subcutaneous tissue to measure glucose
in the interstitial fluid.34
Microcirculation, which is the body’s capillary system performs one o f the most
important functions o f circulation—transport o f nutrients to the tissues and removal o f
cellular excreta. The diameters o f the arterioles are controlled by the local conditions in
the tissues themselves. Capillaries are extremely thin structures with single layered walls
o f highly permeable endothelial cells to permit free interchange o f nutrients and cellular
excreta between the tissues and circulating blood49.
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About one sixth o f the body consists o f spaces between cells containing fluid
called the interstitial fluid. It has solid structures composed o f collagen fibers and
proteoglycan filaments that give it its gel-like constitution. Figure 5(a) shows the
lymphatic system, which represents an accessory route for fluid flow from the interstitial
spaces into the blood, especially for large proteins and particulate matter from the tissue
spaces that cannot be removed by absorption directly into the blood capillary. Though
most o f the fluid filtering from the arterial capillaries flows among the cells and is finally
reabsorbed back into the venous ends o f the blood capillaries, one tenth o f it enters the
lymphatic capillaries instead and returns to the blood through the lymphatic system rather
than the venous capillaries. Though this amount is a minute quantity, it is extremely
important because this route is the only one allowing high molecular weight substances
such as proteins to be reabsorbed into the blood. As shown in Figure 5(b), the walls o f
the lymphatic capillaries have a special structure. The endothelial cells are attached by
anchoring filaments, and the edge o f one endothelial cell overlaps the edge o f the
adjacent cell in such a way that the overlapping end is free to flap inward, thus forming a
valve. These valves can be pushed open by the interstitial fluid, and backflow is
prevented because o f the closing o f the valve.
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Figure 5. The interstitial fluid compartments o f the body, (a) lymphatic system (b)
special structure o f the lymphatic system which allows for transport o f large
molecules
(Source: http://training.seer.cancer.gov/module_anatomy/unit8_2_lymph_compo.html
and www.deeptissue.com/ leam/leam.html)

A prominent volume fraction o f the human skin is interstial fluid (45%), and
blood vessels represent only 5%55. Hence, glucose changes in skin tissue for the most
part represent changes in the extravascular spaces rather than blood glucose. However, in
the adipose tissue, the proportion o f ISF is lower than in the skin and varies according to
the size o f adipocytes. There is constant free and rapid exchange o f glucose molecules
between blood plasma and interstitial fluid. Though there is much debate about the
amenability o f measuring ISF glucose as a measure o f blood glucose, it has been reported
that changes in blood glucose and interstitial glucose are strongly correlated55’50.
However, there is a delay between changes in the ISF and the blood vessels, which can
vary between few seconds to 15 minutes55,56. This delay reduces reliability o f ISF glucose
measurements, and can lead to dangerous situations if blood glucose levels decline to
hypoglycemic values more rapidly than ISF. Also, diabetic patients have altered capillary
walls due to glycosylation o f wall proteins by excess amounts o f glucose, which may
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increase the diffusion barrier and hence the time lag. It also remains to be established as
to how much the intra- and inter-individual variability o f the delay between glucose
changes in the intra- and extravasal compartments typically is. The agreement o f absolute
glucose values between the two compartments is also debatable. It has been reported that
there is 50-100% variation between glucose values in the two compartments55. Hence,
even the percentage o f variation between glucose values in the ISF and blood shows a
wide variability from one region o f the body to another. This variability is mainly due to
local factors determining ISF clearance in different body regions. Finally, the relationship
between the two during non-steady-state conditions, i.e. exercise or postprandially, still
need to be determined.

2.3 Smart Tattoos and the Use of Human Skin for
Implantation of Minimally Invasive Sensors
2.3.1 The Human Skin
The human skin (Figure 6) is divided into two main regions: the epidermis, and
the dermis (which is attached to the underlying hypodermis)57. The epidermis is the most
superficial layer o f the skin, principally composed o f ceils called keratinocytes. It is
composed o f five layers: the stratum comeum, the stratum lucidium (present in areas o f
very thick skin like the palms o f the hands and the soles o f the feet), the stratum
granulosum, the stratum spinosum, and the stratum germinatum. The epidermis is
constantly regenerated. Newly formed cells from the stratum germinatum undergo a
progressive maturing process called keratinization and migrate to the outer layer, the
stratum comeum.
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The dermis is the innermost layer o f the skin. It supports the vascular network that
supplies the avascular epidermis with nutrients. The dermis contains mostly fibroblasts
which secrete collagen, elastin and ground substance that give the support and elasticity
o f the skin. It is made out o f two layers: the outer papillary layer, which contains the
vascular network, and the inner reticular layer, which houses hair follicles and glands
among other things. The hypodermis is a subcutaneous layer o f connective tissue which
connects the skin to deeper structures.
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Figure 6. Cross-section o f the skin.
(Source: http://www.agen.ufl.edu/~chyn/age2062/lect/lect_19/lect_19.htm)
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2.3.2 Optics of the Skin
The structure and chemical composition o f the skin is reflected by the optical
properties o f the skin. As shown in Figure 7, when a beam o f light reaches the skin
surface, a part o f it is specularly reflected (4%) by the surface; the rest o f it will be
reflected and transmitted into the skin (96%). The transmitted light will be scattered and
absorbed by the skin tissue. After multiple scattering, some o f the transmitted light will
re-emerge through the air-stratum interface into the air, which is called diffuse
reflectance. This scattering contributes to a diffuse distribution o f light in the tissue that
extends beyond the boundaries o f the collimated incident beam.
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Figure 7. Tissue Optics- W hat happens to light in the skin
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The amount o f diffuse reflection is determined by both scattering and absorption
properties o f the skin. A back scattered photon from the diffuse part o f the light
distribution that reaches the tissue-air boundary at an angle with the inward normal larger
than the so called critical angle for total reflection, is reflected back into the tissue. A
much smaller diffuse back-reflectance coefficient may be more appropriate for laser
irradiated skin because light close to boundaries may not be perfectly diffuse but more
forwardly directed. After a photon is absorbed by the skin, an electrically excited
absorbing molecule may rapidly return to a more stable energy state by re-emission o f a
photon with lower energy, i.e. fluorescence emission. Autofluorescence is caused by
native fluorophores inside the skin.

2.3.2.1

Tissue Absorption and Scattering. An endogeneous or exogeneous

fluorophore is required for interrogation o f tissue biochemistry and to obtain useful
information from a reemitted optical signal. Endogeneous chromophores are oxy- and
deoxyhemoglobin, melanin, myoglobin, and water. These chromophores are primarily
responsible for absorption o f light in the wavelength region o f 600-1000nm, or the
“therapeutic window,” where tissue scattering predominates over absorption. Because o f
the large absorbance o f hemoglobin and myoglobin at wavelengths <60Gnm and the
predominant absorbance o f water in the IR range (>1000), optical characterization
beyond a millimeter o f tissue is impractical when outside the therapeutic window o f 600lOOOnm. Hence, back-scattering measurements at these wavelengths characterize surface
and subsurface tissues. Typically, endogeneous tissue absorption coefficients range from
0.1 to 10,000 cm '1 from NIR to UV range, and correspond to an optical penetration depth
o f 10cm to 0.1mm before absorption. NIR light can propagate several centimeters, which

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

25

enables one to extract information non-invasively and deeply. The elastic tissue scattering
arises from the microscopic inhomogeneities o f refractive indices between extracellular,
co

cellular, and subcellular components .

W ater is the main tissue constituent o f the skin. Along with many other
components o f the skin, it absorbs MIR radiation very effectively. Hence, in-vivo
penetration o f MIR light is low. However, light in NIR and VIS regions penetrates deeper
into the blood perfused skin layers allowing for glucose monitoring. If tissue thickness is
low, transmission spectra can be recorded, otherwise, only diffusely reflected light
intensity can be used. For the most part, light scattering in tissue is caused by Mie
scattering4. Mie scattering happens when the size o f the scattering particles and the
wavelength o f the light are comparable or o f the same order o f magnitude. This idea has
been illustrated in Figure 8. Mie scattering mainly happens due to the passage o f light
through the boundary between media with different refractive indices. The scattering
properties strongly depend on the ratio o f the refractive indices o f the scattering and the
solute in a suspension. A decrease in the refractive indices o f the scattering particles
causes a decrease in the scattering and vice versa. The scattering suspension becomes
optically transparent when there is a perfect match o f both the refractive indices.
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2.3.3 Tattoos and Smart Tattoos
As discussed in the previous section, the skin is divided into three basic areas,
epidermis, dermis, and the hypodermis. The epidermis constantly renews itself from the
bottom up; new skin cells are created by stem cells at the bottom o f the epidermis,
pushing the older cells up towards the surface. The cells at the surface are the oldest, and
they die and flake off. Hence, for a tattoo to be permanent, ink must be poked deeper into
the skin, past the basement membrane and into the dermis. Ink molecules are too big and
so unlike other foreign objects that are hauled away by leukocytes, the ink molecules can
remain in the dermis for decades. The process has been illustrated in Figure 9. Tattoos
are usually inserted in the skin’s dermal layer with needles.
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Figure 9. Process o f tattooing.
(Source: http://www.cockeyed.com/science/tattoo/tattoo.html)
The concept o f “smart tattoos” to monitor blood glucose was proposed as a
minimally-invasive method for improved metabolic control in diabetics. Polyethylene
glycol (PEG) beads coated with fluorescent molecules are injected beneath the surface o f
the skin, and the glucose in the ISF interacts with the fluorescent molecules o f the
sensors. When the glucose concentration is low, the tattoo is highly fluorescent; when the
concentration increases, the glucose binding causes displacement o f fluorescent
molecules, and the overall fluorescence o f the tattoo decreases.
The excitation and detection system consists o f a fiber optic probe containing
fibers for delivery o f excitation light and collection o f emission light or some other
appropriate optical system that can be held to the skin at the implantation site.
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2.4 In-vivo Glucose Sensing: Totally Implanted, Minimally
Invasive, Non-invasive Monitoring and
Fluorescent Sensing Techniques
2.4.1 Totally Implanted Sensors
Needle-type sensors implanted transcutaneously for a short term have been found
to be unstable because acute inflammation resulting in cellular accumulation, changing
protein and fluid composition at the site o f implantation results in variable glucose and
oxygen concentrations. Long term implantation, on the other hand, was found to be a
more stable sensing environment after an encapsulating foreign body response. Glucose
sensors implanted in the subcutaneous tissues o f dogs were inactive for the first few days,
unstable for the next 7-14 days after which they became relatively stable for the next
several weeks; the stability was insufficient for satisfactory clinical use59,60.

2.4.2 Minimally Invasive Techniques
2.4.2.1

Transdermal M ethods. Transdermal methods are based on removal o f

interstitial intradermal fluid (ISF) across the skin, thus avoiding penetration o f the
skin61,54. Reverse iontophoresis is a popular method that is being used in a commercially
available glucose sensor, GlucoWatch, (Cygnus, Redwood City, CA, USA). In this
device, a low current is applied to the skin to drag ions through the skin, thereby
extracting ISF across the skin. Small amounts o f glucose (1/1000 o f blood levels) are also
transferred with the fluid. Feasibility studies have shown that acceptable results for
accuracy o f measured glucose levels can be obtained from 40 to 400 mg/dl. However, the
glucose oxidase reaction used to measure glucose must be pushed to its limits for
accurate measurements due to the small quantities o f glucose available. Also, the system
needs a three hour warm-up period and can provide up to three glucose readings per hour
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for 12 hour after a single-point calibration with a conventional self-blood glucose
measurement54. The current applied to the skin can cause a mild to moderate skin
irritation that clears within 3-27 days, and the reliability o f the device is questionable
during sweating and varying degrees o f skin hydration.
Other methods involve using transdermal patches (TCPI, Fort Lauderdale, FL, USA)
with permeation enhancers. The patch is placed on the skin for five minutes, after which
time a meter is placed in the tabbed area o f the patch to take a spot glucose reading. Yet
another method involves application o f ultrasound to increase skin permeability resulting
in an increase in transdermal glucose flux60.
2.4.2.2

Electrochemical Methods and the Glucose Electrode. In the 1980s,

biosensors were among the most promoted technologies both by researchers and industry,
and were touted to have significant clinical applications62. Reagentless probes or
“biosensors” for measuring glucose in vitro were first mentioned in the 1960s63, and it
was in the early 1970s64 that glucose sensors were first tested in vivo in animals.
Figure 10 shows one o f the most studied type o f glucose sensors called
“amperometric enzyme electrodes”. Glucose oxidase is immobilized by chemical crosslinking at a charged electrode, and glucose changes are monitored by the change in
current flow caused by the enzyme catalyzed production o f hydrogen peroxide65,66’67 or
by the consumption o f oxygen68. The electrode itself is constructed o f two different
metals with an insulating material between them. A modified enzyme electrode is now
being used in most commercial devices for self monitoring o f finger prick samples for
blood glucose concentration (MediSense)69. Sensor configuration usually comprises a
fine needle or flexible wire, the active sensing element being at the tip; it is implanted in
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the subcutaneous tissue. Such an implantation is regarded “minimally invasive,” and it
avoids septicaemia, fouling and blood clot, and embolism associated with intravascular
placement62.
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Figure 10. Typical construction o f an electrochemical/amperometric
electrode62.

Although there have been encouraging test results with needle type sensors in
animals and humans65,70 clinical development has been slow. The sensor output in vivo is
suppressed by a variable amount compared w ith the in vitro signal at the same glucose
concentration, requiring careful calibration procedures71. Also, there is an unpredictable
72

drift in output over time . Since the exact cause o f these erratic responses is unclear, a
rational modification o f the design has been precluded. Presently, evidence points
towards a reversible coating o f the implanted sensor or a diffusion o f low molecular
weight inhibitors into the sensor; the chemical nature o f the interference is still unclear62.
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2.4.2.3

Microdialysis. Microdialysis has been the most popular among the tissue

sampling methods,

which has undergone considerable testing in humans60,73. It presents

a possible alternative to the implantable and transcutaneous measurement methods, which
have biocompatibility problems. Microdialysis imitates capillary function4. The
procedure involves insertion o f a semi-permeable dialysis fiber into the subcutaneous
tissue and perfusion o f the fiber with isotonic glucose-free fluid. Due the concentration
gradient, glucose diffuses from the interstitial fluid through the dialysis membrane into
the perfusate. By including a glucose sensing mechanism outside the body in the path o f
the perfusate, the glucose concentration can be measured continuously.
This method is advantageous in that a foreign body reaction is avoided and hence
continuous monitoring without a pronounced signal drift is possible. A significant
disadvantage, especially because applications such as continuously monitoring o f brain
analytes mandates the use o f a method that can rapidly detect transient changes in
concentrations, is that there is an inherent time lag o f 5-45 minutes associated with this
technique74. This delay depends on the length, the inner diameter o f the tubing, and the
perfusion flow rate selected (between 0.1 and lOpl/min). This method also requires re
calibration at least once daily. Also, the procedure may buffer transient changes75, is
imprecise because the dialysate concentration with respect to those in the body
concentration never reaches 100% (the ratio depends on instmmental variables such as
perfusion rate, surface area, and molecular weight cutoff o f the membrane, and
physiological factors such as temperature, analyte species, anlayte metabolism etc.), also
the sampling procedure may cause a depletion o f the analytes and hence is an
underestimation

of

the

concentrations.

Although

incorporation
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fluorescence

(LIF)

detection76,

and

have been suggested to improve temporal resolution,

none are commercially available to date for in vivo applications.
2.4.2.4

Fiber and Submicron Fiber Probes. Fiber optic probes for glucose sensing

based on both glucose oxidase and competitive binding assays have been developed by
no

O ')

various groups o f researchers ' . The sizes o f these fiber probes range from millimeter
to submicron diameter. The sensing chemistry is immobilized at one end o f the fiber, and
a light source and detector are connected to the opposite end. The larger probes suffered
from disadvantages such as limited spatial resolution and sensing applications due to size.
Also, the response time and sensitivity are reduced because methods o f immobilization o f
sensing chemistry increase diffusion lengths. These problems were alleviated by the
development o f submicron fiber-optic probes. However, these probes still had a limited
lifetime (4-6 days) because o f the loss o f sensing chemistry from the immobilized
polymer matrix.

2.4.3 Non-Invasive Sensing Techniques
The human skin allows penetration o f light up to some centimeters into the skin only
in the near infrared region (NIR, 600-13QQnm)- the so called “optical window.” Above or
below this optical window, light is absorbed by water, skin pigments, or blood within the
outer layers o f the skin84; primarily, light in the NIR region can penetrate to the deeper
blood-perfused skin layers, potentially allowing glucose monitoring.
Some o f the other technologies which are at the preclinical stage and have not yet
been established as precise methods are polarimetry, far infrared radiation spectroscopy,
oe

on

radio wave impedance, and pulsed photoacoustic spectroscopy ’ ’ .
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2.4.3.1

Spectroscopic Techniques. Glucose shows a characteristic absorption

spectrum called “fingerprint” when a light beam is directed through a cuvette with a clear
solution (otherwise, light scattering causes an additional attenuation o f light) of glucose
in water. Spectrophotometry, which is a well established method for quantification o f
solutes in liquids, is based on solute-specific absorption bands in the visible (VIS), near
infrared (NIR) or mid infrared (MIR) spectral range. Using this method, solutes are
quantified by determination o f light attenuation caused by absorption at a single
wavelength (taking light path length into account).

Hence, using high performance

spectroscopic equipment in combination with sophisticated mathematical calibration
procedures, ex vivo quantification o f glucose in complex matrices such as plasma, serum,
DO

or whole blood is possible using this approach . MIR radiation is particularly appropriate
for this purpose because glucose exhibits specific absorption bands in this region. In vivo
measurements in the skin, however, are difficult to make using M IR because o f
absorption by water. Hence, the in vivo penetration depth o f M IR light in the skin is
low89. Light in the NIR and VIS regions penetrates into deeper blood perfused skin layers
and provides an optical window for glucose monitoring. However, glucose does not
exhibit specific absorption properties in this region.
Despite more than 25 years o f research, patents and publications, the major
challenge with this approach has been to achieve sufficient precision within the clinically
relevant blood glucose range over prolonged periods o f time90. The various problems
associated with optical spectroscopy have been 1.) glucose has no specific absorption
pattern in the near infrared region; 2.) low glucose concentration occurs in the tissue; 3.)
scattering greatly reduces the absorption signal; 4.) high concentrations o f other light
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absorbers such as water interfering with the signal; 5.) light absorption depends on
temperature; 6.) heterogeneous distribution o f glucose occurs in different tissue
compartments, 7.) light absorbing structures are heterogeneously distributed in the skin.
Due to these reasons very small and unspecific changes in the absorption spectra can be
seen by changes in blood glucose.
2.4.3.2

Scattering. The major optical interaction mechanism in tissue is light

scattering, caused by different structures in skin tissue such as cell membranes, cell
organelles, collagen fibers. A photon in the NIR range is more likely to be scattered than
absorbed in tissue because in this range, the wavelength o f light is comparable to the size
o f the scattering structures. “Mie scattering” is the principal scattering mechanism that
takes place in tissue when the size o f the scattering particles (cell membranes, collagen,
organelles, etc.) is comparable with the wavelength o f light. The human skin comprises a
turbid system, and the scattering o f light depends on the ratio o f the refractive indices o f
the particles to the solution. Each change in the ratio o f the refractive indices o f the
scattering particles and solute leads to a variation in the “transparency” o f the tissue54.
When blood glucose increases, there is a subsequent rise in the refractive index o f blood
and ISF (solution), whereas the refractive index o f scattering particles in the skin is not
changed91,92. Thus, the ratio is reduced and so is scattering. Thus, since the proportion o f
light scattered in the skin is slightly lower, the intensity o f light reflected back into the
skin is also lower.
The sensitivity o f this method o f glucose monitoring (based on light scattering
properties o f the human skin) is small in absolute terms but was found to be much higher
A-2

than those due to glucose-specific light absorption in the NIR region . This method does
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not measure glucose concentration per se, but derives glucose concentration indirectly
from glucose-induced changes in the refractive indices o f components o f the human skin.
Hence, other blood analytes and physiological factors, such as shifts in the water/plasma
distribution between the intra- and exfravasal compartments, may influence the scattering
coefficient. Due to a significant variability o f the baseline scattering coefficient, in vivo
calibration o f the scattering signal with respect to the prevailing blood glucose is required
at regular intervals.
2.4.3.3

Fluorescence Techniques. Numerous glucose-sensing mechanisms based

on fluorescence spectroscopy have been proposed and are advantageous because o f their
inherent characteristics o f specificity and sensitivity.

Numerous fluorescence-based

optical sensors have been developed94'96; most use GOx for oxidation o f glucose, and the
fluorescence intensity is measured as a function o f dissolved oxygen concentration. For
oxygen sensitive dyes that exhibit quenching o f fluorescence in the presence o f oxygen,
the relationship between the fluorescence intensity and oxygen concentration is given by
the Stem-Volmer equation:
I / I c = 1 + K [0 2 ]

(1)

where 70........fluorescence intensity o f the sensor in absence o f oxygen,
Ic
K

fluorescence in a given dissolved oxygen concentration [O2 ],
.Stem-Volmer quenching constant.

Some o f the advantages o f optical sensing schemes over electrochemical schemes
are absence o f electrical connection to the subject and potential for simultaneous multi
analyte sensing using spectroscopy. The rapid development o f optical communication
systems has produced cheap and reliable sources and detectors.
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disadvantages are the limited penetration depth o f the optical signal due to scattering and
absorption by the human skin tissue, and difficulty in calibrating changes in optical
signals due to changes in analyte o f interest.
Fluorescence measurements are particularly useful for totally implanted sensors,
particularly by using NIR dyes (dyes that are excited and emit in the NIR region). Light
in the NIR region can penetrate through several centimeters o f tissue and hence; NIR
probes implanted in the subcutaneous tissue can be excited and interrogated from outside
the body more efficiently, as they are less affected by interference from scattering or
absorption by water or other components in the skin (collagen, organelles, membranes
etc.). Also, lifetime measurements are advantageous over measurements o f fluorescent
intensity because lifetime measurements are less affected by changing concentrations o f
the fluorescent label, photobleaching or light scattering in the tissues.
The following is an overview o f the types o f fluorescent sensing mechanisms that
can be used when a certain combination o f glucose receptor/enzyme and indicator can be
co-immobilized. The items in the overview have been segregated on the basis o f
receptor/enzyme type and further subdivided into various transduction mechanisms.
Finally, there is a section on some o f the immobilized fluorescent sensing techniques
currently being researched.
2.4.3.3.1
Fluorescence Resonance Energy Transfer (FRET) and Competitive
Binding Sensors. Fluorescence resonance energy transfer (FRET) is based on the transfer
o f excitation energy from one fluorescent molecule (donor) to a nearby molecule
(acceptor) that has overlapping spectral properties. Changes in fluorescence intensity or
lifetime give an estimate o f the changing distance between the donor and acceptor.
Shultz97 demonstrated the basic principle o f this system as illustrated in Figure 11.
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Figure 11. Illustration o f a FRET-based competitive binding glucose sensor62

Concanavalin A (Con A) was used as a receptor for competing species o f FITC
labeled dextran and glucose. TRITC-Con A binds with the FITC-dextran in the absence
o f glucose, excitation o f FITC results in TRIC emission due to FRET. W ith the increase
in glucose concentration, FITC-dextran is displaced by glucose causing increased FITC
emission. FRET systems for glucose sensing in vitro have also been developed using NIR
fluorescent molecules coupled with Con A29.
Unlike the sensing scheme using glucose oxidase, there is no consumption o f
substrates or production o f byproducts in the competitive-binding scheme. However, it is
debatable whether the sensing scheme involving the Con A-dextran system is
reversible98.
2.4.3.3.2

Boronic Acid Receptor Based Fluorescence Sensing. Synthetic boronic

acid derivatives are able to complex glucose rapidly and reversibly by means o f covalent
*

99

interactions . Synthetic receptor 1,2- anthrylbronic acid was used, with the boronic acid
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moiety being responsible for the binding o f glucose, and the anthracene moiety for the
transduction o f the fluorescent signal. The major disadvantages o f this system are small
analytical signal, poor selectivity in the order- D-fructose>D-allose>D-galactose>Dglucose, and the ability to work only in basic media (pKa o f 2-anthrylbronic acid =8.8).
The pka (4.8) o f the boronic acid receptor was improved by introducing a tertiary
amine in the proximity o f the boronic acid m oiety100. This improvement lead to the use o f
another phenomena, photoinduced electron transfer (PET) for transduction o f the
fluorescent signal. The fluorescence signal is quenched by the nitrogen atom via PET in
the absence o f glucose. Upon binding o f glucose, PET from the nitrogen to the
fluorophore is suppressed, which “switches on” the fluorescence signal o f anthracene.
The selectivity o f the synthetic receptors towards glucose was also improved by a
designed alignment o f the two boronic acid moieties. The following selectivity was
presented by this arrangement with the binding constants presented in paranthesis: Dglucose (3981 M_1)> D-allose (630 M ‘!) > D-fructose (316 M_1)> D-galactose (158 M’1).
However, all these improvements do not really favor the use o f this form o f the
acid for physiological applications due to the limited solubility o f the receptors. This
situation, too, was improved upon by Norrild et al by developing the ionic receptor101.
This modification however, reduced the sensitivity o f the system. Another aqueous
soluble system was introduced by another group102 . It comprised o f two distinct parts, a
pyranine playing the role o f the fluorescent transducer and a discrete diboronic acid
receptor. A dual-fluorescence system was designed by Heagy et al which displayed two
emission bands (430mn and 550nm) after excitation at 370nm103. It, however, had limited
sensitivity at physiological glucose levels.
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Lifetime based sensing was introduced by Lackowicz’s group using phasemodulation methods. Upon interaction o f the boronic acid receptor w ith glucose, there is
a shift toward low-modulation frequencies indicating longer mean lifetim es104. The same
group is working on a glucose sensing contact lens for ex vivo glucose monitoring105.
They designed boronic acid based receptor which was found to respond to physiological
tear glucose within disposable contact lens. Even though it showed comparable
selectivity for both glucose and fructose, the authors state that the interference for such an
application was minimized due the fact that concentration o f fructose is tenfold lower
than glucose.
2.4.3.3.3

Lectin-Based Fluorescence Sensing. Concanavalin A (Con A) is a plant

sugar-binding protein which is mannose and glucose specific. It has been used in
numerous

fluorescence

resonance

energy

transfer

(FRET)

glucose

sensing

mechanisms106. In this work, two sets o f dextran polymers, one labeled w ith rhodamine
and the other with fluorescein, were used. In the absence o f glucose, a multivalent lectin
interacted with the dextrans o f both types o f polymer beads bringing them close together.
FRET occurs due to the close proximity o f the two fluorescent labels. These affinity
sensors are based on fluorescene quenching o f the donor emission by FRET. When a high
concentration o f glucose is added, the lectin binds to glucose instead and as a result the
FRET decreases. Other work involves using TRITC-apo-GOx instead o f Con A with
FITC-dextran107.
The attachment o f ruthenium to Con A to form a metal-ligand complex (RuCon
A) permits the selective detection o f glucose. This method o f detection involves using a
FRET based system with RuCon A as the donor and maltose-insulin-malachite green
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(MIMG) complex as the acceptor. The maltose offers the affinity o f an acceptor for
ConA. The method utilizes the long lifetime o f ruthenium, and changes in the decay time
o f the complex due to the presence o f glucose can be measured . Frequency domain
intensity decays showed a decrease in in the average lifetime o f the RuCon A emission,
which was attributed to energy transfer. Steady-state fluorescence measured for 2juM
RuCon A and 4 fxM M IMG demonstrated a consistent increase in the RuCon A emission
signal as the glucose increased up to 150mM.
Another sensing mechanism used has addressed donor/acceptor distribution in
FRET assays. The donor-acceptor distribution function was assumed to remain
unchanged throughout a monitored FRET process (glucose sensing).

Structural

information can be obtained by measuring the fluorescent decay with nanosecond
resolution, called distribution sensing. The donor/acceptor distribution changes were
calculated at a single Forster radius for glucose concentrations ranging from 0-3 OmM .
2.4.3.3.4

Glucose Sensing Based on GBP (Glucose Binding Protein) Fluorescence

Sensing. Proteins can be used as biorecognition elements because protein-based
biomolecular recognition events are normally accompanied by conformational changes o f
the protein due to binding with the ligand. Reporter groups can be introduced into the
protein structure, which respond to ligand binding. Also, a pair o f fluorophores can be
arranged on selected sites o f the protein to allow detection o f ligand binding by energy
transfer.
GBP is a glucose/galactose binding protein that has binding affinity for glucose in
the micromolar range. The protein has two conformations, an “open” conformation where
the domains are far apart and a “closed” conformation where they come together. Thus,
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biosensing involves monitoring conformational changes that occur when proteins and
ligands bind to each other. Incorporation o f a fluorescent reporter near the ligand-binding
site allowed sensing glucose due to conformational changes when the GBP binds glucose.
The labeled GBP mutant was found to be stable at 37°C for over three months, and the
secondary structure o f the protein is stable up to 64°C. Hence, this system was claimed to
be as an ideal system for in vivo monitoring o f glucose108’109.
2.4.3.3.5

Other Protein Based Fluorescence Sensing. Thermostable proteins that

are isolated from bacteria are active at room temperature and do not lose activity at shelf
temperature; e.g., BSGK is a thermostable glucokinase isolated by Lakowicz’s group and
can be used to as a binding protein to develop a sensor for the substrate. This
development is done in the absence o f ATP whereby it does not convert hexose to
hexose- 6 -phosphate (utilizing ATP).
Among the different sensing mechanisms that have been cited so far, FRETbased sensing mechanisms and those involving monitoring GBP conformational changes
seem most promising. FRET-based sensing mechanisms do not require any referencing
system for calibration, they have been shown to be linear in the physiological range with
good response times, and analyte consumption can be avoided by using FAD deactivated
enzymes. A variety o f donor-acceptor pairs with long Stokes shifts are available. By
using NIR fluorophores, the sensor can be made amenable to skin tissue measurements.
GBP can be used by incorporating a wide variety o f reporter groups at appropriate
sites on the protein. Again, either intensity changes or FRET changes can be monitored
with changes in conformation o f the protein as it binds the substrate. Genetic engineering
o f GBP has made it possible to produce more robust forms o f the protein. Also, with

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

42

genetically engineered GBPs, detecting perturbations in glucose homeostasis by
monitoring glucose measurement in living cells with temporal and cellular resolution is
possible. Mutants can be engineered with varying binding constants to sense different
concentrations o f glucose at different locations in the body. For example, Formmer et
al 110 have developed GBP labeled with a FRET pair with a binding affinity o f 0.17uM for
glucose to monitor cellular glucose. Yet another mutant has a glucose binding constant o f
0.59uM and can monitor physiological glucose (0.07-5mM)109.
2A 3.3.6

Enzyme

Based-

Glucose

Oxidase,

Hexo-

and

Glucokmases.

Apoenzymes Fluorescence Sensing. Glucose oxidase (GOx) catalyzes the conversion o f
D-glucose and oxygen to D-glucono lactone and hydrogen peroxide. The detection o f
oxygen consumption, hydrogen peroxide production, or local pH change has been widely
used in the development o f GOx-based glucose sensors. GOx has been used in numerous
biosensors due to its high selectivity over other sugars to glucose, ex vivo enhanced
enzyme stability, and low cost.
This inner filter effect between FAD and GOx-FC (GOx is labeled with
fluorescein) can be used as a transduction mechanism111. The molecular adsorption o f
FAD overlapped with the molecular adsorption o f GOx-FC (creating the inner filter
effect) but not with that o f FADH 2 . This inner filter effect is canceled in the presence o f
glucose due to conversion o f FAD to FADH 2 , increasing the fluorescence o f GOx-FC.
However, this method is found to be insufficient in terms o f sensing the physiological
range o f glucose values.
Among the various transduction mechanisms o f glucose oxidase-based optical
sensors, the sensing o f oxygen consumption by using an oxygen-sensitive dye, or use o f
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pH sensitive polyacrylamide polymer gels which were fimctionalized with fluorescent
dyes have been reported

112
. Also a number o f fiber-optic probes for pH sensing

applications have been developed113,114. However, to date, there have been few reports o f
the use o f pH sensitive ratiometric dyes for measurement o f glucose. Pyrene 8 -hydroxy1,4,6-trisulfonylchloride (HPTS), is a pH indicator dye that has been used by several
groups to demonstrate pH sensitivity in thin films46,47. It has numerous advantages such
as large Stokes shifts, high quantum yield, high absorbance, excellent photostability and
lack o f toxicity45.
Some o f the other pH sensitive dyes that have been used to demonstrate pH
sensitivity in thin films are pyranine115, which is based on the analyte causing a
wavelength shift in the excitation and emission spectrum; the amount o f analyte can thus
be correlated with the ratio o f fluorescence intensities at the two wavelengths. Other pH
sensitive probes include Benzo[c]xanthenes such as carboxy seminaphthorhodarfluors
(SNARFs) and carboxy seminaphthofluoresceins (SNAFLs), which are long wavelength,
dual emission dyes and can be excited in the green region116. All o f these have been used
in fiber-optic configurations for pH sensing and not for glucose sensing. But with the
incorporation o f GOx, they can potentially be used for glucose sensing. The main
disadvantage in using pH sensing mechanism is that it is subject to interference from
global pH changes and local pH changes due to factors other than the glucose-sensing
reaction. In order to overcome this problem, in addition to sensing pH changes due to
oxidation o f glucose, pH changes due to other reasons need to be monitored
simultaneously. This can be achieved by using sensors incorporating pH-sensitive dyes
with spectral properties different from those used in the glucose sensor without co-
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immobilizing GOx or other enzymes which catalyze the oxidation o f glucose; a
combination o f these, together with the glucose sensors will help differentiate between
pH changes due to glucose oxidation and otherwise.
To monitor oxygen consumption, an oxygen sensitive fluorophore (ruthenium
(II),4,7-diphenyl-1, 10-phenanthroline)-dodecylsulfate- Ru(dpp) or Ru[dpp(S 0 3 Na) 2 ]3 Cl2
) has been used by some groups23,26. The basic principle is the monitoring o f quantity o f
oxygen consumed by the enzymatic reaction. The excitation and emission wavelengths o f
the dye are 465 and 610nm, respectively. The drawback is that they should be
accompanied by an oxygen sensor to compensate the partial oxygen pressure variations
from sample to sample and during the continuous monitoring o f glucose.
In the case o f hydrogen peroxide based sensors, not much work has been reported
in optical sensing o f hydrogen peroxide produced during glucose consumption by GOx.
M ost references to H 2 O 2 sensing have been with respect to amperometric sensors. Some
work has been done regarding fiber-optic biosensors for H 2 Q 2 and glucose117. Arnold et
al have developed two different configurations. In the first biosensor used homovanillic
acid as the substrate; the H 2 O 2 diffused across a microporous PTFE (Teflon) membrane
and entered an internal solution o f the substrate and horseradish peroxidase (HRP) and
the fluorescence o f a dimeric product formed was monitored as a function o f time118. The
rate o f the fluorescence intensity was related to the H 2 O 2 concentration in the sample. In
the

second

configuration,

the

substrate

was

luminol

and

the

HRP-catalyzed

chemiluminescent reaction between hydrogen peroxide and luminol produced light,
which was measured and related to the HPR concentration. The second configuration
produced faster response times and lower limits o f detection. The resulting H 2 O 2
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biosensor was used as an internal sensing element o f a glucose biosensor by
immobilizing GOx on the outer surface o f the gas-permeable m em brane159.
Sukhorukov et al 16 reported the use o f an Amplex red reagent to visualize the
localization of the active enzyme into microcapsules produced by LbL assembly o f
biodegradable polyions, dextran sulfate, and protamine on MF cores, followed by
dissolution o f the core. In the presence o f peroxidase (HRP), Amplex Red reacts with
H 2 O2 in a 1:1 stoichiometry to produce red-fluorescent resorufin (ex 563nm and em
587nm). Though this scheme was not used to sense glucose, it could be applied in the
following way. By co-encapsulation o f GOx, HRP and Amplex Red, the changes in
fluorescent emission o f the dye can be monitored with changes in glucose consumption
by GOx resulting in production o f H 2 O 2 .
Researchers from the University o f Illinois at Urbana-Champaign 120 have created
a near-infrared nanoscale glucose sensor by using carbon nanotubes as the fluorescent
indicators. This sensor was fabricated by assembling a monolayer o f GOx on the surface
o f nanotubes and then functionalizing the surface with ferricyanide (an ion sensitive to
hydrogen peroxide). When glucose encounters GOx, hydrogen peroxide is produced,
which reacts with ferricyanide to modulate the electronic structure and optical
characteristics o f the nanotube and cause it to fluoresce in the NIR region, which is very
advantageous for measurements from deeper tissues or blood. The more glucose that is
present, the brighter it will fluoresce. However, carbon nanotubes have been proven to be
toxic121.
Glucokinases in the liver and Hexokinases in most other cells are responsible for
phosphorylation o f glucose by utilization o f A TP122. Hexokinases, unlike glucokinases,
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have a broad specificity and are sensitive to D-mannose, D-fructose, sorbitol, and Dglucosamine in addition to glucose

’ . Glucokinases, unlike hexokinases, are

insensitive to inhibition by glucose-6 -phosphate and can respond to changes in glucose
concentration in the physiological range125. Hexokinases, on the other hand have a Km o f
0.1mM and get 95% saturated at 5mM glucose; a further increase in glucose does not
significantly affect glucose binding. Hence, hexokinase is ruled out as a possible glucose
sensor. Only a few species, especially bacteria, are known to contain true glucokinases,
1.e., enzymes specific for glucose126. However, glucokinases with true glucose specificity
are not easily available and are, therefore expensive.
An insignificant amount o f work has been done in the use o f hexokinases and
glucokinases for glucose biosensing applications

197 198 190

’ ’

perhaps due to high cost and

lack o f availability. However, if recombinant forms o f these enzymes could be produced,
it may aid in mass production and hence decrease in cost. One group has reported (though
the work has not been published yet) the use o f a conformational change in heterokinase
on glucose binding, and the optical monitoring (intrinsic fluorescence or FRET) o f this
change, both in solution and after entrapment, in a sol-gel matrix. The intrinsic
fluorescence has been attributed to tryptophan (ex 290nm, em 330-340nm); it decreased
with increasing glucose concentration. Also, extrinsic covalent labeling o f the enzyme
with RBITC (donor) and Cy5.5 (acceptor) led to changes in FRET with changes in
glucose concentration130.
D ’Auria et al presented an approach for reversible GOx fluorescent sensors by
using apo-GOx (obtained by removal o f FAD, which still binds glucose with comparable
affinity to that o f the holoenzyme, but does not consume glucose)24. Apo-GOx interacts
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non-covalently with the fluorophore ANS ( 8 -anilino-1-napthalene sulfonic acid) with
excitation wavelength at 325nm and emission at 480nm. The fluorescence intensity and
mean lifetime o f ANS decrease with an increase in glucose concentration. These give
reversible sensors; however, the dynamic range o f the sensors was not found to be
satisfactory.
The same group demonstrated a similar mechanism with glucose dehydrogenase
(GD)131. The main advantage o f the apoenzyme sensors is that there is no consumption
o f the analyte and no formation o f byproducts such as gluconic acid and hydrogen
peroxide, which may cause inflammatory responses in the body.
Hence, an ideal system for glucose sensing m ust not consume analytes, is non
toxic, is unperturbed by changes in local oxygen or pH, and yet has the range and
sensitivity to measure physiological glucose changes. If glucokinases can be mass
produced by DNA recombinant technology, which will also reduce the cost, then it may
be ideal to label it with a FRET donor-acceptor pair o f N IR dyes (cy5 and cy5.5). In the
absence o f ATP, glucose is not consumed (phosphorylated), and there are no reaction
products. Since the transduction mechanism has nothing to do with sensing changes in
oxygen or pH, it is not prone to interference due to random changes in oxygen partial
pressure or pH. It has also been reported that glucokinases can respond to changes in
glucose in the physiological range.
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2.5 Immobilization Methods for D yes and
Enzymes Used in Optical Sensors
2.5.1 Fiber-Optic and Non-Fiber
Optic Immobilization Methods
The early use o f fluorescent probes involved injection o f liquid fluorescent
indicator dyes into the sample and analysis using a spectrometer or microscope. This
procedure has numerous disadvantages including toxicity to the biological sample,
compartmentalization o f the dye and leakage over time, and hence requires reintroduction
o f the dye. For these reasons, sensor systems involving immobilization o f the dye using
microelectrodes
developed

1 “XO 1 '3 1 1 ' XA

’ ’

and

special

sub-micron

fiber

optic

probe

tips

have

been

. Encapsulation o f enzymes is primarily aimed at using a semi-

permeable support matrix to entrap the enzyme, prevent its leaching out o f the matrix,
while allowing exchange o f analytes, products and co-factors between the encapsulated
enzyme and the surroundings 135 .Liposomes136, microspheres prepared by microemulsion
| •> '7 -i fv

techniques

’ , and silica matrices

are among the various carrier systems used for

various chemicals, drugs and biomacromolecules. Medical applications o f such microand nanocontainters include using them as protective shells for cell and tissue
encapsulation or as carriers for drug-delivery.
Among the non-fiber optic micro and nanosensors are the probes encapsulated by
biologically localized embedding (PEBBLEs), ranging in sizes from 20 nm to 200 nm in
diameter that have been developed by the Kopelman group at the University o f Michigan.
Microemulsion techniques were used to fabricate these probes, which consist o f a
polymer matrix containing dyes and/or enzymes. The main advantages o f these sensors
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are protection o f the dye from the environment and vice versa, ability to immobilize
multiple dyes for multianalyte monitoring and ratiometric monitoring, a good correlation
between in vitro and in vivo calibrations, and a biocompatible surface provided by the
polymer matrix. Though PEBBLEs have been used for intracellular monitoring (pH 138,
glucose138, sodium139, calcium142, zinc540, oxygen141, potassium142), they have a few
significant disadvantages. There is no guarantee o f uniformity from sensor to sensor
within the same batch and from batch to batch fabricated using the same process, due to
the nature o f the emulsion process. Another problem is leaching o f the encapsulated
chemistry over tim e143. Since, PEBBLEs are typically less than 200nm in diameter, they
are useful for intracellular monitoring but unsuitable for use as “smart tattoos” because
the size o f implants plays an important role in phagocytosis144. Implants or substances in
particulate form are o f a size that can easily be phagocytosed by macrophages.

2.5.2 Laver-bv-Layer Assembly (L b L )
Electrostatic layer-by-layer self-assembly (LbL) has been employed for highly
controlled assembly o f charged polyions (polymers), nanoparticles, proteins, dyes and
other supramolecular species onto arbritrary sufaces o f any shape and size. It is possible
to design ultrathin ordered films in the range o f 5 to 1000 nm, with precision better than
Inm, and a definite knowledge o f their molecular compositions. The method consists o f
alternate depositon o f oppositely charged polyions after re-saturation o f the terminal
charge after each layer is deposited. The forces governing spontaneous assembly o f
layers are primarily ionic and covalent in nature; however, they can also include
hydrogen bonding, hydrophobic, and other types o f interactions. This idea also implies
that there are no major restrictions on the choice o f polyelectrolytes.
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There have been numerous reports demonstrating assembly o f polyions and
dyes145' 148, viruses and charged nanoparticles149’350, and organized protein multilayers on
charged substrates. Proteins have been assembled by alternate electrostatic adsorption
with

positively

charged

polyions

such

as

polyethyleneimine

(PEI),

poly

(allylaminehydrochloride) (PAH), poly(dimethyldiallyl ammoniumchloride) (PDDA),
and chitosan or with negatively charged PSS, DNA, and heparin. Proteins are maintained
sufficiently charged under experimental conditions by setting the protein solution pH
apart from the isoelectric point. There are numerous references to assembly o f water
soluble proteins in alternation with oppositely charged polyions, including cytochrome c
and P450, lysozyme, histone type YIII-S, myoglobin (Mb), pepsin, horseradish
peroxidase (POD), hemoglobin, glucoamylase (GAM), concanavalin A (Con A),
albumin, glucose oxidase (GOx), catalase, invertase, diaphorase, acteriorhodopsin, and
immunoglobulin IgG151"154.
The pioneering work o f Her155 first demonstrated the principle o f film formation
by alternate adsorption o f charged colloids and proteins; a related method was later
introduced for film assembly by alternate adsorption o f linear polycations and
polyanions145"150. This method has been illustrated in Figure 12. Polyions are used at pHs
that ensure a high degree o f ionization.
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Figure 12. Schema o f layer-by-layer film assembly on flat solid supports
(Source: Dissertation, Mengyan Li. 2003)
A negatively charged solid planar substrate is immersed in a solution o f cationic
polyelectrolyte, thus adsorbing a layer o f polycation.

Since a relatively high

concentration o f polyelectrolytes is used, a number o f ionic groups remain exposed, thus
reversing the surface charge and preventing further polycation adsorption. The substrate
is then rinsed and immersed in a solution o f anionic polyelectrolyte. The adsorption o f
the anionic polyelectrolyte layer reverses the original surface charge.
Various templates have been used for the fabrication o f microcontainers such as
polystyrene, melamine formaldehyde (MF) 156’157’158, metal particles159, inorganic
crystals44and biological cells42,160. Figure 13 illustrates how the assembly o f polyions on
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flat supports can be extended to charged solid spherical supports (polystyrene, MF and
silica particles 0.1-5jUm).

Mierotessplates
(Latex)

Pdyanioa
(PAAi

Polycatoi
(RET)

Amomc enzymes

Figure 13. Schema o f layer-by-layer film assembly on spherical solid supports
(Source: Dissertation, Mengyan Li. 2003)

This method can be used to create hollow microcapsules by removal o f the solid
template post polyion multilayer assembly for encapsulation o f dyes161’162, enzymes 163
A'y

and other macromolecules , or the template can be retained for creation o f complex
catalytic particles. The process involves addition o f polyelectrolyte solution to a
suspension o f particles. After adsorption saturation is reached, the particles are separated
fro m the polyelectrolyte solution by centrifugation or filtration and then rinsed and

exposed to the oppositely charged polyelectrolyte solution.
2.5.2.1 Encapsulation Techniques for Macro/Biomacromolecules. Over the last
ten years, the use o f electrostatic layer-by-layer assembly to assemble particles and
molecules in a highly controlled manner has advanced rapidly164’163,166. Multilayer
coatings o f thickness in the range o f 5 to lOOOnm, with precision better than Inm and a
definite knowledge o f their molecular compositions, have been fabricated on both solid
supports as well as charged micro- and nano-sized particles to produce hollow core
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shells. This method is also advantageous in that the fabrication process is easy and
repeatable and does not require complicated and expensive equipment. Various templates
have been used for the fabrication o f microcontainers such as polystyrene, melamine
formaldehyde (MF) 16/’168’169, metal particles170, inorganic crystals 44 and biological
cells42,43. Also, several groups have demonstrated encapsulation o f biomolecular and nonbiomolecular materials by different methods.
The following is an elaboration o f the use o f LbL in encapsulation o f
macromolecules. Although some o f these techniques have been used to encapsulate nonenzymatic macromolecules, the techniques have been described as potential methods for
the purpose.
Encapsulation o f urease 163 and FITC-dextran 171 into prefabricated capsules by
solvent and pH induced variations in arrangement o f polyelectrolytes in the capsule wall
has been reported. The capsule architecture used was {PSS/PAH }4 and the MF template
was used. It was shown that the capsule walls are in the open state at low pH (pH 3) and
closed state at high pH (pH 10). Hence, the opening o f pores allows the FITC-dextran
(MW 45000) to penetrate the capsule interior. The closing o f pores at pH 10 ensured that
the capsules remained loaded with FITC-dextran. The open state for FITC-dextran was
observed for pH values up to 6 . M ost o f the capsules were closed from pH

8

and above.

The capsules were initially exposed to a FITC-dextran solution at pH 3. Then the pH was
shifted to 10, and the rest o f FITC-dextran was removed from the bulk by centrifugation.
Similar results were obtained for MW 2000000 FITC-dextran.
It was observed that the transition between the open and closed state o f the
polyelectrolyte multilayer capsules introduced by adding ethanol in aqueous solution is
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reversible165. The permeability o f capsules

{PSS/PAH} 4 (MF template) for high

molecular weight compounds changes from closed to open by adding water and ethanol
respectively to a capsule suspension. For encapsulation o f urease, the enzyme was first
exposed to polyion capsules in a water/ethanol mixture, then ethanol was removed after
centrifugation, and the capsules were resuspended in water. At this point, their walls were
closed and the urease was captured inside. This process has been illustrated in Figure 14.
It has been speculated that there is a segregation o f the polyion network in water/ethanol
media. This segregation leads to defects in the shell, and the pores might be open big
enough to pass 5-nm diameter urease globules through the wall. Returning the capsules
into pure water relaxes the polyion walls to a closed state again. The encapsulated urease
was found to retain 13% o f its activity compared with the free enzyme.

In W ater, dosed

E thanol/W ater 1:1, open

In W ater, Encapsulated

Figure 14. Illustration o f encapsulation o f materials by changing so lv en t 161
The advantages o f the above methods include the ease with which enzymes and
drugs can be encapsulated for sustained release and other drug-delivery applications after
treatment with pH or salt treatment. Selective wall permeability allows for substrates and
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reaction products to diffuse rather easily through the walls while the encapsulated
enzymes are kept in the capsules. The disadvantages o f the methods include the inherent
reversibility o f the mechanism and dependence o f the processes on external environment.
Hence, they are not suitable for all applications, especially in the case o f biosensors
where an irreversible change in the physico-chemical properties o f the wall architecture is
warranted in order for the encapsulated material to be retained.
Another method o f encapsulation involves the use o f microcapsules as reaction
cages for formation o f a charged internal matrix by polymerization o f monomeric units
by enzyme-catalyzed or free-radical reactions 172 and the use o f the matrix to attract and
encapsulate oppositely charged macromolecules. This technique is based on the principle
that microcapsule walls are impermeable for polymers whereas monomers penetrate the
wall easily. This procedure is called “ship in bottle” synthesis. Polymers and
functionalized copolymers have been synthesized inside the capsules ({PSS/PAH}^ MF
template) from water-soluble anionic, cationic, and neutral monomers. Polymerization
was carried out at various sodium styrene sulfonate (SS) concentrations in the presence o f
capsules for 4 h at 80°C under nitrogen atmosphere. 1% potassium peroxodisulfate was
added as initiator. There was increased polymerization in the walls.
This approach was based on the selective permeability o f capsule walls for
monomer molecules, while the biocatalyst and the polymeric chains formed in the
capsule interior were trapped inside because o f their higher molecular weight. In another
similar approach, horseradish peroxidase (HRP) was encapsulated into {PSS/PAH }4
capsules (MF template) using pH driven pore regulation. Tyramine was used as a
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monomer173. It started fluorescing after polymerization upon addition o f hydrogen
peroxide to the system to catalyze the reaction.
The advantages o f these techniques include use o f these

capsules In

micromechanics by inducing a reversible swelling and collapse o f the capsules by
application o f a high concentration o f polyelectrolytes in the bulk solution and the
subsequent application o f a counter pressure. Due to synthesis o f polymers in and on the
capsule walls, it can be strongly charged and hence used as an ion exchange membrane.
Moreover, they can be used to attract and entrap enzymes and proteins.
The technique is limited by the availability o f suitable monomeric units which
will form polymers that are oppositely charged to the enzyme o f interest. Moreover, the
polymers should not hamper the conformation and hence the activity o f the encapsulated
enzymes.
Dyes have been precipitated into hollow polyelectrolyte capsules in a controlled
manner by changing the ionic or solvent composition174,175. Also, DNA has been
precipitated on manganese carbonate templates after which polyelectrolytes were
adsorbed to form a protective biocompatible shell, followed by dissolution o f the core
material to entrap the enzyme in the hollow interior 176 as shown in Figure 15.
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Figure 15. DNA encapsulation by precipitation on M11CO3 template

Capsules with

architecture

{PSS/PAH } 4

precipitation o f water soluble dyes, acid
rhodamine (R-6 G).

6

6

were

used

to

176

demonstrate the

-carboxyfluorescein ( 6 -CF), and base

6

G

-CF was precipitated from basic solution in the presence o f empty

capsules by dropwise addition o f 10' M HC1 until supersaturation took place at pH 6. R6

G was precipitated by increasing the value o f pH (2x10' M NaOH). Fast and random

precipitation o f the dye occurs at pH 12. The cationic cyanine dye 1,1’- diethlcarbocanin
(pseudoisocyanine, PIC) was precipitated by the addition o f 10’3 M solution o f
ammonium hexafluorophosphate to a solution o f PIC bromide (10'3M) and capsules. The
crystals showed a narrow fluorescence band after aggregation.
Yet

another

method

of

encapsulation

involved

formation

(chymotrypsin) aggregates followed by LbL adsorption o f polyelectrolytes

of

protein

I -nn 1nq

"

. This

encapsulation was performed by salting out the proteins by mixing with appropriate
volume of saturated solution o f NaCl (0.0IN HC1 and NaCl 1:1 by volume) yielding
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particles between Q.ljxm to 0.4/rm in dimension.

The advantages o f these methods

include the fact that they are simple, and they obtain high encapsulation efficiency.
These methods, however, m ay cause denaturation o f enzyme and other
biomolecules due to the use o f extreme pHs and solvents. Also, crystallization may lead
to an unfavorable conformation o f the enzymes and hence render them inactive (though
the protein crystals were found to retain 73% o f their activity as compared with free
enzymes, which lost 56% o f activity after six days. This result may not hold true for all
proteins, enzymes and biomolecules).
Low molecular weight dyes have been encapsulated b y first coating them as weak
inner sacrificial layers capped by layers o f strong polyelectrolytes (the weak layers
dissociate when the template is dissolved, whereupon they get encapsulated in the
capsule interior)

1RA
. Multilayer films composed o f Tb3+/polystyrene sulfonate (PSS) and

4-pyrene sulfate/polyallylamine (PAH) were successfully assembled on polystyrene
sulfonate (PS) and MF latex particles.
Dissolution o f the MF particles leads to formation o f hollow capsules with the
release o f multivalent ions and the entrapment o f the inner polyelectrolyte layers, due to
selective permeability o f the walls. The simplicity o f the method is its main advantage. If
this method were used to encapsulate biomolecules, they would be subjected to very low
pHs. Hence, they m aybe selectively appropriate for encapsulation o f biomolecules.
Some groups have reported the encapsulation o f macromolecules into capsules
fabricated using MF template due to the formation o f a gel-like matrix comprising o f the
inner polyelectrolyte layers and MF. A case in example is the loading o f horseradish
peroxidase (HRP) into capsules “spontaneously” due to electrostatic attraction between
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the positively charged enzyme and the negatively charged complex o f the innermost
anionic layer, namely, poly (styrene sulfonate, sodium salt) (PSS) and MF oligomers
formed during the dissolution o f the core181.
However, it has also been pointed out that this matrix formation does not occur in
all cases, and that to a large extent it is dependant on the nature o f polyelectrolytes used
to coat the MF

1fi

and in some cases the age o f the capsules

1S’?
. Hence, depending on the

nature o f interaction between the template and the multilayers, microcapsules that are
completely hollow or those with internal charged matrices are produced. Other examples
include encapsulation o f a- chymotrypsin in capsules formed by assembling

8

bilayers o f

negatively charged alginate/protamine followed by formation o f an alginate matrix in the
interior by dissolution o f the core . 183
The above method has high encapsulation efficiencies since the loading is
spontaneous and driven by electrostatic attraction o f the dense charged inner matrix,
rather than just by diffusion. A possible disadvantage is that there is some MF in the
capsule interior and may be toxic. However, long-term studies have not been done with
in-vitro experiments to prove it.
Diazoresin has been used in the past to demonstrate cross-linking with
polyelectrolyes having sulfonate or carboxyl groups by photocrosslinking reaction as
shown in Figure 16. Recently, hollow capsules were fabricated with 5jum manganese
carbonate (MC) templates, by depositing {PSS/PAH} i+{PSS/PAH} 5 + (PSS/PAH) i and
dissolving the core with 0.1M HC1. Loading o f RITC-GOx, RITC-HRP, and FITC
dextran was demonstrated followed by irradiation with UV lamp for five minutes to
crosslink the multilayer wall (refer Figure 17)184. This method is useful for biosensors,
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where a permanent alteration o f wall properties is desired for stable encapsulation o f the
molecules. However, diazoresin is a known carcinogen.
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Figure 16. Crosslinking o f diazoresin
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Figure 17. Fabrication, loading and crosslinking o f capsules with DA R in their walls.
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Though alginate-based hydrogels have been used for encapsulation o f materials
before, the high porosity o f the matrix has made it difficult to retain macromolecules

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

61
inside the alginate matrix, leading to leaching out o f the encapsulated material over time.
However, recently, it has been shown that by coating alginate microspheres with different
combinations o f polyelectrolyte bilayers, it is possible to reduce leaching and maintain
activity o f encapsulated glucose oxidase183. Alginate microspheres (<5f£) w ere fabricated
using an emulsiflcation technique and were ionically crosslinked with calcium ions;
glucose oxidase was encapsulated inside. It was found that with a single bilayer o f
{PSS/PAH}, the total loss o f enzyme was reduced to 20%.

Alginate is biocompatible,

and alginate microspheres have high encapsulation efficiency.
Almost all methods described above have certain advantages and disadvantages.
The parameters on the basis o f which they can be compared are the application/purpose,
cost, repeatability, ease o f fabrication, mono/polydispersity, biocompatibility, stability
and activity o f the encapsulated enzyme, ease and feasibility o f commercialization, and
effect o f the location o f entrapped enzyme on desired activity. Some o f the methods
involve use o f harsh conditions such as low or high pHs, high salt concentrations, and/or
organic solvents when the biomolecule is present in the capsule, or encapsulation is
carried out using harsh conditions. The capsules fabricated after coating the MF and
removing the core are rinsed after acid treatment and hence are under m ilder conditions
before encapsulation o f biomolecules. Some o f these methods have higher encapsulation
efficiency than others. However, this difference does not directly translate to higher
activity o f the enzyme. A tight packing o f the enzyme can actually hamper enzyme
activity due to diffusion constraints and the unfavorable conformations o f enzymes. Also,
a stable entrapment o f enzymes in the walls may actually lead to higher activity due to
easy availability o f the enzyme to the substrate and assay chemistry. On the issue o f
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biocompatibility, none o f these methods have been tested in-vivo to confirm
biocompatibility or toxicity. The use o f DAR in capsules for medical applications is
questionable because o f its known carcinogenicity. As far as cost is concerned, M F is
expensive compared with the inorganic crystal templates. However, it does offer other
advantages such as formation o f charged internal matrices when certain materials are
coated on it, whereas with inorganic crystals, other techniques have to be used for the
same purpose.
In summary, this chapter has described the pathophysiology o f diabetes, which is
not the only though the single most important reason for the development o f inexpensive
and reliable minimally invasive glucose sensors. The exciting prospect o f using “smart
tattoos” for glucose sensing has also been discussed. Various totally implanted,
minimally invasive, non-invasive and fluorescent sensing techniques have also been
elaborated. The need for reliable encapsulation techniques for immobilization o f the
sensing dye and the enzyme required for sensor fabrication has been underlined; some
methods for encapsulation have been discussed and application o f the versatile LbL selfassembly technique to encapsulation o f molecules has been elaborated. The next chapter
describes the techniques used to characterize the fabrication o f microcapsules and the
encapsulation, activity and stability o f enzyme. Also discussed are the techniques for
characterization and testing o f glucose sensors fabricated by encapsulation o f GOx
labeled with a pH sensitive fluorophore HPTS.
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CHAPTER III

EXPERIMENTAL DESIGN AND THEORIES

The ultimate goals o f this project were to fabricate and test glucose sensors using
GOx for glucose specificity, and to delineate a method to optically sense the reactants
consumed or the products o f the reaction involving the enzymatic consumption o f
glucose. Another purpose o f this research was to demonstrate the use o f nanotechnology,
particularly the versatile LbL technique to construct hollow microcapsules and use them
as microcontainers for the encapsulation o f the sensing chemistry.
With the above aims in mind, numerous experiments were performed; capsules
with different wall architectures were compared for loading, stability, and activity o f
encapsulated GOx. The wall permeabilites o f capsules with these architectures were also
compared using fluorescent recovery after photobleaching. In the course o f this study, it
was discovered that the presence o f a charged internal matrix in some capsules aided the
attraction and encapsulation o f oppositely charged GOx. These matrices were produced
during the capsule fabrication process (during LbL assembly o f polyions) due to the
interaction o f the polyions with the template material.
For capsules that did not have internal matrices, a novel method o f polymerization
o f internal matrices using free-radical polymerization o f acrylic acid monomers was
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found to be suitable for encapsulation o f HRP but not for GOx. Another method involved
the use o f amino acid arginine and its polymerization using a heterobifonctional cross
linker EDC. Finally, HPTS (a pH sensitive excitation ratiometric dye) was used to label
GOx, and the glucose sensitivity o f the system was studied both in solution and after
encapsulation.
This

chapter

gives

a

detailed

description

o f chemical

instrumentation used to perform the above experimental procedures.

techniques

and

The first section

describes the chemical cross-linking techniques used in the fabrication o f charged capsule
internal matrices. The second section describes the optical techniques used for imaging
the capsules and sensors, obtaining fluorescence spectra for glucose sensitivity tests, and
for obtaining fluorescence recovery profiles for photobleaching studies used to compare
permeabilities o f capsules with different wall architectures. The third section describes
the various surface characterization techniques for studying surface topographies o f
capsules, and the instrumentation and methodology for studying the coating o f charged
materials on surfaces (thin films and on particles). The last section is an account on the
working o f enzymes, the pH sensitive dye HPTS used in the sensor and theory behind
absorbance measurements used to assess efficiency o f encapsulation, stability, and
activity o f the encapsulated enzyme.
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3.1 Chemical Techniques for Fabrication
of Internal Matrices of Capsules
3.1.1 Cross-linking Techniques
Cross-linking is the process o f using a covalent bond to chemically join two or
more molecules; they contain reactive ends to specific functional groups (primary
amines, sulfhydryls, etc.) on proteins and other molecules. Due to the availability o f
reactive chemical groups in proteins and peptides, they can be easily conjugated and
studied using cross-linking methods. Among the various applications o f cross-linking
techniques are determination o f three-dimensional structures o f proteins; near-neighbor
relationships;

hapten-carrier protein

conjugation;

molecular associations

in

cell

membranes; and preparation o f enzyme-antibody conjugates, immunotoxins, and other
labeled protein reagents. Cross-linking techniques have also been used to modify nucleic
acids, drugs, and solid surfaces.
By performing cross-linking studies before and after the interaction occurs,
conformational changes o f a protein with a particular reaction can be studied. Distances
between molecules can be determined by comparing cross-linkers with different arm
lengths. Information can be obtained about the exposure o f specific protein domains and
amino acids in the tertiary and quaternary structure and may be interpreted as
conformational changes in proteins by examining which cross-linkers effectively
conjugate to specific domains o f the proteins. Cross-linking techniques also made the
study o f receptors easier. Isolation o f the receptor-ligand complex was possible by
derivatizing a receptor with a cross-linker before and after contact with a ligand 186.
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3.1.2 Homo- and Heterobifunctional
Cross-linkers
Homo- bifunctional cross-linkers have two identical reactive groups. They are
used in one-step reactions to crosslink proteins, to each other, or to stabilize quaternary
structures, in solution. This procedure is unsuitable when the goal is to cross-link two
different proteins, as it often results in seif-conjugation, intramolecular cross-linking
and/or polymerization. Such procedures can be performed effectively using hetero
bifunctional cross-linkers, which have two different reactive groups that allow two-stage
sequential conjugations. This method helps minimize undesirable polymerization or self
conjugation. Hetero- bifunctional cross-linkers are especially useful when modification o f
amines is problematic due to the locations o f these reactive groups at the active sites. In
such cases, other moieties such as sulfhydryls, carboxyls, phenols and carbohydrates are
more appropriate targets. For example, cross-linkers that are amine-reactive at one end
and sulfhydryl-reactive at the other end are particularly useful in such cases.
In sequential reactions involving heterobifunctional reactions, the cross-linker is
reacted with one protein using the most labile group o f the cross-linker first, followed by
removal o f excess non-reacted cross-linker and addition o f the modified first protein to a
solution containing the second protein where reaction through the second reactive group
o f the cross-linker occurs. The most widely-used heterobifunctional cross-linkers have an
amine-reactive succinimidyl ester (NHS ester) at one end and a sulfhydryl- reactive group
on the other end. The sulfhydryl-reactive groups are usually maleimides, pyridyl
disulfides, and a-haloacetyls. Since NHS-ester stability is less in aqueous solution and is
usually reacted first in sequential procedures. NHS-esters react with amines to form
amide bonds. Carbodiimides are zero-length cross-linkers (EDC) and cause direct
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coupling between carboxylates (-COOH) and prim ary amines (-NH2) and have been used
in peptide synthesis, hapten-carrier protein conjugation, subunit studies and proteinprotein conjugation.
Some heterobifunctional reagents have one reactive group that is photoreactive
instead o f thermoreactive. These groups are useful in case o f protein-protein interaction
studies where the availability o f thermoreactive target groups is a factor. This option
allows for specific attachment o f the labile thermoreactive group first, followed by
conjugation to any adjacent N-H or C-H sites, which may be initiated through the
photoreactive group by UV light activation. The reactivity o f the photochemical reagent
allows for formation o f a conjugate that m ay not be possible with a group-specific
reagent. Photoreactive cross-linkers have low efficiency; yields o f 10% are considered
acceptable.
N-Hydroxysuccinimide-Esters (NHS-Esters) react with primary amines with
relatively efficient coupling at physiological pH and yield stable products (a covalent
amide bond is formed when the NHS-ester cross-linker reacts with a primary amine,
releasing N-hydroxysuccinimide) as shown in Figure 18.
Carbodiimides couple carboxyls to prim ary amines or hydrazides resulting in the
formation o f amide or hydrazone bonds (Figure 19). No spacer exists between the
molecules being coupled. Both carboxyl as well as glutamic and aspartic acid residues
can be targeted, and in the presence o f excess cross-linkers, polymerization occurs
because all proteins contain carboxyls and amines. EDC reacts with carboxylic acid
group and activates the carboxyl group to form an active O-acylisourea intermediate,
allowing it to be covalently attached to the amino group in the reaction mixture. The O-
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acylisourea intermediate is unstable in aqueous solutions. This instability makes it
ineffective in two-step conjugation procedures without increasing the stability o f the
intermediate using hydroxysuccinimide. Failure to react with an amine results in
hydrolysis o f the intermediate and regeneration o f the carboxyls. The reaction is
performed between pH 4-5, though the yield o f the reaction is similar between pH 4.57.5.
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Figure 18. Reaction ofN H S cross-linker
(Source: www.piercenet.com/Proteomics/)
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Figure 19. Reaction o f EDC cross-linker
(Source: www.piercenet.com/Proteomics/)
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3.1.3 Free Radical Polymerization
Free-radical initiators are chemical substances that, under certain conditions,
initiate chemical reactions by producing free radicals. These free radicals are the starting
point o f the free radical polymerization process which can be broken down into three
main steps: Initiation, Propagation and Termination.
Prior to the aforementioned steps, the initiator is first decomposed into free
radicals. This decomposition is followed by initiation, which involves reaction o f the free
radical w ith double-bonded monomers. This reaction leads to generation o f free radical
monomeric units, which further propagate the reaction by attacking other double bonded
monomers. The termination o f the reaction happens by a combination reaction (two free
radicals react and combine to a single molecule) or a disproportionation reaction (transfer
o f a proton from one monomer to another leads to formation o f a double bond in one).
These steps have been illustrated in the following reactions:
R adical G eneration

R—R

--------►

Initiator

Initiation

R®

+

C=C

2

R*

Radicals

--------► R — C--C®

M onom ers

Propagation

r_ c_c

*

Term ination

R— C-C®

+ C=C

--------►

R - C — C-C®

+ ®C— C— C— R --------► R - C — C— C— C— C--R.
Polym er
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In summary, this section described the chemical cross-linking techniques (faomoand heterobifunctional crosslinking agents and free-radical polymerization technique)
used in the fabrication o f charged capsule internal matrices.

3.2 Optical Imaging Techniques
3.2.1 Fluorescence
The past 15 years have seen a sensational growth in the use of fluorescence
techniques in biological sciences. What was confined to the fields of biochemistry and
biophysics until a few years ago is now being extended to applications in environmental
monitoring, clinical chemistry, flow cytometry, genetic analysis by fluorescence in situ
hybridization (FISH), DNA sequencing, and the study o f intracellular substances by
fluorescence microscopy to name a few187.

The high costs and handling difficulties

associated with radioactive substances, combined with the sensitivity of fluorescence
detection, have led to continuous development o f medical tests based on fluorescence
principles.

Enzyme

linked

immunoassays

(ELISA)

and

fluorescence

polarization

immunoassays are examples of this development.
Fluorescence is the result o f a three-stage process that occurs in certain molecules
(generally polyaromatic hydrocarbons or heterocycles) called fluorophores or fluorescent
dyes188. Fluorescent probes are fluorophores designed to localize within a specific region o f a
biological specimen or to respond to a specific stimulus. The Jablonski diagram (Figure 20)
demonstrates the process responsible for the fluorescence o f fluorescent probes and other
fluorophores. It is a simple electronic-state diagram Illustrating the processes involved in
the creation o f an excited electronic singlet state by optical absorption and subsequent
emission o f fluorescence For polyatomic molecules in solution, the discrete electronic
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transitions represented by So, Si, S2 , etc., are replaced by rather broad energy spectra called
the fluorescence excitation spectrum and fluorescence emission spectrum, respectively. The
bandwidths of these spectra are parameters of particular importance for applications in which
two or more different fluorophores are simultaneously detected.

excited vibrational states
’(excited rotational states not shown)

n
* SaTT
IC

s1
>
O)
m

c

ISC

A = photon absorption
F = fluorescence (em ission)
P = phosphorescence
S = singlet state
T = triplet state
IC = internal conversion
ISC = intersystem crossing

IC

LU

■Ta
T -,

electronic ground state
Figure 20. The Jablonski diagram
(Source:http://elcliem.kaist.ac.kx/vt/chem-ed/quantum/jablonsk.htm)

The entire fluorescence process is cyclical; the same fluorophore can be repeatedly
excited and detected unless the fluorophore is irreversibly destroyed in the excited state (an
important phenomenon known as photobleaching). The fact that a single fluorophore can
generate many thousands of detectable photons is fundamental to the high sensitivity of
fluorescence detection techniques. With few exceptions, the fluorescence excitation spectrum
of a single fluorophore species in dilute solution is identical to its absorption spectrum. Under
the same conditions, the fluorescence emission spectrum is independent of the excitation
wavelength, due to the partial dissipation o f excitation energy during the excited-state

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

72

lifetime. The emission Intensity is proportional to the amplitude o f the fluorescence
excitation spectrum at the excitation wavelength as shown in Figure 21. Currently,
fluorophores used as fluorescent probes offer ample permutations o f wavelength range,
Stokes shift, and spectral bandwidth to satisfy demands imposed by instrumentation, while
allowing flexibility In the design o f multicolor labeling experiments. The fluorescence output
of a given dye depends on the efficiency with which it absorbs and emits photons and its
ability to undergo repeated excitation/emission cycles.

lM te s s i% r

100 1

Figure 21. Excitation and fluorescence emission spectra
(Source:http://www.zeiss.com/C12567BE0045ACFl/allBySubject/A
0ACC4A12EA4EF86C1256AEA0050794E)
Important parameters for quantification o f absorption and emission efficiencies are
the molar extinction coefficient (e) for absorption and the quantum yield (QY) for
fluorescence, both o f which are constants under specific environmental conditions. The value
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of e is specified at a single wavelength (usually the absorption maximum), whereas QY is a
measure o f the efficiency of conversion from excitation to emission.
W ith the availability o f a wide spectrum o f reagents, fluorophores, and
derivatization methods for the development o f fluorophores with improved sensitivity,
*
•
2*h
p|
selectivity and applications, the use o f dye indicators for ions (Na , K , Cl , Ca , Mg ,
Zn2+), pH etc. to study intracellular events and related extracellular dynamics has grown
tremendously. However, there are limitations to the current technology, in that liquidbased indicators after introduction into cells leak over time, get compartmentalized within
organelles, are toxic and cannot be used for long-term monitoring without being
reintroduced.

Hence,

encapsulated-dye-based

monitoring

systems

offer

several

advantages over liquid indicators and, for this reason, great potential. In combination
with analyte specific receptors or enzymes, they can respond to specific reactions in the
body.

3.2.2 Confocal Microscopy
New and improved synthetic fluorescent probes and genetically engineered
fluorescent proteins, a wide spectrum o f laser light sources coupled to very accurate
acousto-optic tunable filters, and more advanced software packages combined with high
performance computers have led to one o f the most significant advances in optical
microscopy, namely, the refinement o f laser scanning confocal microscopy (LSCM).
Confocal microscopy has several advantages over conventional wide-field optical
microscopy, namely, ability to control the depth o f field, ability to take serial optical
sections from thick specimens, and reduction o f background information from planes
away from the focal plane.
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The basic principle o f the confocal approach involves the use o f spatial filtering
techniques to eliminate out-of-focus light or glare in thick specimens from planes other
than the plane o f focus. The tremendous popularity o f confocal microscopy in recent
years has been due to the ease with which high quality images can be obtained, and the
growing num ber o f applications in cell biology for imaging both fixed and living cells
and tissues.
Figure 22 shows a schematic o f the optical train in a typical confocal microscope,
indicating all the vital optical components. Point A in the specimen is in the focal plane.
The laser beams focus at the observation point; fluorescent light generated by the
specimen (red line) enters the overhead detector.189
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Figure 22. Schematic o f a Confocal M icroscope
(Source:http ://www.nikon.co .jp/main/eng/society/tecrep/ confocal_02_e.htm)
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Light from the specim en’s surface and the underside (green and blue lines) also
heads towards the detector. The Z axis indicates the depth o f the specimen, which is
crucial mapping information. The image blurs if light from anywhere other than the focal
plane enters the detector. The pin-hole, which allows light only from the observation
point (point A) to enter the detector, prevents such blurring.
3.2.2.1 Optical slicing o f 3-D specimens. As shown in Figure 23, numerous points
along the Z axis o f the specimen can be imaged or examined in order, just as if the
specimen has been sliced into segments. This information can be fed into a computer, and
3-D reconstruction software can be used to obtain a 3-D image o f the specimen by
combining all the sections.

~Specimen
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Figure 23. Concept o f optical slicing o f specimen using confocal microscope
(Source :http ://www.nikon.co .jp/main/eng/society/tecrep/confocal_02_e.htm)

The confocal system’s ability to discriminate between slices o f the specimen
made it invaluable in imaging capsules and identifying the area o f localization o f the
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enzyme. Imaging with a fluorescent microscope made it impossible to distinguish
between entrapment o f the enzyme in the walls and encapsulation in the interior because
o f the out-of-focus blur.

3.3 FRAP - Application to Studying
Capsule W all Permeabilities
3.3.1 FRAP History and Applications
Fluorescent recovery after photobleaching experiments were started over 30 years
ago as a non-invasive technique to visualize the lateral diffusion and dynamics o f
fluorescent proteins in living cells, especially over the last 10 years after non-invasive
fluorescent tagging became popular using the green fluorescent protein (GFP) 190,191. This
research facilitated the performance o f FRAP on living cells without disruption by
microinjection. FRAP has been used extensively to study the lateral diffusion o f
membrane-associated proteins has been used to study protein localization, dynamics, and
interactions with other components in living cells. Also, membrane continuity and
mobility o f molecules within specific cell compartments has been visualized.
FRAP can also be used to study events during cell division and signaling as well
as to measure protein interactions, conformational changes, and protein dynamics. FRAP
has also been used to study diffusion o f macromolecules in cross-linked polymer
solutions and gels192. An important example is the study o f effect o f enzyme treatment on
diffusion of macromolecules in guar galactomannan and titanium guar hydrogels. These
hydrogels are extensively used in petroleum, textile, and food industries because o f
advantages such as, natural abundance, biodegradability, low cost, and unique ability to
alter rheological properties.
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In most o f the studies involving the study o f lateral diffusion o f adsorbed proteins,
data acquisition was performed by using a photomultiplier tube (PMT), which measures
the total intensity in a single spot192. The diffusion coefficient was obtained by fitting the
plot o f the total fluorescence intensity versus time after bleaching to a diffusion model.
This method did not provide spatially resolved fluorescence intensities, and hence was an
exchange o f protein between the surface and the bulk. Thus, changes in total intensity
contributed from factors other than lateral diffusion would also be attributed to lateral
diffusion. Using a charge-coupled device (CCD) camera helps in direct visualization o f
the bleached and unbleached areas and the measurement o f intensity profiles showing
surface mass transfer and fluorescence recovery. These intensity profiles can be
normalized relative to those prior to bleaching. Hence, by changing the measurement
method, the reliability o f can be improved and non-standard transport mechanisms can be
detected by making use o f a more complete data set. However, the potential to obtain and
analyze the intensity profiles within the microscope filed o f view has not been fully
utilized to date. Another method o f improving the reliability o f FRAP is by obtaining
spatially resolved fluorescence data by scanning confocal fluorescence microscopy, by
which the collected intensity can be limited to the focal plane. It thus enables the
performance o f 2D diffusion measurements in bulk samples.
Yet another application that merits the use o f using CLSM is the study o f
diffusion o f macromolecules through cartilage193. This study is important because the
transport o f solutes is critical to the normal function o f articular cartilage and is affected
by the local structure and composition o f the cartilage, which is dependent on depth from
the tissue surface. Magnetic resonance imaging (MR!) and nuclear magnetic resonance
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(NMR) have been used to track the movement o f only very small molecules and ions.
Tracking of radiolabled solutes and fluorescence desorption allow for tracking o f a
variety o f molecules. They measure spatially averaged diffusion coefficients over large
volumes and for this reason are not reliable.

3.3.2 What is FRAP?
FRAP (also microphotolysis) is the process by which irreversible photobleaching
o f fluorescent molecules (permanent destruction o f the fluorescence o f molecules) is
carried out in a small area o f the region o f interest by a high-powered focused laser beam.
The geometry o f the bleached spot can be either a spot or parallel stripes (P, or pattern
photobleaching) 194. Subsequent diffusion o f non-bleached fluorescent molecules from
the surrounding area into the bleached area leads to fluorescence recovery in the
previously photobleached area, which is recorded at low laser power, and the diffusion
coefficient (D) o f the fluorescent molecules can be derived. The rate o f recovery o f the
fluorescent signal is a measure o f the mobility o f the species in the system. The amount
o f recovery is a measure o f the fraction o f the species that is mobile in the observed
region195. The lateral diffusion o f fluorescent molecules into the bleached spot can be
modeled on the basis o f two assumptions: all fluorescence recovery is due to twodimensional diffusion in an infinite plane, and that there is no diffusion in or out o f the
spot during bleaching194. Bleaching during measurements is assumed to be also ignored.

3.3.3 Principle of FRAP
Two parameters regarding mobility o f a fluorescent molecule in a defined
compartment can be obtained from, namely, the mobile fraction o f fluorescent molecules
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and the rate o f mobility, which is related to the characteristic diffusion time rD, The
mobile fraction can be determined by comparing the fluorescence in the bleached region
after full recovery (F») with the fluorescence before bleaching (Fi) and just after
bleaching {Fg), as shown in the typical fluorescence recovery curve in Figure 24.
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Figure 24. Fluorescence recovery after photobleaching (FRAP).
The mobile fraction is given by R defined by:
* = ( F .- F o > '( F ,- F o >

'

(2)

The mobile fraction is affected by the interaction between fluorescent molecules
with other molecules and by presence o f membrane barriers and microdomains in
membranes, which are discontinuities that can prevent or temporarily restrict the free
diffusion of membrane molecules. In the context o f study o f cellular proteins in living
cells, when motion due to active transport or unidirectional flow can be ruled out, protein
mobility is due to Brownian motion. The mobility is expressed in terms o f diffusion
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coefficient, D, which is related to the characteristic diffusion time T&, which is given by
the two-dimensional diffusion equation described by Axelrod et al.
(3)

To = « V 4 D

o)
7

2

*

4

radius o f focused circular laser beam at the e' intensity
-correction factor for the amount o f bleaching

The equation holds good for unrestricted two-dimensional diffusion in a circular bleached
area and assumes that there is no recovery from above and below the focal plane. The
Stokes-Einstein formula describes unrestricted diffusion o f a particle in a free-volume
model:
D=kT/67n?Rh

(4)

T----- absolute temperature
r]------viscosity o f solution
k------ Boltzmann constant
Rh---- hydrodynamic radius

The diffusion coefficient D is determined mainly by Rh because the temperature
and viscosity remain constant during bleaching. The diffusion coefficient is directly
1/T
proportional to the inverse o f the cube root o f the molecular mass (D~M‘ ), when the
diffusing molecule is assumed to be a sphere with a volume proportional to its molecular
mass.
New FRAP recovery equations for three-dimensional apertured scanning using a
Gaussian approximation for the axial beam profile have been successfully developed and
used to extract lateral diffusion coefficients from CLSM experimental data. Two
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dimensional diffusion coefficients o f fluorescent species can be successfully measured by
FRAP using CLSM; a big advantage o f using this technique is that bleaching can be
targeted at a well-defined volume element in bulk samples. Diffusion coefficients as high
as 2x1 O'6 cm2/s can be measured. FRAP can be performed within a conventional
microscope. A laser beam is focused into a specimen placed on a stage o f a light
microscope. The fluorochrome is excited as well as bleached by the laser; an acoustooptic device switches between low laser intensity for measuring and high laser intensity
for bleaching. A photomultiplier is used for measuring the intensity o f the fluorescent
signal. This system suffers from the dearth o f good imaging and probing techniques for
the bleach experiment; the laser beam cannot be positioned for exact local bleaching. On
the other hand, using a CLSM, images can be obtained from a two-dimensional area
located at a precise depth inside a specimen. The CLSM also has the advantage o f threedimensional laser beam probing and three-dimensional imaging. Thus FRAP can be
performed on well-defined volume elements in a sample.
Axelrod et al (1976) developed the FRAP theory, and this theory is valid for the
idealized case o f pure two-dimensional diffusion monitored by a laser beam with a
Gaussian intensity profile195. The normalized recovery is given by:

-k "

n=0 nl

1

(5)

l + *P + <— )]
Td
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k is the bleach constant given by

w

f = e ‘
Fi

To is the 2-D characteristic diffusion time, which is related to the 2-D diffusion
coefficient, D by

t

Td

=FL
AD

(7)

h alf the width o f the Gaussian profile o f the focused laser spot determined at e‘
times the height o f the profile. D(cm2/s) is defined by
(8)

D= kT/6x»jRh
k->Bolzmann’s constant
T -> temperature (K)
ij-> viscosity

'y

(N.s/m ) o f the medium

Rh~> effective radius (m) o f the diffusing particles

The fluorescent recovery when an immobile fraction is present, e.g. due to irreversible
adsorption, is given by
F ( t) = F ( i ) { i - m - f m

m

Where F(i) is the intensity o f the bleach spot before bleaching, and R is the mobile
fraction defined by equation x above.
By using FRAP and the inherent advantages o f a CLSM system, permeabilities o f
various hollow capsule architectures to labeled GOx were compared. This comparison is
essential for understanding how the composition o f the wall affects the loading o f
enzyme and the leaching after loading.
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3.4 Suface Characterization Techniques
3,4.1 Atomic Force Microscopy (AFM)
There are about two dozen types of scanned proximity probe microscopes that work
by measuring a local property (height, magnetism, optical absorption, etc) with a probe or
“tip” placed close to the sample. The ability o f these devices to image at atomic resolution
together with the ability o f most of these devices to image a wide variety o f samples under a
wide variety of conditions has facilitated its usage in the study o f biological structures196.
Typical applications include materials evaluation (surface roughness o f silicon wafers,
surface profiles, and magnetic field mapping of recording media or reading heads), failure
analysis (defect analysis o f compact disk stampers), and quality control (surface finish of
substrates for thin film deposition)197. The AFM works by measuring attractive or repulsive
forces between a tip and the sample. Unlike its predecessor the scanning tunneling
microscope (STM), which maps the surface topography by measuring the tunnel current
between an atomically sharp tip and a metallic sample, the AFM can be used to image
insulated samples. Measurements can be taken over a small area because of the small probesample separation (on the order o f the instrument’s resolution, which is typically o f
nanometer range198 and can even go as low as 10pm199). Image acquisition is done by a raster
scanning the probe over the sample while measuring the local property in question.
The concept of the AFM and the optical lever is illustrated in Figure 25. In its
repulsive "contact" mode, the instrument lightly touches a tip at the end o f a leaf spring or
"cantilever" to the sample. A detection apparatus measures the vertical deflection of the
cantilever as a raster-scan drags the tip over the sample; this scan indicates the local sample
height. Hence, hard-sphere repulsion forces between the tip and sample are measured in the
contact mode.
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Though in principle, AFM resembles the record player as well as the stylus
profilometer, it incorporates a number of refinements that enable it to achieve atomic scale
resolution. Also, because AFM is based on interaction between the tip and sample, as well as
surface topography, local properties, such as stiffness and friction can be determined.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

85

j^etector and

electronics

Photodiode
(detector)

/ / lasts
OalBslor: sends sgfsai to a computer
for analysis nod itm§®een@ra.tien

u iser s&wce
c a n tile v e r and tio

Sam ple surface

^>^PiSB3S
L a » sight is cteftected

by the- moving tip
Vertical mmrnM a? the tip
M ows the contears af the sample
Controlled tmvemenl of tfw

Horizontal tractenq

bp at the end of the cantilever 0f §}e g»
(under constant force)

a-

Samoie
84® 8 nm
.4245 ran

H
4.

.

100 juris

5 0

h it s

to o pm

How tie atomic force microscope scans surfaces
Expert Reviews to Molecular Medtems ®2000 Cambridge University Press

Figure 25. Working o f the Atomic Force Microscope. Inset (Feedback control o f the
AFM). (Source: http://www-ermm.cbcu.cam.ac.uk/00001587h.htm)
The high resolutions attainable using the AFM make it ideal for the study o f
surface topography o f capsules. It was used to assess the change in surface structure and
the overall structure o f capsules before and after loading, as well as to study the effect o f
formation o f internal matrices inside a capsule on its overall structure. While
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transmission microscopy can give this information by indicating changes in optical
properties (such as opaqueness o f capsule interior when it is not hollow), it cannot give
fine details o f the surface and the overall topographical (or physical) information.

3.4.2 Zeta-potential Analysis
A charged particle suspended in an electrolytic solution attracts ions of opposite
charge to those at its surface, where they form the Stem layer (Figure 26). To maintain the
electrical balance of the suspending fluid, ions of opposite charge are attracted to the Stem
layer. The potential at the surface of that part o f this diffuse double-layer o f ions that can
move with the particle when subjected to a voltage gradient is the zeta potential. This
potential measured is very much dependent upon the ionic concentration, pH, viscosity, and
dielectric constant of the solution being analyzed.

C a p illa r y w aif

£teetneal duubte-fay&r

\

1
0

0

apll «nry vs. urn

Figure 26. The electrical double layer—Stem layer
(Source:http://www.desicca.de/index.html?/intemational/engl
and/zeta-potential/hauptteil_zeta-potential.html)
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Thus, the zeta potential is based on the measurement o f migration rate o f
dispersed particles under the influence o f an electric field.

v /E = pE

(U)

v - observed velocity
E=strength o f the applied electric field
P e = electrophoretic mobility

The zeta potential can be calculated from mobility using the Henry equation:
H E = e * 4 * f { m ) l 67n j

( I2)

e - dielectric constant o f the medium
h - viscosity o f the medium
f(k a) - correction factor which takes into account the thickness o f the
double layer and particle diameter.
The unit k is a reciprocal length.

1/k is frequently described as the thickness o f the

double layer. In practice an approximation can be made for f(k a), this is f(k a) = 1.0 for
non-polar media,
f(k a)=1.5 for particle dispersions in polar media. This number is a good
approximation for particles >100nm In aqueous solutions with an ionic strength >10‘3 M.
This formula is known as the Smoluchowski approximation.
p i E = e * £ * l 4 jr r ]

(I3)

The second limiting case f(k a)=1.0 applies for very small particles in media with
a low permittivity. This equation is known as the Hiickel approximation.
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Charged particles in a liquid suspension can be made to move by applying an electric
field to the liquid through two electrodes as shown in Figure 27. By alternating the charge
between the electrodes, the particles move back and forth between the electrodes at a velocity
relative to their surface charge and the electrode potential. This velocity can be determined
by measuring the Doppler shift of laser light scattered off the moving particles.

Photomultiplier

C over
Electrodes

S a m p le
Reflective
Coating

Reflective
; C o ating

Prisms

Figure 27. The sensing portion o f the zeta potential instrument
(Source:http://www.rpi.edu/dept/chem-eng/Biotech-Environ/COAG/zeta.htm)

This instrument is particularly useful in determining the feasibility o f using
charged polymers for coating charged templates and was used to confirm the assembly o f
polyions on charged templates.
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3.5 Absorbance Measurements for Characterization
of Efficiency., Stability, and Activity of
Encapsulated Enzyme
3.5,1 Beer’s Law
The absorbance, A(>l), o f a species at a particular wavelength o f electromagnetic
radiation, A, is proportional to the concentration, c, o f the absorbing species and to the length
o f the path, L, of the electromagnetic radiation through the sample containing the absorbing
species.
A(A) = e{X)Lc

(14)

The proportionality constant e(/4) is called the absorptivity of the species at the
wavelength, A. The way in which e(/l) depends on wavelength defines the spectrum of the
substance in question. The wavelength at the maximum value is called the analytical
wavelength of the substance. Figure 28 shows the absorbance spectrum of DNA with the
wavelength at the absorbance maximum indicated as the analytical wavelength. Normally,
the Beer’s law applies at the analytical wavelength. Hence, the sensitivity to concentration
changes is the highest at that wavelength.
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Figure 28. UV-Vis spectrum o f DNA and protein
To experimentally obtain the Beer’s Plot, the following steps can be followed:
• Prepare a series o f samples of known concentration o f the substance, the analytical
wavelength of which is known (danai).
• Measure the absorbance of each o f the solutions of known concentration at the analytical
wavelength and plot the values o f the absorbance as a function of the concentration (Figure

29).
• Verify that, within experimental error, the absorbance is a linear function o f the
concentration. If linear, the slope of the best straight line through the experimental points in
the absorbance vs. concentration plot gives the Beer's Law slope. The Beer's law slope has
the value e(ylanai) 1, where 1 is the path length through the sample.
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Figure 29. B eer’s Law Plot
(Source: http://icn2.umeche.maine.edu/genchemlabs/images/beerplot.gil)
The slope can be used to determine the concentration corresponding to an absorbance
for samples of unknown concentration if the same experimental arrangement (same
spectrometer, same cell) are used. If a different experimental arrangement will be used (e.g.,
a different cell), the Beer's Law slope will need to be adjusted by the path length through the
cell used in the Beer's Law determination. This slope will provide the value o f the
absorptivity, e(danai), which should be characteristic only of the substance and the
wavelength, and independent of the experimental arrangement used to determine it.

3.6 Glucose Sensor Components
An ideal glucose sensor needs to satisfy a number o f criteria, such as selectivity,
linear range and response time, biocompatibility, storage and operational stability at body
temperature, reversibility o f signal, reproducibility o f sensor fabrication, which current
endeavors have not been able to completely satisfy1. Moreover, the sensor components
must be inexpensive and fabrication method must be simple.
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This section describes the components o f the glucose sensor designed in this
research. The sensor is selective to glucose because o f the use o f flavoenzyme GOx. The
numerous advantages o f this enzyme have been enumerated in the following sections.
The incorporation o f HPTS in the sensor makes it a ratiometric sensor o f glucose based
on changes in pH. Being ratiometric, it is less affected by fluctuations in instrumental
parameters. The sensor fabrication procedure, which will be described in the Chapter IV
is simple and repeatable.
The

following

sections

expound

on

the

sensor components

and their

characteristics, which made them amenable to the constmction o f a glucose sensor.

3.6.1 Enzymes and Enzymatic Activity
Enzymes bind to one or more ligands (substrates) and convert them into one or
more chemically modified products. This binding happens over and over with
phenomenal speed. They speed up reactions by a factor o f a million or more, without
themselves changing. They act as catalysts that permit cells to make or break covalent
bonds in a controlled way. Catalysis is a vital function that creates and maintains the cell
by aiding organizing sets o f chemical reactions, making life possible. Enzymes work in
teams, with the product o f one enzyme becoming the substrate for the next. Thus an
elaborate network o f metabolic pathways provides the cell with energy and produce
molecules, both large and small that the cells need200.
The basic reaction path o f an enzyme is as follows:

E + S “>EP">E-TP.
There is a limit to the amount o f substrate that a single enzyme molecule can
process in a given time. Figure 30 shows the relationship between substrate concentration
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and enzyme activity. Enzyme activity (reaction rate) is defined as the number o f substrate
molecules processed per second. W ith the increase in the concentration o f substrate, the
rate at which product is formed also increases, up to a maximum value (the enzyme is
now saturated with substrate). The rate o f reaction Vmax at this point depends on how
rapidly the enzyme can process the substrate molecule. The turnover number is defined as
the enzyme rate divided by the enzyme concentration. It is typically 1000 substrate
molecules processed per second per enzyme molecule, though, numbers between 1-1000
are also known. Another important parameter in enzyme kinetics is Km , defined as the
concentration o f the substrate that allows the reaction to proceed at one-half its maximum
rate (0.5Vmax) . If the Km is low, the enzyme generally binds tightly to the substrate and
hence reaches its maximum catalytic rate at a low substrate concentration.

Vmax:

uninhfcited

concentration of su b stra te [S |
Figure 30. An illustration o f enzyme kinetics
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The enzyme increases the local concentration o f substrate molecules at the
catalytic site, holds all the appropriate atoms in the correct orientation for the reaction
that is to follow, and most importantly, the binding energy contributes directly to
catalysis. Substrate molecules have to pass through a series o f intermediate states (altered
geometry and electron distribution) before they form the final products o f the reaction.
Activation energy is the free energy required to attain the most unstable transition state
(Figure 31); it is the major determinant o f the reaction rate. Enzymes have a much higher
affinity for the transition state o f the substrate than they have for the stable form. The
tight binding lowers the transition state energies tremendously, and hence accelerates a
particular reaction by lowering the activation energy that is required.
By experimentally determining the rates o f enzyme reactions using standard
assays, the effect o f various parameters (concentrations o f substrates, products, inhibitors,
regulatory ligands, effect o f binding and entrapment o f enzymes in matrices) can be
studied. This determination is particularly important in enzyme encapsulation studies
because the effect o f encapsulation on enzyme conformation and hence activity, and the
availability o f substrates to the enzyme after encapsulation, can be studied by measuring
enzyme activity. By comparing activities o f the enzyme before and after encapsulation,
the effect of encapsulation on the enzyme can be interpreted both for short and long
periods o f time.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

95

t
| A c tiv a tc r #n§fciy

| wlbc J t enzyma

(Efi)

i

! Activation energy | € 4 !
I w ifi e n z y m e

;

I
g

a

g

LL.
i
!
E n e rg y of p ro d u c ts

s § -mm

r« t!l

Figure 31. Enzymatic acceleration o f chemical reactions by decrease o f activation
energy. (Source: http://w3.dwm.ks.edu.tw/bio/activeleamer/06/ch6c 1.html)

3.6.2 Theory of Glucose Measurement
Using GOx
Glucose oxidase is a slightly elongated globular protein with an axial ratio o f
2.5:1, an average diameter o f 8nm201. The absorbance spectrum has maxima at 278, 382
and 452nm. The enzyme is a dimer composed o f two identical subunits. The holoenzyme
is made o f two identical subunits, each with a M W o f 80000. There is a long but narrow
contact area connecting the monomers non-covalently with either salt linkages or
hydrogen bonds. Each monomeric unit is a compact spheroid with dimensions
A x 37

A202. It

60A x

52

folds into two structural domains, one binding the FAD and the other

involved with substrate binding. The carbohydrate content o f the enzyme ranges from 8
to 12, which accounts for variations in the isoelectric point between 3.9 and 4.3. It is
anionic at physiological pH.
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Figure 32 illustrates the glucose oxidase reaction. Similar to other flavoenzymes,
the enzymatic reaction can be divided in two steps203. The reductive half consists o f
transfer o f two protons and electrons from glucose to the enzyme yielding dgluconolactone. The oxidative half reaction consists o f the oxidation o f the enzyme by
molecular oxygen yielding hydrogen peroxide. Finally, d-gluconolactone can be
hydrolyzed non-enzymatically to gluconic acid.
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Figure 32. The glucose oxidase reaction
(Source: http://www.imb-jena.de/www_bioc/post/GOX/)
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GOx is easy and cheap to obtain; it is one o f the most robust enzymes, which can
withstand greater extremes o f pH, ionic strength, and temperatures (these properties
allow less stringent conditions during manufacturing and relatively carefree storage and
use by home-users o f the biosensor incorporating it); the concentration range o f glucose
with which GOx reacts optimally coincidentally agrees with the range o f concentrations
encountered in human blood.

3.6.3 HPTS as a pH Sensitive Dye
HPTS (Figure 33(a) and (b)) has many attractive features that make it an ideal
fluorescent indicator, namely, large Stokes shifts, high quantum yield, high absorbance,
excellent photostability, and non-toxicity204. It has a pKa o f 7.3, which is in the middle o f
the physiological pH range. At near neutral pH, HPTS fluoresces green (conjugate base
form exclusively) and independent o f whether it was excited in its conjugate base or
acidic form, or both205. The ratio o f fluorescence intensities resulting from excitation
(Figure 33(b)) at 470nm and 405nm can be used to quantify pH values between 6 and 9.
This ratio is not influenced by temperature and ionic strength206.
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Figure 33. (a) Structure ofH PT S, (b) Spectra o f HPTS
(Source: http://www.probes.com/handbook/figures/0578.html)
In summary, this chapter described the techniques used to study the encapsulation
efficiency, stability, and activity o f encapsulated enzymes, comparison o f wall
permeability o f capsules o f different architectures, and the study o f response o f glucose
sensors. The next chapter describes the chemicals, materials and methods used to
implement the goals o f this project using the techniques described in this chapter.
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CHAPTER IV

MATERIALS AND METHODS

This section describes the chemicals, instruments and methods used in
experiments. Detailed information about the inventory o f these materials and instruments,
can be found in Appendices A and B, respectively. Appendix A includes product name,
number and vendor information for chemicals and other materials used. Appendix B
contains vendor information about the instrumentation used.
The methods described here pertain to capsule preparation, visualization o f
capsules using CLSM, and characterization o f capsule topography before and after
loading o f enzyme with the AFM. Procedures for testing glucose sensitivity o f HPTSGOx sensors have also been described. Use o f specific equipment such as the UV-Vis
spectrophotometer in studying the stability and activity o f encapsulated enzyme has also
been described. Chemical procedures involving labeling o f enzymes and polyions, as
well as free radical polymerization o f acrylic acid monomers have been mentioned.

99
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4.1 Chemicals and Materials
4.1.1 Polvions
Poly

(sodium

4-styrenesulfonate)

(PSS,

MW

70000),

Poly

(allylamine

hydrochloride) (PAH, M W 15kDa), Poly (diallyldimethlyammoniumchloride) (PDDA,
MW 100-200kDa) and Poly (vinyl sulfate, potassium salt) (PVS, M W 170,000) were
purchased from Sigma. Chitosan (CHT, low molecular wt, 50,000 Da) was obtained from
Aldrich.

4.1.2 Enzymes and Enzymatic Activity Assays
Glucose oxidase (GOx, 160K and 200000 units/g) was obtained from Sigma.
Horseradish Peroxidase (HRP, 40K and 181 purpurogallin units/mg) was obtained from
Sigma. Potassium Phosphate Buffer (lOOmM, pH 6.0 at 20°C), 0.5% (w/w) Hydrogen
Peroxide, and 5% (w/v) Pyrogallol solution were used to prepare the enzymatic assay for
HRP. 3,3’- Dimethoxybenzidine (O-dianisidine, FW 317.2, Sigma), /3-D (+) glucose
(Sigma) and HRP were used to prepare the enzymatic assay for GOx. Sodium
bicarbonate buffer was used for the labeling reaction and was obtained in powder form
from Sigma.

4.1.3 Colloids (template)
Monodisperse melamine formaldehyde (MF) particles (5.25pm, 10% solids
weight) with positive surface charges were purchased from Microparticles GMBH,
Germany. Monodisperse manganese carbonate (MnCOs) microparticles (5.8pm) with
positive surface charges were synthesized according to a previously established
protocol207. Polymethacrylate (PMA) particles

(6

pm, 10% solid content) were purchased

from Fluka chemicals.
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4.1.4 Labeling Reactions
Tetramethylrhodamine-5 - (and-6 )-isothiocyanate (TRITC) was obtained from
Molecular Probes and was used to label GOx to visualize loading o f the enzyme. Pyrene
8

-hydroxy-1,4,6-trisulfonylchloride (HPTS, MW 513.78) was purchased from Marker

Gene Technologies, Inc., and GOx was labeled with HPTS for sensor experiments. PD10 desalting columns were obtained from Amersham Biosciences and were used for
separation o f the labeled enzyme from the free dye. Tetramethylrhodamine-5- (and- 6 )isothiocyanate (TRITC) was obtained from Molecular Probes and was used to label HRP.
All labeling reactions were performed using a standard amine labeling protocol208, which
has been described in the methods section. Fluorescein isothiocyanate isomer I was
obtained from Sigma and was used to label PAH.

4.1.5 Formation of Polv(Acrylic Acid)
Acrylic acid monomer (99%) and ammonium persulfate ((NFLO2 S2 O 8) were
purchased from Aldrich and Sigma, respectively.

4.1.6 Other Chemicals and Materials
Glacial acetic acid (99.7%) was purchased from J.T. Baker. L-Arginine was
obtained

from

NOW

Foods,

Bloomingale,

IL;

N-(3 -DimethyaminopropyI)-N’-

ethylcarbodiimide hydrochloride (EDC, MW 191.7) and N-Hydroxysulfosuccimnimide
Sodium salt (NHS, MW 217.13) were purchased from Fluka. Phosphate buffered saline
(PBS) buffer was obtained from Fluka BioChemika. Coverslips and microscope slides
were obtained from VW R Scientific and Cole Parmer Instruments respectively.
Centrifuge tubes and cuvettes were purchased from Fisherbrand.
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All chemicals were reagent grade and used as received. Deionized water
(18.75MO) was used for all solutions.

4.2 Methods
This section describes the procedure for preparation o f capsules for all
experiments described in this dissertation. The first section describes the labeling
procedures for labeling GOx, HRP and PAH with dyes (FITC, TRITC and HPTS) and the
procedure for imaging o f capsules using the atomic force microscope. The second section
describes the fabrication procedure for capsules with wall architectures {PVSPAH} 4 (MF)

{PSS-PAH}4 (MF),

PAH}2(MF),{PVS-CHT}2 +

{PSS-PDDA}4(MF),

(PSS-PAH}2(MF)

using

{PVS-PAH}2
MF

template

+

(PSS-

and

(PSS-

PAH} 4 (MC- internal arginine matrix) using the MC template. It also describes the
procedure for loading GOx and evaluation o f encapsulation efficiency, long-term
stability, and activity o f encapsulated GOx. The third section describes the FRAP
procedure for evaluation o f permeabilities o f various capsule architectures to FITC-GOx.
The fourth section describes the procedure for fabrication o f capsules and
formation o f internal poly(acrylic acid) (PAA) matrix for encapsulation o f HRP, and
evaluation o f encapsulation efficiency, long-term

stability, and activity o f the

encapsulated HRP. It also explains the experimental procedure for studying the effect o f
(acrylic acid:(NH 4 )2 S 2 08)) concentration on efficiency o f enzyme encapsulation and
enzyme activity.
The fifth section explains the procedure for using PMMA as the template for
fabrication o f microcapsules. Finally, the sixth section describes the experimental
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protocols for testing the glucose sensitivity o f HPTS-GOx both in solution and after
encapsulation.

4.2.1 Labeling Reactions
The procedure was used for making FITC-PAH: 0.1 M sodium bicarbonate
(NaHCOs) buffer was prepared and adjusted to pH 9 by HC1 and KOH. Next, 60 mg PAH
was dissolved in 1 mL 0.1M NaHC03 buffer and 0.25mg FITC was dissolved in 100 pL
N,N-Dimethylformamide (DMF). FITC solution was added into PAH solution and stirred at
room temperature for one hour. Then, the FITC-PAH conjugate was precipitated in 30 mL
acetone and centrifuged at 3000 rpm for five minutes. After removing the supernatant, the
rem a in in g

FITC-PAH conjugate solid was resuspended and dissolved in 30 mL pH 7 tris

buffer. FITC-PLL was made in a similar way, but 5mg PLL was dissolved in 1 mL 0.1M
NaHCCb buffer in place o f the PAH.
A protein-labeling procedure for tagging GOx and HRP with FITC was developed
from the guidelines provided by Molecular Probes and Sigma-Aldrich. For labeling GOx
with FITC and TRITC, 0.1 M sodium bicarbonate buffer was prepared and adjusted to pH 9.
Next, 20 mg o f the enzyme was dissolved in 1 mL o f 0.1 M NaHC03 buffer. Then, 2.5 mg
FITC powder was dissolved in 5mL DMF. While stirring the enzyme solution slowly, the
FITC solution was added. The reaction was incubated at room temperature with continuous
stirring for one hour. Finally, the conjugate was separated from unreacted labeling reagent
with an Amersham Pharmacia Biotech PD-10 desalting column. For labeling GOx with
TRITC, lOmg/ml GOx and 0.5mg/ml TRITC were used. For labeling GOx with HPTS
(lOmg/ml), 6 mg/ml o f GOx and 70/iL o f HPTS were used in the labeling reaction.
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4.2.2 Characterization of Capsule Surface
Topology Using Atomic Force
Microscopy CAFM)
A volume o f 10/d o f the suspension to be imaged was dispensed onto a mica
substrate and incubated at 60°C for five minutes, to remove water from the interior o f the
capsules. Scanning probe microscopy (AFM Quesant, Model 250) was used to obtain
morphological information o f the capsules before and after polymerization o f acrylic
acid, and after encapsulation o f enzyme. The intermittent contact mode (Wave Mode)
was used to scan the sample with a 40/im scanning head. The NSC16 cantilever used had
the following tip specifications: -30° full tip cone angle,

15-20/rm tip height,

tip

curvature radius < 1 0 nm.

4.2.3 Capsule Fabrication
Among the architectures studied, {PSS-PAH} 4 (MF), |PSS-PDDA} 4 (MF), {PVSPAH }2 +

{PSS-PAH}2 (MF) were hollow capsules and

{PVS-CHT } 2 +

{PSS-

PAH} 2 (MF) , {PSS-PAH} 4 (MC- internal arginine matrix) were believed to have internal
matrices due to the capsule preparation procedures described in the next section. PAH,
PDDA, PSS and PVS solutions were prepared using DI water, and 0.2M NaCl was added
to each o f them. For the preparation o f CHT solution (1% wt), 0.5g o f chitosan was
added to 49.5g water, 3ml o f 3% (3ml acetic acid and 97ml water) acetic acid was added
to CHT solution, and this solution was sonicated at level 2-3 for 15-20 minutes.
The general procedure for coating particles is as follows: Depending on the type
o f template used, the polyanion was added to 100/tL (10% solids) o f MF colloid
suspension or 30mg o f MC particles, and 15 minutes were allowed for complete
adsorption saturation o f the polyanion. After rinsing with DI water, the sample was
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centrifuged at 5000rpm for 3 minutes. Three such rinse cycles followed every
polyelectrolyte adsorption step. The particles were then immersed in polycation for 15
minutes. This process o f adsorbing alternate layers o f polycations and polyanions was
continued until the desired numbers o f bilayers were deposited on the template. Except
for {PVS-CHT } 2 + {PSS-PAH }2 architecture with MF templates, the core material (MF
or MC) was then dissolved by suspending the coated particles in 0.1M HC1 for five
minutes and rinsed four to five times with DI water.
Capsules with {PVS-CHT } 2 + {PSS-PAH }2 architecture with MF templates were
believed to have internal matrix formed during the process o f polyelectrolyte coating. MF
begins to dissolve partially due to low pH (2-3) o f the CHT solution and hence a matrix
was formed due to the interaction o f the template with the initial bilayer materials,
consisting o f MF oligomers, CHT and PVS. No additional dissolution steps were required
for these particles.
Capsules with {PSS-PAH } 4 architecture with MC templates were used to test a
novel method o f formation o f internal charged matrices using amino acid arginine using
zero-length cross-linking reagent EDC with NHS. Briefly, 300/d o f 80mg/m! o f arginine
monomer solution was added to 250/d o f freshly prepared capsules, followed by addition
o f 300/d each (1:1 ratio) o f 15mg/ml EDC and NHS. All solutions were prepared with
sodium bicarbonate buffer (pH 8.5). Though the crosslinking action o f EDC/NHS is most
effective between pH 4-5, the reaction was carried out at an alkaline pH because arginine
is mildly protonated and more reactive. The mixture was incubated overnight to allow
sufficient reaction time for the slower action o f EDC/NHS.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

106

4.2.4 Loading of Capsules
A fter fabrication o f capsules, each capsule suspension was incubated with
unlabeled GOx (2mg/ml, pH=5 in DI water) for six hours for long-term stability, and
activity studies. At this pH, GOx (pl=4.2) is negatively charged. In the case o f {PVSCHT}2 + (PSS-PAH} 2 (MF) capsules, the internal matrix inside the capsule was positively
charged (likely due to chitosan and MF oligomers) at this pH, and GOx was
electrostatically attracted into the capsule and entrapped in the matrix.
TRTTC-GOx

was

used

for

visualization

of

{PSS-P AH} 4 (MF),

{PSS-

PDDA} 4 (MF), {PVS-PAH} 2+{PSS-PAH} 2 (MF), and {PVS-CHT} 2 +{PSS-P AH} 2 (MF)
capsules. PAH} 4 (MC) capsules were visualized using FITC-GOx . A Leica TCS SP2
system, Germany (HCXPL APO CS 63x1.4 oil immersion objective) was used to
perform confocal imaging. After adding 3 ill o f capsule suspension to a coverslip, 3 /xl o f
labeled GOx (1 mg/ml, pH=5) was added to the drop o f capsules. Imaging was performed
with the 488nm line o f the A r : K r laser set to 50% and the PMT voltage at 500V. The
Leica Lite software was used to analyze data. For FRAP studies, 3 jul o f capsules in
loading solution was pipetted on a coverslip precoated with {PEI-PSS } 4 layers (to
stabilize capsules on the surface o f the coverslip). The edges o f a coverslip were smeared
with paraffin wax and was then placed on the sample and sealed by gently pressing
against the surface o f the slide to prevent evaporation o f the sample. Sealing was
necessary to prevent evaporation during the experiment.
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4.2.5 UY-Vis Spectrophotometry for
Stability and Activity Studies of
Encapsulated GOx
A Perkin Elmer Lambda 45 UV/Vis spectrometer was used for estimation o f the
quantity o f GOx encapsulated, stability o f the encapsulated GOx, and its activity. The
percentage o f GOx encapsulated was estimated by measuring the absorbance at 280nm o f
the enzyme in the loading solution and the supemate after loading; the difference in the
two absorbance values followed by conversion to mass using the B eer’s law (in mg)
gives an estimate o f the mass o f enzyme encapsulated. For the activity study, the standard
assay protocol from Sigma was used209. Upon addition o f 60/rl o f capsules with
encapsulated GOx, O-dianisidine, which is one o f the constituents o f the assay, is
oxidized by H 2 O 2 (this reaction is catalyzed by peroxidase), which is a byproduct o f the
reaction between glucose and GOx to a highly colored substance. The formation o f this
product can be measured

at

500nm.

The continuous

spectrophotometric

rate

determination was used to record changes in absorbance at 500nm, at 30-second
intervals, for a total o f 15 minutes. The initial linear increase in absorbance with time was
taken as a quantitative measure o f the catalytic activity o f glucose oxidase.

The

temperature was maintained at 25 °C for all activity tests using a Quantum Northwest
temperature controller.

4.2.6 Long-term Stability and
Activity Studies
Two samples per architecture were prepared for long-term stability and activity
studies; one sample was used for activity study and the other for stability study. For long
term leaching studies, GOx loaded capsules were stored in deionized water for a period
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o f four weeks. Both stability and activity measurements were first made on the first week,
on the day o f loading. Subsequently, measurements were made one and three weeks after
loading. F or the stability measurements, each o f the samples was centrifuged to separate
the loaded capsules from the supemate. The supemate was drawn off, and absorbance
measurements were made to calculate the amount o f enzyme leached into the supemate
during the storage period.

4.2.7 Protocol for FRAP Studies
A slide was coated with {PEI-PSS }4 layers (to stabilize capsules on the slide
surface) and three /d o f capsules in loading solution was pipetted on the slide. The edges
of a coverslip were smeared with paraffin wax, and it was placed on the sample. The
edges o f the coverslip were sealed by gently pressing them against the surface o f the slide
to prevent evaporation o f the sample during the experiment.
The Marquardt procedure was used to fit the intensity o f the FRAP signal with the
theoretical curve given by equation (5). From the MATLAB code, it can be seen that
three different models were used to perform curve fitting. Two parameters, k - bleaching
constant and rD - characteristic diffusion time characterize the theoretical curve. Ideal
values o f k and Td (k_guess and Td respectively) were first obtained by random
substitution o f values for these parameters in the theoretical curve to obtain an ideal
representation for the diffusion recovery. To obtain the Least Squares Fit (LSQ) using
modelO, the value o f k evaluated from equation x l (k_calc) was used in the theoretical
curve equation and fitted for 7p. In model 1, t d was fitted first, followed by k. In model2,
both Tp and k were fitted simultaneously. For all architectures, model 1 and model2
provided better fits for the data.
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4.2.8 Multilayer and Capsule Preparation
And Polymerization of Acrylic Acid
Matrix for Peroxidase
Encapsulation
Manganese carbonate (MnCCb) particles were coated with four bilayers o f
PS S/PAH using the LbL nanoassembly approach37. Briefly, 0.5mL o f PSS solution
(2mg/ml, 0.2M NaCl) was added to 50/tL o f M nC 0 3 particle suspension, and allowed to
react for 15 minutes to achieve complete adsorption saturation. The sample was then
rinsed with DI water and centrifuged at 5000rpm for 3 minutes. Three such rinse cycles
followed every polyelectrolyte adsorption step. The particles were then dispersed in 0.5
ml PAH (2mg/ml, 0.2M NaCl) for 15 minutes and then rinsed thrice with DI water. The
consecutive adsorption o f alternating polyelectrolytes was continued to achieve
deposition o f four bilayers o f PSS/PAH. After coating, the MnCCb core was dissolved by
immersion in HC1 (0.1M) for 30 minutes,, followed by rinsing and immersion in EDTA
for 15 minutes. The resulting suspension o f microcapsules was then rinsed four times
with DI water. These capsules were used in the following process for free radical
polymerization o f acrylic acid to form a poly (acrylic acid) matrix in the interior,
followed by loading o f HRP.
Figure 34 contains a schematic illustrating the process o f fabrication and
spontaneous loading o f microcapsules with HRP. An internal anionic poly (acrylic acid)
matrix was formed by incubating capsules in a highly concentrated solution (99%) o f
acrylic acid and 2mg/ml o f initiator in a microcentrifuge tube at 60°C.
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Figure 34. Schematic of acrylic acid matrix formation and loading and entrapment
of peroxidase inside the capsule

In a pilot experiment, it was discovered that using lOOpl each of the monomer
(99%) and snainitiator (2mg/ral) produced a highly viscous gel of polyacrylic acid and
the capsules indicating a high degree of polymerization; progressively reducing the
volumes of the reactants produced less viscous gels, indicating lower degrees of
polymerization. Hence, acrylic acid and (NH4)2S20s were added in 1:1 ratio by volume to
100j.il of freshly prepared microcapsules (three different volumes of reactants, lOpil, 50jil
and lOOpl each of monomer and initiator; the corresponding concentrations of acrlylic
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Il l
were 0.23M, 1.18M and 2.36M, and o f the initiator were 0.13mM, 0.65mM, and
1.3 ImM ). The mixture was diluted with DI water to make up a total volume o f 600/xl.
This mixture was then incubated in an oven maintained at 60-70°C for 30-120 minutes.
The sample with the highest volumes o f the reactants (monomer and initiator) was
incubated only for 30 minutes, that with intermediate volumes for 45 minutes and the
sample with the lowest volume o f reactants was incubated for 120 minutes. The change
in viscosity o f the mixture, as assessed by visual observation was used as an indicator for
polymerization o f acrylic acid monomers. After polymerization the capsules were rinsed
with DI water and centrifuged (5000rpm for 10 minutes) twice, then dialyzed against DI
water to remove unreacted monomers and the initiator from the capsule suspension.
These capsules were then loaded with TRITC-HRPx as described in the next section.

4.2.9 Spontaneous Loading of Capsules with
TRITC-HRP/HRP After Polymerization
of Internal PAA Matrix
After polymerization and rinsing, the capsule suspension was incubated with
1mg/ml TRITC-HRP in DI water (pH 5) for

6

hours. At this pH, HRP is positively

charged (pl= 8 .8 ); since the acrylic acid matrix inside the capsule is negatively charged at
this pH, TRITC-HRP was electrostatically attracted and spontaneously loaded into the
capsules and entrapped in the matrix. The loaded capsules were then imaged to visualize
loading and localization o f TRITC-HRP using a confocal microscope as described in the
next section. For activity studies and estimation o f loading efficiency, unlabeled HRP
(1 mg/ml) was used instead o f TRITC-HRP, and the same loading procedure described
above was used.
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4.2.10 Assessment of Time-Dependent
Loading Behavior of Capsules Using
Confocal Laser Scanning
Microscopy (CLSM)
A Leica TCS SP2 system, Germany (63X, 1.4 oil immersion objective) was used
to perform confocal imaging. After placing three microliters o f capsule suspension on a
microcover glass (24x6Gmm, 0.16-0.19mm thickness), three microliters o f TRITC-HRP
(1 mg/ml, pH -5) was added to the drop o f capsules. Imaging was performed with the
intensity of with the 543nm line o f the Ar : Kr laser set to 50% and the PMT voltage at
500V. A single capsule was located and multiple images o f the same x-y section o f the
capsule were collected over time (30second intervals) to record the spontaneous loading
o f TRITC-HRP. The Leica Lite software was then used to analyze data; data analysis
involved representation o f loading o f the capsule by considering a region o f interest
(ROI) in the capsule interior and plotting the average intensity in the ROI against time.

4.2.11 Assessment of Encapsulation
Efficiency and Activity Using
UV-Vis Spectrophotometry
The procedure described previously in this chapter for estimation o f percentage
encapsulation o f GOx in the capsules after loading was also used for HRP. The
assessment o f activity o f encapsulated HRP was done using the following procedure.
60/d o f capsules with encapsulated peroxidase is added to the assay; pyrogallol, the dye
constituent o f the assay, is oxidized by peroxidase to purpurogallin, which is a highly
colored substance. The formation o f his product can be measured at 420nm. The
continuous spectrophotometric rate determination was used to record changes in
absorbance at 420nm, at 30-second intervals, for a total o f 60 minutes. The initial linear
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increase in absorbance with time was taken as a quantitative measure o f the catalytic
activity o f peroxidase.

4.2.12 Effect of Acrylic AcidrfNHASqO*
Concentration on Efficiency of
Enzyme Encapsulation
and Enzyme Activity
Six batches o f {PSS/PAH } 4 capsules (three pairs, each with a different volume o f
reactants, acrylic acid and (NHU^SaOs in

1 :1

ratio) were prepared and the poly (acrylic

acid) matrix was formed as described previously. The capsules were split into three pairs,
each pair consisting o f one sample for stability tests and the other for activity tests. After
dialysis, loading, and rinsing, the capsules were used for activity studies and were
assessed for efficiency o f encapsulation as described in the previous section. The
encapsulation efficiencies and activities o f capsules were compared as a function o f the
volume o f reactants used in the preparation o f the internal poly (acrylic acid) matrix.

4.2.13 Capsule Preparation Using
PMMA Template
The assembly o f oppositely charged polyelectrolytes was carried out on
negatively charged PMMA. Three methods were attempted to improve the yield and
quality o f microcapsules produced. In the first attempt, 50/d o f 6 /im PMMA template was
coated with

6

bilayers o f PAH-FITC and PSS. The coated PMMA particles were then

suspended in acetone overnight. This coating was followed by two more acetone rinses
and finally with four rinses with deionized water. Since the first attempt produced a large
number o f broken capsules, the number o f bilayers in the subsequent attempts was
increased. Also, since labeling o f PAH with FITC reduces the charge density o f PAH and
hence weakens its electrostatic interaction with PSS, PAH-FITC was used in the
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fabrication o f only the three outermost bilayers, the other bilayers used unlabeled PAH.
In the second attempt 50/xl o f

6

jtim PMMA template particles were coated with

{PAH/PSS } 3 + {PAH-FITC/PSS} 3 . This coating was followed by immersion in acetone
for five hours. A small portion o f the sample was then observed with the confocal
microscope, while the rest was left immersed in acetone. Another aliquot o f the sample
was observed after 17 hours, and yet another after 24 hours. In the third attempt,

6

jUm

PMMA template particles were coated with eight bilayers o f PAH and PSS followed by
three more bilayers o f FITC labeled PAH and PSS to help in visualization. They were
immersed in acetone for 1.5 hours, followed by gradual titration o f DI water into the
sample. The volume o f supernatant drawn o ff from the sample was gradually increased
and replaced with an equal volume o f DI water. The capsules were visualized using
confocal microscopy and AFM.

4.2.14 HPTS-GOx for Glucose Sensing
For studying glucose sensitivity o f encapsulated GOx, capsules with architecture
{PVS-CHT } 2 + {PSS-PAH} 2 (MF) were used. The procedure for fabrication o f these
capsules has been described previously in this chapter. The loading o f the capsules has
also been described previously. For visualization o f loading with confocal microscopy,
TRITC-GOx was used to load capsules.

4.2.15 Study of Effect of Titration ofO.lM HC1
on the Change in pH of PBS (pH-7.4)
Buffered HPTS-GOx, PBS
Buffer and HPTS
After mixing 40/d o f HPTS-GOx with 1.2ml o f PBS 7.4 buffer, the initial pH was
recorded with a Thermo Orion pH meter. Aliquots o f 0.1M HC1 were added successively
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to the solution, and the pH was recorded after each increment. The solution was
continuously stirred using a magnetic stir bar throughout the titration experiment. The
variation o f pH o f HPTS in PBS was recorded similarly.

4.2.16 Fluorescence Spectroscopy to Record
Change in Excitation Peak Ratio of HPTS
A scanning fluorescence spectrometer (QM1, Photon Technology International) was
used to record the change in peak ratio o f HPTS with the changes in pH. Fluorescence
excitation scans were obtained by using the “Excitation scan” mode o f the PTI. An
emission wavelength o f 520nm and an excitation range o f 350nm-500nm were used. All
solutions and dispersions were continuously mixed (using magnetic stirring) during the
titration experiments. Measurements were made in triplicate.

4.2.17 Response of PBS Buffer (pH=7.4).
PBS Buffered HPTS and HPTS-GOx
to Titration of 0.1 M HC1
Initial excitation spectra o f HPTS-GOx in PBS buffer before addition o f acid were
obtained. Measurements were made after each successive aliquot o f HC1 was added. The
acid was added until changes were no longer observed in the acid to base peak ratio
(405/454nm) after addition o f HC1. The experiment was carried out in a similar way for
PBS buffered HPTS.

4.2.18 Glucose Sensitivity Study of HPTS-GOx
Both in Solution and After Encapsulation
in Chitosan Capsules
Glucose sensitivity experiments were carried out using four different conditions,
namely, (1) HPTS-GOx in DI water, (2) HPTS-GOx in PBS buffer, (3) HPTS-GOx
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encapsulated in chitosan capsules and suspended in DI water, and (4) HPTS-GOx
encapsulated in chitosan capsules and suspended in PBS buffer.
In each case, initial excitation spectra o f the solution or dispersion were obtained
before addition o f glucose. After each addition o f glucose measurements were made to
observe the change in acid to base peak ratio. All spectra were normalized to 412nm,
which is the isobestic point of the two emission peaks.
In summary, this chapter described the methods used to fabricate and visualize
capsules and characterize capsule topography before and after loading o f enzyme, and
procedures for testing glucose sensitivity o f HPTS-GOx sensors. Chemical procedures
involving labeling o f enzymes and polyions, as well as free radical polymerization o f
acrylic acid monomers have also been described. The next chapter elucidates the results
obtained using the aforementioned techniques.
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CHAPTER V

RESULTS AND DISCUSSION

Results o f the various stages o f the project are explained in detail in this chapter.
A comparison o f microcapsules with different wall architectures with respect to
encapsulation, stability, and activity o f GOx is presented in the first section. As will
become obvious, the type o f template material used, together with the wall architecture,
determines the internal composition o f capsules (presence or absence o f an internal
matrix). Melamine formaldehyde (MF) and manganese carbonate (MC) were used as
templates for the fabrication o f microcapsules. Capsules with wall architectures
(PSS/PAH}4,

(PSS/PDDA}4,

{PVS/PAH } 4 +

{PSS/PAH } 4 , and

{PVS/PAH}4

+{PSS/CHT } 4 were fabricated using MF as template material. Internal matrices were
formed in the case o f {PVS/P AH} 4 +{PSS/CHT } 4 capsules during the capsule fabrication
process, due to the interaction o f CHT and PVS with the MF. In the case o f {PSS/PAH } 4
capsules fabricated using MC templates,

internal matrices were fabricated by

polymerizing amino acids using crosslinking agents EDC and NHS. The second section
deals with the use o f fluorescence recovery after photobleaching (FRAP) to compare the
effect o f capsule wall architecture on mobility o f labeled GOx. Finally, the third section
describes the results for experiments demonstrating glucose sensitivity o f HPTS-GOx
both in solution and after encapsulation in {PVS/P AH} 4 +{PSS/CHT}4 capsules. Also,
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while exploring various possibilities for encapsulation o f GOx using capsules with
charged internal matrices, a novel method o f encapsulation o f HRP using the “ship-in-abottle” concept was developed. The results o f this study have been described in
APPENDIX A. Also, in APPENDIX B a short study to determine the possibility o f using
PMMA as an alternative template has been described.

5.1 Effect of Polvelectrolvte Architectures on
Microencapsulation- Encapsulation Efficiency,
Long-Term Stability and Activity
of Glucose Oxidase
5.1.1 Evaluation of (PVS/PAHI^-fMF)
Microcapsules to Encapsulate GOx
It was previously reported that the formation o f a charged matrix inside capsules
fabricated by LbL assembly depends on the choice o f materials used to coat MF210"213.
Different materials interact with the dissociating template in different ways; the
innermost polyions that are in contact with the template can detach from the wall
structure and participate in matrix formation by interacting with the MF oligomers.
However, if the innermost layers are strongly attached to the next layer, the likelihood o f
dissociation during core dissolution is small and they will remain firmly in the wall
structure. Initially, the effect o f capsule wall architecture on matrix formation was studied
using PVS (Figure 35 [a]) instead o f PSS (Figure 35 [b]) as an alternative polyanion in
multilayer assembly.
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Figure 35. Structures o f PSS and PVS

The procedures for fabrication o f capsules, loading, and imaging were described
in Chapter IV. Figure 36 contains microscope images showing the spontaneous loading
of the microcapsules with FITC-GOx. The concentration o f FITC-GOx used for the
loading experiment was 2mg/ml. At t=0 seconds, prior to addition o f FITC-GOx, the
fluorescence intensity o f the capsule interior was zero. The rapid increase in fluorescence
intensity in the capsule interior for the first 20 seconds after addition o f the FITC-labeled
enzyme can be characterized by the polynomial expression y = 2.6x2 - 53x + 270 (R 2= l),
where y is the intensity in the capsule interior which changes polynomially with time (x) .
The intensity then plateaued due to saturation o f the PMT.
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Figure 36. Loading o f {PVS/PAH} 4 -(M F) microcapsules with FITC-GOx. Images:
Left to right: region o f interest (ROI) inside capsule (ROI Area=1.2/rm2) microcapsule
imaged at 0s, 5s, 10s, 15s, 20s and so on after addition o f loading solution.
A typical linescan o f (PVS/PAH } 4 -(M F ) capsule in a loading solution o f FITCGOx is shown in Figure 37. It can be seen that the fluorescence intensity o f capsule
interior is high enough to cause saturation o f the PMT o f the confocal instrument, while
the intensity o f the surrounding solution is zero. Though a quantitative estimate o f the
enzyme encapsulated was not made, the linescan data indicate that a large quantity o f
enzyme in the loading solution is drawn into the capsule interior and densely packed
inside, indicating the presence o f an internal matrix.
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Figure 37. Linescan o f {PVS/PAH } 4 -(MF)microcapsule in a
solution o f FITC-GOx.

loading

The encapsulated enzyme was found to be active. The absolute activity o f the
encapsulated enzyme was calculated as 2.0x1 O' 5 absorbance units/sec (not scaled to mass
o f enzyme). Though the activity was not compared with that o f free GOx, it is important
to state that the procedure for encapsulation did not inactivate the entire quantity o f
immobilized enzyme.
An examination o f the capsule using the transmission mode o f the confocal
microscope showed that the capsule interior was not hollow after core dissolution.
Transmission images o f {PSS/PAH } 4 capsules (Figure 38[a]) show that hollow capsules
after dissolution o f the core have the same contrast both inside and outside the capsule.
The (PVS/PAH} 4 -(M F) capsules (Figures 38[b] and 38[c]), however, have a highly
refractive interior indicating that the MF template did not dissolve completely. This
observation is an example o f how the unpredictable quality o f MF can lead to erratic
results. The solubility o f MF varies inversely with its age. As the MF ages, it develops
more stable crosslinks and does not dissolve completely into lower molecular weight
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oligomers214. Another influencing factor is the concentration o f the acid usedz14. The pH
o f the acid used determines the rates o f two competing reactions— decomposition o f MF
to form soluble oligomeric products and further polymerization which prevents
degradation by acid. A pH lower than 1.1, decomposition surpasses polymerization
reaction, and at higher pH values, polymerization surpasses decomposition leading to
partial dissolution o f MF. Since the acid used had an appropriate pH (1.1), this factor was
not responsible for the findings o f this experiment. Any o f the other aforementioned
reasons m ay have contributed to the behavior o f MF. Since a new batch o f MF was used
for the experiments, age o f the capsule was not a factor contributing to the results. It is
therefore presumed that the MF was defective, and that either manufacturing or handling
conditions were responsible for its poor solubility.

Figure 38. Transmission mode images o f (a) & (b) {PVS/PAH } 4 -(M F) capsules,
(c) {PSS/PAH }4 capsules
An attempt to repeat the fabrication o f capsules o f the same architecture failed. The
capsules collapsed and disintegrated after dissolution o f the core. The process o f
dissolution o f these particles after LbL assembly o f (P VS/P AH} 4 was captured in the form
o f a time-lapse series o f confocal images (Figure 39). This experiment proved that it was
difficult to fabricate capsules using only PVS as the polyanion. The reasoning behind this
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conclusion is that the bilayers are unstable because o f interaction o f hydrophobic (PVS)
and hydrophilic (PAH) polyions. As a result, the wall is not strong enough to withstand the
osmotic pressures experienced during core dissolution. Since the fabrication o f stable
microcapsules using {PSS/PAH} bilayers has been well documented in literature, hybrid
capsules were prepared for further studies using two bilayers o f (P VS/P AH} followed by
two bilayers o f {PSS/PAH}. These capsules did not disintegrate and collapse after core
dissolution. W ith this hybrid architecture, stable capsules were fabricated, and the effect o f
using PVS instead o f PSS on the formation o f internal MF matrices during the core
dissolution process was studied.

wwm

istall
...
•«

•** ‘ •

Figure 39. Time-lapse images o f dissolution o f MF templates coated with
(PVS/PAH} 4 . Time based dissolution shown in succession in images(a)-(c),
closeup o f clumps o f polyelectrolytes after dissolution o f core shown in (d)

5.1.2 Long-term Studies Using Capsules with
Different Wall Architectures; Comparison and
Determination of Best Capsule Configuration
for GOx Encapsulation
5.1.2.1

Zeta-Potential Measurements to Confirm Adsorption o f Polyion. Capsules

with architectures {PVS-PAH}2 + {PSS-PAH}2(MF) and {PVS-CHT}2 + {PSSPAH}2(MF) were fabricated as described in Chapter IV. The alternate assembly o f
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oppositely charged polyions {PVS-PAH}2 + {PSS-PAH}2(MF) and {PVS-CHT}2 +
{PSS-PAH}2(MF) was confirmed by zeta potential measurements, as shown in Figures
40 and 41. The MF microparticles possessed strong positive surface charge (+69mV).
The surface potential o f the coated microparticles changed regularly between positive for
PAH and CHT to negative for PSS and PVS. Though surface potential values were not
constant for each subsequent positive or negative layer deposited, they indicate that the
polyelectrolytes were assembling.
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Figure 40. Zeta potential measurement o f {PVS-PAH }2 + {PSS-PAH}2(MF)
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Figure 41. Zeta potential measurement o f {PVS-CHT}2 + {PSS-PAH}2(MF)

5.1.2.2

Estimation o f Percentage Encapsulation. The encapsulation or entrapment

of GOx was different in terms o f both distribution and quantity for each architecture
employed, depending upon the wall composition and the presence or absence o f an
internal matrix. Figure 42 contains confocal images, corresponding line scans, and phase
images o f each o f the samples while still in a loading solution o f TRITC-GOx except for
{PSS-PAH}4 (MC- internal arginine matrix) capsules, which are in a loading solution o f
FITC-GOx. It can be seen from Figures 42 (a), (b), (d), (e), (g) and (h) that in the case o f
{PSS-PAH}4(MF), {PSS-PDDA}4(MF), {PVS-PAH}2 + {PSS-P A H ) 2(MF) capsules,
GOx was entrapped mostly in the walls. The line scans show that the concentration o f the
enzyme was the same inside the capsule as the loading solution, which suggests that
loading in these three cases occurred by a process o f simple diffusion.
In contrast, for {PVS-CH T }2 + {PSS-PAH} 2(M F) capsules, it can be seen from
Figure 42 (j), (k) and (1) that the loading solution intensity was effectively zero while the

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

126

intensity from the capsule interior shows that the concentration o f GOx was nearly
uniform throughout the interior o f the capsule. Also, it can be observed from the phase
image o f the capsule that, unlike the previous three architectures discussed, there is a
refractive character to the interior, which is indicative o f the presence o f a matrix. For
{PSS-PAH } 4 capsules with an internal matrix o f arginine (Figure 42 [m], [n], [o]) , the
intensity o f the capsule interior was approximately 12 times that in the loading solution,
determined by taking the ratio o f the average intensities o f the linescan o f the interior to
that o f the loading solution. Thus, for capsules without internal matrices studied here, the
enzyme was mainly entrapped in the walls due to electrostatic interaction o f the charged
enzyme with the charges in the capsule walls. On the other hand, capsules with charged
internal matrices attracted and encapsulated large quantities o f oppositely charged GOx
in the capsule interior.
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Figure 42. Confocal images of {PSS-PAH}4(MF), {PSS-PDDA}4(MF), |PV SPAH}2 + {PSS-PAH}2(M F),{PVS-CHT}2 + {PSS-PAH}2(MF) and {PSSPAHJAMC- internal arginine matrix) capsules in loading solution. Figures
1.(a) through (1), in TRITC-GOx loading solution, Figure (m) through (o) in
FITC-GOx loading solution
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Capsules o f different architectures were evaluated for the quantity o f enzyme
encapsulated after loading with GOx and separation o f capsules from the remainder o f
the enzyme by rinsing with DI water using the equation:
_ Enzym efn-E n zym e^

Enzymeper capsuie

Number o f capsules

Enzymein is the initial encapsulated enzyme mass and Enzymeo is the enzyme mass
leached out at weekO immediately after loading and rinsing. Figure 43 contains a graph
showing the comparison o f uptake efficiency o f the capsules. It can be seen that {PVSCHT}2 + {PSS-PAH}2(MF) capsules, believed to have an internal matrix (comprising o f
MF oligomers, CHT and PVS), had the maximum encapsulated GOx (37pg/capsule).
Among the capsule architectures that did not have an internal matrix,

{PSS-

PDDA} 4 (MF) had a relatively high mass o f encapsulated GOx (31pg/capsule) entrapped,
though this was primarily in the walls, as is evident from the confocal images o f Figure
42(a).
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Figure 43. Mass o f GOx encapsulated per capsule
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In the case o f {PSS-PAH}4 (MC) capsules it can be observed from the confocal
line scans in Figure 42 (m) and (n) that the maximum entrapment o f enzyme occurs to a
greater extent around the walls and progressively decreased towards the center o f the
capsule. This indicates that the polymerization o f arginine is higher in the periphery o f
the walls than the capsule interior. Hence, the mass o f GOx encapsulated enzyme is less
compared with the {PVS-CHT }2 + {PSS-PAH} 2 (MF) capsules, which also have an
internal matrix.
5.1.2.3

Leaching o f GOx from M icrocapsules. Leaching o f encapsulated GOx was

studied over a four-week period to evaluate the percentage o f the enzyme retained in the
capsule for each o f the different wall architectures. The percentage o f enzyme remaining
in the capsules at the end o f the four-week study is graphically shown in Figure 44. These
values were calculated by using the equation:
Enzyme jn —(E nzym e^+Enzym e\+Enzyme^)
Enzymerem = ----------------------- - --------------------------------Enzymejn
Enzymein is the initial encapsulated enzyme mass. Enzymeo is the enzyme mass
leached out at weekO immediately after loading and rinsing. Enzymej and Enzymes are the
enzyme masses leached out at w eekl and weekS respectively
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Figure 44. Percentage o f GOx remaining in capsules with architectures (PSSPAH} 4(MF), (PSS-PDDA} 4 (MF), {PVS-PAH}2 + {PSS-PAH} 2 (MF),{PVSCHT } 2 + {PSS-PAH} 2 (MF) and (PSS-PAH} 4 (MC- internal arginine matrix) at the
end o f the 4-week leaching study
It can be seen that {PSS-PAH } 4 (MC) capsules with internal ariginine matrices
had the least leaching o f GOx, with 97% o f the enzyme remaining in the capsules. (PVSCHT } 2 + (PSS-PAH} 2 (MF) capsules also retained a large quantity o f enzyme (79%). In
contrast, (PSS-PAHM M F) capsules showed complete leaching o f GOx by the second
week o f study. From these results, it is apparent that capsules with internal matrices retain
more encapsulated enzyme over a period o f time. Among the hollow capsules, (PSSPDDA} 4 (MF) capsules retained the largest percentage o f encapsulated GOx (59%);
(PSS-PAH}4(MF) capsules showed 100% leaching o f the enzyme and (PVS-PAH}2 +
(PSS-PAH) 2 (MF) could retain only 14% o f the initial encapsulated GOx. Different
materials interact with GOx in different ways; some can entrap enzymes more efficiently
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than others. These interactions may be electrostatic, hydrophobic and hydrophilic
interactions, hydrogen bonding and coordination bonding or a combination o f many or all
o f these interactions. Also, depending on the elasticity o f the materials used, the walls
react differently to the osmotic pressures generated during core dissolution, as a result o f
which wall structures are also different; some capsules may have larger pores than others.
The wall structure also determines the quantity o f enzyme entrapped.
5.1.2.4

Estimation o f Number o f Capsules in Each o f the Samples. The Coulter

counter was used to obtain sizes and concentrations o f the capsule samples. The results
obtained are shown in Figure 45. Though a distribution o f values for size and
concentration are indicated in the figures, the mean values o f size and concentration have
been considered for calculations.
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Figure 45. Results o f sizing and concentration o f capsules

5.1.2.5

Activity o f Entrapped/Encapsulated GOx Over a Four-W eek Period. The

activity/unit mass is a measure o f the percentage o f active entrapped enzyme; i.e., the
fraction o f encapsulated enzyme that is active. Higher encapsulation efficiency does not
necessarily mean that the entire percentage o f encapsulated enzyme is efficiently
available for reaction. There are a number o f reasons for this. Tight packing o f enzymes
in the capsule and interaction o f enzymes with the matrix in the capsule interior may
cause the enzyme to conform unfavorably, which may lead to concealment o f its active
site. Also, constraints placed on diffusion o f the analyte and components o f the activity
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assay may lead to difficulty in accessibility of the enzyme. Hence, the net activity
obtained is either that of a fraction of the active enzyme that is accessible to the analyte
or assay, or the activity of the fraction of the encapsulated enzyme that has been able to
retain its most stable conformation, or a combination of both factors. A possible reason
for variability in results is that the concentration of capsules/active enzyme is not
sufficient because of which the signal to noise (SNR) ratio is small.

Among the

significant contributors to noise are the continuous stirring of the assay using a magnetic
stir bar and scattering of light by the capsules themselves. In order to compare activities
of each of the capsule architectures over the four-week period (Figure 46), student t-tests
were used to determine if the activity/unit mass values differed significantly over the
weeks ( a value of 0.05).
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Figure 46. Activity of effective active encapsulated GOx in capsules over a
four-week period. Calculated activity is per unit mass. Symbols indicate
significant difference in activity over time, determined using student t-tests
using a = 0.5
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According to the tests, capsules with architectures {PSS-PDD A} 4 (MF) and {PVSCHT } 2 + (PSS-PAH} 2 (MF) did not show a significant change in activity over the fourweek period. Except for {PSS-PAH} 4 (MF) capsules, which completely lose activity by
the second week, a distinct trend in change in activity was not identifiable in the case o f
the other architectures. Since the activities were normalized to enzyme mass the
activity/unit mass is indicative o f the effects o f materials comprising the capsule wall and
capsule interior on the encapsulated enzyme. From Figure 46, it is can be concluded that
since there were no significant differences in activity/unit mass over the four-week study
in the case o f both {PSS-PDDA} 4 (MF) and {PVS-CHT}2 + {PSS-PAH} 2 (MF) capsules,
the capsule materials did not have an adverse effect on enzyme conformation.
Summarizing the above results, {PSS-PDD A) 4(MF) and {PVS-CHT }2 + {PSSPAH} 2 (MF) capsules retained a significant portion o f encapsulated enzyme at the end o f
the four-week study (59% and 79%, respectively). However, it has to be underscored that
the enzyme was entrapped in the walls and there was no internal matrix in the case o f
{PSS-PDDA} 4 (MF) capsules, whereas in the case o f {PVS-CHT } 2 + {PSS-PAH} 2 (MF)
capsules it was encapsulated in the internal charged matrix. This m ay be the reason why a
higher percentage o f GOx leached out in the former case.
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5.2 Comparison of Diffusion Properties of
Different Wall Architectures by
Fluorescent Recovery After
Photobleaching (FRAP)
5.2.1 FRAP Experiments to Study the Effect
of Capsule Wall Architecture on
Diffusion of FITC-GOx.
Diffusion coefficients for GOx were obtained in the case o f each o f the four
architectures by performing FRAP experiments and using mathematical models for
calculation o f diffusion coefficients o f GOx as described in Chapter IV. Figure 47
contains a graph showing the comparison o f diffusion coefficients for various wall
architectures.
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Figure 47. Comparison o f average GOx diffusion coefficients o f the 4 capsule
types. Models, M l and M2 were used to estim ate diffusion coefficients from raw
data o f fluorescence recovery obtained after photobleaching o f capsules.n = 8 for
{PSS-PAH}4 (MF) and {PSS-PDDA} 4 (MF) , n = 6 for (PVS-PAH } 2 + {PSSPAH} 2 (MF) and {PVS-CHT } 2 + {PSS-PAH} 2 (MF)
Student t-tests were performed to statistically verify i f the diffusion coefficients
were significantly different from each other. Average diffusion coefficients for GOx were
three times higher for {PSS-PDDA} 4 (MF) capsules than for {PSS-PAH}4 (MF) capsules
indicating that {PSS-PDDA} 4 (MF) capsule walls are more permeable than {PSSPAH} 4 (MF) capsule walls. However, referring back to the leaching results, larger
quantities o f GOx leached out (PSS-PAH}4(MF) capsules than {PSS-PDDA}4(MF)
capsules. The two results cannot be corroborated because the entrapment o f GOx in the
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two cases occurs in the capsule walls; though the diffusion coefficients are indicative o f
the permeability o f the walls, they cannot be used to describe the capacity o f capsules to
retain the enzyme entrapped in the walls. Hence, though {PSS-PDDA} 4 (MF) are highly
permeable to GOx by simple diffusion, they entrap and retain GOx more efficiently in the
walls than (PSS-PAH} 4 (MF) capsules.
Diffusion coefficients o f GOx for {PSS-PDDA} 4 (MF) and {PVS-PAH } 2 + {PSSPAH} 2 (MF) capsules were comparable. This result was expected, because {PVS-PAH } 2
+ {PSS-PAH} 2 (MF) capsules had only two bilayers o f PSS-PAH, and it has already been
mentioned that the inner PVS-PAH layers are weak. Hence, the inner PVS-PAH bilayers
may have partially disintegrated during the core dissolution process or may be
discontinuous and for this reason, more permeable than {PSS-PAH} 4 (MF) capsules.
GOx had higher diffusion coefficients in the case o f {PVS-CHT } 2 + {PSSPAH} 2 (MF) capsules compared with the other three types o f capsules. A possible reason
for this result is that the internal charged matrix o f the capsules played an important role
in attracting and hence rapidly drawing the enzyme into the capsule interior, whereas in
the other three cases, the enzyme entered the capsules by simple diffusion.
The mobile fraction (R) was calculated in each o f the four cases (Figure 48).
The mobile fraction can change due to. different circumstances: interaction o f the
fluorescent labeled molecules with other molecules or materials (capsule wall, internal
matrix etc), which could prevent or restrict the free diffusion o f molecules. Capsules with
architectures

{PSS-PDD A} 4 (MF)

and

{PVS-PAH} 2

+

{PSS-PAH} 2(MF)

comparable mobile fractions that were approximately twice that o f

had

{PVS-CHT}2 +

(PSS-PAH} 2 (MF) and {PSS-PAH} 4 (MF) capsules. For capsules with higher mobile
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fractions, diffusion coefficients for GOx were higher, except for {PVS-CHT }2 + {PSSPAH} 2 (M F) capsules. A possible reason is that while the presence o f a matrix reduces
the mobile fraction, the inward movement o f the labeled enzyme is faster because o f
electrochemical attraction by the charged matrix.
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Figure 48. Comparison o f average mobile fractions o f the 4 capsule types.n = 8
for {PSS-PAH} 4 (MF) and (PSS-PDDA} 4 (MF) , n = 6 for{PVS-PAH } 2 + {PSSPAH} 2 (MF) and {PVS-CHT } 2 + (PSS-PAH} 2 (MF)
Recently,

a

novel

LbL

assembly

of

photosensitive

diazoresin

was

demonstrated215. This technique is advantageous in that it can be used to improve stability
o f multilayer films by converting weak interactions between adjacent layers into strong
covalent bonds, and can be applied to a variety o f materials containing sulfonate groups,
carboxylic acid groups, or phenol groups216. Further, the procedure is uncomplicated and
comprises o f two steps: first, self-assembly involving ionic (for sulfonate groups) or
hydrogen-bonding (for carboxylic acid or phenol groups) forms the initial multilayer;
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second, the weak interaction between the neighboring layers is converted to a covalent
one by U V irradiation. A previous report described how the stability o f hollow capsules
based on DAR was improved by this procedure. A useful conclusion drawn from this
work was that DAR-based systems can be prospective candidates for permanent
encapsulation

o f materials

217
.

Another

recent

publication

reported

the

stable

encapsulation o f GOx using DAR-based microcapsules184. Confocal microscopy and
atomic force microscopy confirmed stable encapsulation o f enzyme after UV irradiation,
and activity assays revealed that encapsulated enzyme possessed 52.8% o f the catalytic
activity exhibited by the same amount o f free enzyme

184.
. The following section describes

the application o f the FRAP procedure to study the effect o f number o f DAR bilayers on
diffusion o f labeled GOx.

5.2.2 FRAP Experiments for Study of Effect
of Number of DAR Bilayers in Capsule Wall
on Diffusion of FITC-GOx.
Figure 49 shows that alternation o f zeta-potential with coating o f each charged
layer confirms the successful deposition o f five bilayers o f DAR/PSS.
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Figure 49. Zeta-potential measurements o f {DAR/PSS}s
FRAP
{DAR/PSS }5

experiments performed to

obtain diffusion coefficients

for MC-

and MC- {DAR/PSS }8 showed no significant differences between the

values o f diffusion coefficients obtained for capsules with five bilayers and eight bilayers
(Figure 50).
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Figure 50. Diffusion coefficients o f MC-{DAR/PSS }5 and MC{DAR/PSS}g
Figure 51 contains a graph comparing the mobile fractions for MC- {DAR/PSS} 5
and MC-{DAR/PSS}8 capsules. Though the diffusion coefficients o f the labeled enzyme
are comparable in both cases, the mobile fraction reduces by a factor o f 5 after addition
o f three bilayers o f DAR/PSS. The reduction o f the mobile fraction indicates that the
addition o f layers does obstruct the diffusion o f GOx, which reduces enzyme recovery in
the capsule interior.
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Figure 51. Comparison o f average mobile fractions for MC-{DAR/PSS } 5 and
MC-{DAR/PSS}g.n = 6 for MC-{DAR/PSS } 5 and MC-{DAR/PSS } 8
From the results o f the procedures described in this section to compare
microcapsules with different architectures, it was concluded that
{PSS/PAH }2

{PVS/CHT}2-

capsules were the most stable and showed minimal leaching (79% o f

enzyme retained) and the activity o f the encapsulated enzyme did not change
significantly over four weeks.
Capsules with wall architecture {PVS/CHT}2 - {PSS/PAH} 2

were selected for

demonstration o f glucose sensing. The experiments performed to characterize these
sensors and the corresponding results and discussion are described in the next section.
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5,3 Fluorescence Sensors for Glucose Using
pH-Sensitive Fvrene 8-Hvdroxv-l ,4,6Trisulfonvlchloride (HPTS)
Capsules with an internal charged matrix o f chitosan, PVS, and melamine
formaldehyde oligomers were fabricated by LbL assembly o f {PVS-CHT }2 + {PSSPAH} 2 on M F templates. They were loaded with TRITC-GOx for visualization with
confocal microscopy. Morphology o f unloaded capsules was studied using AFM. The
capsules were loaded with unlabeled GOx to study the stability o f enzyme-loaded
capsules and activity o f the encapsulated enzyme over a period o f four weeks, using
techniques described in Chapter IV. The results o f stability and activity studies were
described in section 5.1. A pH-sensitive dye (HPTS), was used to label GOx, and HPTSGOx was loaded into the capsules. Since HPTS has dual excitation peaks and shows
ratiometric variation in response to changes in pH, no reference dye was required to
account for variation o f sensor response from fluctuations in instrument parameters or
environmental changes. In order to study the effect o f labeling on the pH response o f
HPTS, pH sensitivities o f both conjugated and free HPTS were studied. The sensors were
evaluated for glucose sensitivity and response.

5.3.1 Visualization of Loaded Capsules
Using CLSM and AFM
Confocal fluorescence and transmission images o f capsules in loading solution o f
TRITC-GOx and a typical line scan o f loaded capsules are shown in Figures 52(a)
through (d). The transmission image o f a capsule shows that it has an opaque interior,
which indicates that it is not hollow and empty. The linescan (Figure 52 [d]) proves that
the intensity in the interior o f the capsules and the walls is

100

times the intensity o f the
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loading solution, indicating that the quantity of GOx inside the capsules is far more than
that in the loading solution. From AFM images of “empty” capsules, (Figure 52 [e]
through [g]) it is clear that the capsule is not flat. An estimate of the average height of
capsules was calculated by averaging the heights at 40 random points on the imaged
capsule. The average height was calculated to be 1.3pm. Assuming the average thickness
of the wall to be (4x4nm=;16nm), the height should not exceed (2xl6nm=32nm) when the
capsules collapse after drying if the capsules did not have a matrix,. Thus, the height of
the capsule with an internal matrix is 41 times the height of a collapsed capsule without
an internal matrix, clearly indicating the presence of a matrix.
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Figure 52. (a),(b) Confocal fluorescence and (c) transmission mode images, and (d) line
scan of chitosan capsule loaded with TRITC-GOx, (e)AFM 3-D and (f),(g) 2-D images of
unloaded Chitosan capsule
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5.3.2 Working of HPTS Dye
The pH-sensitive dye HPTS consists o f a conjugate acid and conjugate base pair. The
excitation spectra o f HPTS (Figure x) indicate the presence o f two excitation maxima,
namely, 405nm (excites the conjugate acid part) and 454nm (excites the conjugate base
part). The pH o f the solution decides the relative concentrations o f the acid and base
components, and consequently also decides the intensities o f the two peaks. Hence, the
peak ratio (405/454nm) varies with the pH.
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Figure 53. Spectra o f HPTS
(Source: http ://www.probes.com/handbook/figures/0578.html)

5.3.3 Buffer Solution Equilibrium: Effect of
Addition of Acid on pH of Buffer, HPTS and
HPTS-GOx (Both in Buffer) Solutions
The standard equilibrium equation for a phosphate buffer system is
H2PO4' + H20 < -> H30 + + HPO42'
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T he equilibrium constant Ka= 6.3xl0"8 is calculated using:

Ka -

[H 3 0 +] [HPO 4 2-]
-----------------------[H2PCV]

(15)

Addition o f 0.1M HC1 causes the equilibrium to shift to lower pH values due to
the reaction ofH C l with the conjugate base. This corresponding reaction is:
HC1 + HPO42' -> H2P (V + C f

(16)

A fter estimation o f the change in number o f moles o f the conjugate acid and base
from equation (16), the final value o f the number o f moles o f H 3 0 + is calculated
using equations (14) and (15). The pH o f the buffer after addition o f the acid is
given by:
pH = -log[H 3 0 +]

(17)

In this way, values for pH o f the buffer following each successive addition o f HC1
were calculated. These values were also experimentally determined by measuring the pH
o f solutions o f PBS 7.4 buffer, HPTS in PBS 7.4 buffer and HPTS-GOx in PBS 7.4
buffer while titrating 0.1M HC1. Figure 54 contains a comparison o f the experimental and
predicted values o f changes in pH o f PBS buffer, and the experimental values o f HPTS
and HPTS-GOx in PBS buffer during acid titration. The experimental values in all three
cases, PBS, HPTS in PBS and HPTS-GOx in PBS indicate that pH changes follow the
same trend, irrespective o f the presence or absence o f the dye or the enzyme. The
predicted values agreed with the experimental values with a maximum variation o f 18%
for the last two datapoints. It was experimentally determined that the pH electrode
absorbed 12-15/il o f buffer solution after every measurement. However, the variation
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between the predicted and experimental values for the last two datapoints was observed
even after accounting for the volume changes of the buffer associated with the
measurement process.
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Figure 54. Change in pH with titration of 0.1M HCI solution: comparison of
calculated results with experimental result in the case of PBS 7.4 buffer, HPTS in PBS
buffer and HPTS-GOx in PBS buffer.

5.3.4 Comparison of Response of HPTS
Solution and HPTS-GOx in PBS Buffer
to Titration of 0.1M HCI
The response of the conjugated dye in solution to changes in pH was studied by
recording the fluorescence spectra of HPTS-GOx after subsequent additions of 0.1M
HCI. As mentioned in the previous section, the pH of the solution changed significantly
with the addition of aliquots of acid. It is also apparent that in both cases pH changes
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approximately matched up with each other at every point o f titration. The decrease in pH
caused a corresponding increase in the excitation peak ratio (405/454nm), as shown in
Figures 55(b) and 55(d). The pH changed from 7.4 to 4.4 at the end o f the titration
experiment. The peak intensity ratio also changes comparably in both cases. The shapes
and consequently the ratios obtained in the two cases are different because the number o f
HPTS molecules in a solution o f HPTS is far more than those in the same volume o f
HPTS-GOx due to which a stronger fluorescence signal is obtained from the former.
Also, the process o f conjugation o f HPTS with GOx can alter the spectra o f HPTS
because o f the change in the local environment o f the ligand and its structure after
conjugation218.
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Figure 55 Changes in fluorescence intensities of the acid (405nm) and base (454nm)
peaks of (a) HPTS and (c) HPTS-GOx with addition of aliquots of 0.1M HCI. Peak
intensity ratios of (b) HPTS and (d) HPTS-GOx vs. addition of 0.1M HCI.

The experiments performed in 5.5.3 and 5.5.4 verified that the pH of the buffer
changed in a predictable manner with the addition of HCI, both in the presence and the
absence of the labeled enzyme. Also, though the shape of the curve and the peak ratios
were altered due to labeling, there was an increase in peak ratio with the addition of acid
in both cases. According to the glucose oxidation reaction, for every molecule of glucose
oxidized, a corresponding hydrogen ion is generated, and so the pH changes due to the
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addition o f glucose can be correlated with those due to addition o f HCI. Hence, the
equilibrium equations for the PBS buffer system can be used to estimate pH changes due
to addition o f glucose.

5.3.5 Glucose Titration Test for
HPTS-GOx in P I Water
Initial spectra o f HPTS-GOx in DI water (measured pH o f DI water =5) showed a
prominent acid peak (405nm), and the absence o f a basic peak (454nm). Addition o f 2/d
o f 0.2M KOH to the solution sufficiently raised the pH (7.8-8) to produce a strong basic
peak. Subsequent addition o f small volumes o f glucose( 1OOmg/ml) rapidly reduced the
pH o f the solution. It can be seen from Figure 56 that addition o f only 9/imoles o f glucose
reduced the pH from 8 to 5 and completely suppressed the basic peak.
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Figure 56. Spectra o f HPTS-GOx solution (in DI water) during glucose titration
experiment
The final pH o f the solution was found to be approximately 5. Hence, HPTS-GOx
solution in DI water is not a good medium for testing the glucose sensitivity o f the
protein-dye conjugate because the protons generated by the catalytic action o f GOx on
glucose rapidly lower the pH o f the entire volume o f the solution. Moreover, since the
primary application o f the sensor is intended to be in vivo, and most regions o f the body
are buffered to a pH o f 7.4, a physiological buffer PBS 7.4 was used to study the
sensitivity o f HPTS-GOx to glucose.
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5.3.6 Glucose Titration Tests for HPTS-GOx
in PBS 7.4 Buffer
A t the pH o f the PBS buffer used (7.4), both the conjugate acid and base forms o f
HPTS exist. Therefore, both acid and base peaks at 405nm and 454nm, respectively, are
prominent in the initial spectra before addition o f glucose. Figure 57 shows the effect o f
serial addition o f known aliquots o f glucose (lOOmg/ml), which increased the glucose
concentration o f the solution from GmM to 266mM at the end o f the titration experiment.
OmM
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Figure 57. Response o f HPTS-GOx in PBS 7.4 buffer to glucose titration.
Since three consecutive measurements were made after addition o f glucose, and
the error in measurements was within 2% o f the average value, it can be assumed that the
added glucose reacted completely before each measurement was made. Each addition o f
glucose reduces the pH o f the solution in a controlled manner due to the buffering action
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o f PBS, resulting in a finite reduction o f the acid-to-base peak ratio. The buffer
neutralizes a portion o f the protons generated by the enzymatic reaction between the
conjugated GOx and glucose. However, addition o f large quantities o f glucose surpasses
the buffering action o f PBS, and the overall pH o f the solution at the end o f the glucose
titration experiment was found to be between three and four.
Figure 58(a) shows the sensitivity curve, i.e. the curve showing the change in
peak ratio(405/454nm) o f HPTS-GOx with titration o f known aliquots o f glucose. With
each addition o f glucose to the solution, the cumulative concentration o f acid generated
due to oxidation o f glucose increased. The peak ratio increased approximately linearly
between OmM to 112mM, due to a steady increase in acidity o f the solution with each
successive aliquot o f glucose, caused by the enzymatic catalysis o f glucose by GOx with
acidic byproducts (gluconic acid). The slope o f the sensitivity curve in the linear region
•5

was calculated as 3.3x10" ratio/mM. The pH o f the solution changes significantly (pH 34) at the end o f the titration experiment due to addition o f a large quantity o f glucose and
generation o f acidic products, which cannot be compensated by the buffering action o f
PBS. The measured value o f the final pH agrees with the predicted value (3.6), which
was calculated using the Le Chatelier’s principle and the equilibrium equations for PBS
buffer. Above the linear range, the signal appears to plateau, since HPTS becomes
insensitive to pH changes at very low pH values (pH values around three). The linear
region o f the sensitivity curve, which was obtained by titrating known aliquots o f
glucose, can be used as a calibration curve to measure unknown glucose concentrations.
To measure unknown glucose concentrations, the measured intensity ratio after adding an

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

154

aliquot o f glucose is corroborated with the x-axis values (intensity ratios) o f the
sensitivity curve, and the corresponding y-axis value indicates the glucose concentration.
The estimated error in predicted glucose concentration was calculated as follows
for all glucose sensitivity experiments:
The measured glucose (G) is given by

G=

(18)

A is the actual glucose concentration and ^

O

ratio

is the standard deviation in peak

intensity ratio. S is the sensitivity o f measurement given by

AmM

, The value o f

s

is a measure o f the error in glucose concentration. This value indicates the level o f noise
in the system and hence the error in the values o f predicted glucose concentrations.
Figure 58(b) shows the inverse relation between glucose added and the measured
intensity ratio, with glucose values on plotted on the ordinate and the corresponding
intensity ratios on the abscissa. This curve indicates the contribution o f instrumental
noise to glucose measurement. It is apparent from Figure 58(b), that the noise level
(standard deviation in the concentration o f glucose sensed) is not consistent across all
data points. When smaller quantities o f glucose are added, the acid generated is
correspondingly low. Hence, the change in intensity ratio is small and the measurements
are easily affected by noise. The sources o f noise can be due to continuous stirring o f the
sample, the inherent noise contributed by the electronics (PMT), and the measurement
process- the two excitation peaks (400nm and 454nm) are not measured at the same time
and hence the contribution o f instrumental noise at each peak may vary. The normal
physiological glucose range is 3.8-6.6mM (70-120mg/dl).

It can be observed from
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Figure 58 (b), that there is significant contribution from instrumental noise in this range.
Hence, the predicted value o f glucose will not be accurate because a single standard
deviation in the sensitivity curve can indicate a false-positive for hypo- or hyperglycemic
condition. This system is inappropriate for glucose sensing in the physiological range o f
interest.
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Figure 58. (a) Change in peak ratio (405/454nm) o f HPTS-GOx with titration
o f known aliquots of glucose (b) Inverse graph o f (a) indicating standard error
o f calibration due to instrumental noise

5.3.7 Glucose Titration Tests for Encapsulated
HPTS-GOx in DI Water
Initial spectra o f HPTS-GOx encapsulated in {PVS-CHTH + {PSS-PAHH
capsules in DI water (pH=5) showed a prominent acid peak (405nm) and the absence o f
a basic peak (454nm). Approximately 2/xl o f KOH was added to raise the pH o f the
solution (pH=7.8-8) to produce the basic peak. Subsequently, small aliquots o f glucose
(lOOmg/ml) were titrated to the suspension. From Figure 59 it can be seen that there is a
progressive decrease in 454nm peak with the increase in the 402nm peak with titration o f
glucose.
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Figure 59. Response o f HPTS-GOx encapsulated in {PVS-CHT } 2 +
{PSS-PAH } 2 capsules suspended in DI water to glucose titration.
Just like the glucose titration test with HPTS-GOx solution in DI water, local changes
in peak intensities also lead to global changes in the overall pH o f the dispersion. This
was verified by measuring the pH o f the dispersion after the titration experiment was
conducted. The final pH was between 2 and 3.
The variation in peak intensity with consecutive addition o f glucose aliquots (the
sensitivity curve) is shown in Figure 60(a). The peak ratio increased approximately
linearly (R2-96% ) between OmM and 35mM o f glucose addition. The slope o f the
sensitivity curve in the linear region was 2 1 x l0 ‘3 ratio/mM. The excitation ratio remains
approximately steady beyond the linear region, since HPTS is insensitive to pH changes
below pH 3. Figure 60(b) shows the inverse relation between glucose added and the
measured intensity ratio, indicating the contribution o f instrumental noise to glucose
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measurement, with glucose values plotted on the ordinate and the corresponding intensity
ratios on the abscissa. The contribution of instrumental noise to glucose measurement is
low' in the physiological range of interest (3.8-6.6mM). Unknown glucose concentrations
in the physiological range can be determined by using the sensitivity curve as a
calibration curve and corroborating the changes in intensity ratio with the x-vaiues and
determining the corresponding y-values.
According to confocal images (also indicated at the respective time of acquisition in
Figure 60[a]) of the capsules before and after the glucose sensitivity test, the fluorescence
intensity from the capsule interior indicate that HPTS-GOx did not leach out of the
capsules after the glucose test and that the capsules were intact after the test. Hence, the
response to glucose additions was from the capsule interior.
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Figure 60.(a) Change in peak ratio (405/454nm) of HPTS-GOx encapsulated in
{PVS-CHT } 2 + {PSS-PAH } 2 capsules in DI water with titration of known aliquots
of glucose (b) Inverse graph of (a) indicating standard error of calibration due to
instrumental noise
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Figure 61 is an illustration o f the reaction involving oxidation o f glucose by HPTS
labeled GOx encapsulated in a microcapsule and suspended in D I water. Changes in local
pH (inside the capsule) were responsible for a corresponding change in peak intensity
ratio o f HPTS. In spite o f the possible buffering action o f the indicator (HPTS) in the
capsule interior during the sensing process, some protons diffuse to the solution
surrounding the capsule, and the absence o f any kind o f buffering action by the DI water
raised the pH globally as well as local to the sensor.
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Figure 61. Illustration o f the working o f HPTS-GOx sensors during glucose
titration test in DI water.
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5,3.8 Glucose Titration Test for HPTS-GOx
Encapsulated in Chitosan Capsules (Capsules
Suspended in PBS 7.4 Buffer)
Both acid and base peaks at 405nm, and 454nm, respectively, were prominent in
the initial spectra before addition o f glucose. Figure 62 contains spectra showing the
effect o f serial addition o f aliquots o f glucose.

1 .2 5

E
c
s
5
o
0

OmM

1.2
1 .1 5

'I f

o'
«U.

1.1
1 .0 5

£m

c
a>
1

1
450mM

T3 0 .9 5
a)
N
(0 0 .9

E

O

0.85

0.8
350

370

390

410

430

450

470

W avelength (nm)
Figure 62. Response o f HPTS-GOx encapsulated in {PVS-CHT } 2 + (PSSPAH }2 capsules suspended in PBS 7.4 buffer to glucose titration. The peak
ratio increases steadily with each successive addition o f glucose.
The variation in peak intensity with consecutive addition o f glucose aliquots (the
sensitivity curve) is shown in Figure 63(a) with the inverse graph in Figure 63(b). There
is a linear increase in peak ratio between OmM and 32mM (R2=93%) o f glucose, which
covers the physiological range o f interest. The slope o f the sensitivity curve in the linear
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region was calculated to be 3.7xl(F3 ratio/mM. The contribution from instrumental noise
to glucose measurement as indicated in Figure 63(b); given a real value of
glucose=5.5mM, the indicated value due to instrumental noise can be anywhere between
4.6 and 6.4mM. Similarly, at the lower end of the physiological range of interest, for
actual glucose value=3.3mM, the indicated value can vary anywhere between 2.5 and
4.1mM. For smaller quantities of glucose added, the acid generated is correspondingly
low; this factor combined with the low sensitivity of the sensors leads to smaller changes
in intensity ratio, and the measurements are more easily affected by noise.

Range: 0-63mM
Pre-glucose

1000

-

srE
100
!

Post-glucose
10
=

0 .8 5

1
10

100

GIucoss concentration (mM)

0.78

0.83

0.88

0.93

0.98

1.03

1.08

Normalized intensity ratio (AU)

Figure 63. .(a) Change in peak ratio (405/454nm) of HPTS-GOx encapsulated in
{PVS-CHT }2 + {PSS-PAH } 2 capsules in PBS 7.4 with titration of known aliquots of
glucose (b) Inverse graph of (a) indicating standard error o f calibration due to
instrumental noise
Confocal images also indicated at the respective time of acquisition in Figure
63(a) of the capsules before and after the glucose sensitivity test prove that just like the
previous case, the capsules were intact and HPTS-GOx did not leach out of the capsules
after the test. The pH of the entire suspension was measured with a pH strip both before
and after glucose titration test and was found to remain approximately constant. Hence, it
is apparent that local pH changes (inside the capsule) were responsible for change in peak
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intensity ratio o f HPTS-GOx. Protons that diffuse rapidly into the solution around the
sensors are compensated by the buffering action o f PBS. Each addition o f glucose causes
the pH o f the encapsulated HPTS-GOx to reduce in a controlled manner due to the
buffering action o f PBS, resulting in a steady reduction o f the acid-to-base peak ratio. In
this case, global changes in the overall pH o f the suspension were not observed; the pH
did not vary significantly when measured before and after the glucose test.
Figure 64 illustrates a possible mechanism by which there are pH induced
changes in the response o f HPTS inside the capsule, while the pH o f the suspension
remains approximately constant during the glucose titration experiment. HPTS consists
of a conjugate acid- conjugate base pair, and essentially acts as a buffer for protons. The
conjugate base reacts with protons thus altering the fluorescent properties o f the dye
depending on the equilibrium between the conjugate acid-conjugate base pair. Protons
generated inside the capsule interact with HPTS before they interact with phosphate
buffer due to proximity o f the pH-sensitive dye to the reaction products o f HPTS-GOx
catalyzed oxidation o f glucose. Since these protons are bound to the dye producing a
change in its response, they can no longer change the pH o f the suspension. In this way,
HPTS buffers the internal environment o f the capsule, and predominates over the effect
o f PBS buffer. The protons that do not interact with HPTS are buffered by PBS. There
are references describing this effect when analyte specific dyes are introduced in
cells219’220. Dyes that are pH-sensitive have been shown to buffer the internal cell
environment221.
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The reactions representing a system involving glucose oxidase are:

A

+ E <------ > X i
kj,k-j

> F + gluconate
h

X2

>

F + H 20 2

h,k-3
where ki, k 2 , k 3 , k4 and k-i, k .3 are the forward and reverse reaction rate constants,
respectively, A and C are the primary and co-substrates (glucose and oxygen), F and E
are the reduced and oxidized form o f the enzyme. X] and X 2 are the complexes formed
due to binding o f enzyme with glucose and oxygen, respectively. Since the total enzyme
concentration in the system is constant, and according to the pseudo-steady-state
assumption the formation and dissociation o f intermediate complexes (Xi and X 2 ) occur
very rapidly, and the two coupled differential equations representing the system are:

^
dt

=DgFX-k,AE + k.,X,

(19)

S r)v2

(20)

where D g and D 0 are the diffusion coefficients for glucose and oxygen
respectively. Furthermore, (19) can be related to proton (H4) production and diffusion by

8H +

= k

dt
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where Du is the proton diffusivity. The protons produced during the oxidation o f
glucose are available for reaction with HPTS. The base form o f HPTS reacts with H+
producing the acid form o f HPTS.
H+ + HPTS <—►HPTS (H^)
(base)
(acid)
Since the acid and base forms o f HPTS are excited at different peaks (405nm and
454nm respectively), the peak ratio changes with the change in pH.
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Figure 64. Illustration o f the working o f HPTS-GOx sensors during glucose
titration test in PBS buffer.
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Le Chatelier’s principle and using equilibrium equations for PBS described in
section 5.5.3 were applied for prediction o f change in pH o f PBS buffer with addition o f
aliquots o f 0.1M HC1 to determine the final internal pH o f the sensors suspended in PBS
after performing the glucose titration experiment (Figure 65). For every mole o f glucose
added, correspondingly a mole o f H+ is generated, with the assumption that all the
glucose has reacted. The assumption is valid because after addition of an aliquot o f
glucose, three consecutive measurements were made and the maximum error in
measurements was within 2% o f the measured ratio, which indicates that for every
measurement all o f the added glucose was oxidized. Another assumption was that the
concentration o f PBS molecules is the same inside the capsule as the surrounding
solution. The reason for this assumption is that the sensitivities o f free and encapsulated
HPTS-GOx in PBS solution are comparable (3.3x1 O'3 and 3.7x1 O'3 respectively)
indicating that the availability o f PBS to the labeled enzyme is the same in capsules as in
solution. The value o f pH was calculated to be 3.2 at the end o f the glucose titration
experiment. Since HPTS is insensitive to pH changes below pH 3, the peak ratio remains
steady with the decrease in pH.
A comparison o f the properties o f the HPTS-GOx sensing system both in
solution and after encapsulation is presented in Table 1. It can be seen that encapsulated
HPTS-GOx tested in DI water has higher sensitivity than that tested in PBS because in
the latter case, protons generated during oxidation o f glucose are compensated by PBS.
From the experiments performed above, it is apparent that the response o f sensors
fabricated by encapsulating HPTS-GOx in {PVS-CHT }2 + {PSS-PAH }2 was linear in
the physiological range o f interest, both when the sensitivity experiments were
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performed in DI water and in buffer. Since most regions o f the human body are
buffered at approximately pH 7.34, the results o f the glucose sensitivity experiment in
PBS buffer are more appropriate for in vivo applications.
In order to alleviate the effects o f instrumental noise in order to improve the
response o f the sensors in the physiological region o f interest, especially for experiments
performed in PBS, a number o f steps can be taken: optimization o f stirring speed o f
sample during measurement, using higher concentrations o f sample to minimize the
effects o f the inherent noise contributed by the electronics (PMT), and using a dual
emission channel fluorometer (the two excitation peaks are not measured at the same
time and hence the contribution o f instrumental noise at each peak may vary). The
sensitivity o f HPTS-GOx is 10 times less in PBS than in DI water because o f which the
effects o f noise are more pronounced when experiments are peformed in buffer. In order
to improve the sensitivity o f HPTS-GOx in buffer, the labeling ratio and the strength o f
the buffer can be optimized. Also, by controlling the surface charge o f the outermost
layer o f the wall, diffusion o f PBS buffer molecules into the capsule interior can be
prevented by Donnan exclusion222,223.
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Table 1. Range and sensitivity o f (a) HPTS-GOx solution in PBS buffer, (b)
Encapsulated HPTS-GOx in DI water, and (c) Encapsulated HPTS-GOx in PBS
buffer

HPTS-GOx
solution in
PBS buffer

HPTS-GOx
encapsulated in
{PVS-CHT}2 +
{PSS-PAH}2 tested
in DI w ater

HPTS-GOx
encapsulated in {PVS-

CHT}2 + |PSS-PAH}2
tested in PBS buffer

Linear Range (m i)

0-112

0-35

0-32

Sensitivity (ratio/mM)

3.3x1 O'3

21x1 O'3

3.7x1 O'3

A study o f microcapsules with different wall architectures and the effect o f
capsule wall components on the encapsulation o f GOx has been described. Though the
HPTS-GOx based sensors described in this dissertation have not actually been used to
measure glucose, a novel method o f measuring glucose using pH-sensitive dyes
immobilized in microcapsules has been demonstrated. The sensors exhibit a linear
response in the physiological range o f interest. Future work involves conducting
experiments to demonstrate measurement o f unknown glucose values by using the
sensitivity curves obtained in the experiments as calibration curves. Further, the
aforementioned measures need to be implemented in order to decrease the effects o f
instrumental noise on measurements, especially in PBS buffer.
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CHAPTER VI

CONCLUSIONS

This dissertation is a useful contribution to the science o f enzyme encapsulation
and glucose sensing. The methods described, particularly the application o f LbL
assembly to develop microdevices for biomedical applications, and experimental
techniques to study, compare, and characterize micro-containers serve as a useful guide
to students involved in similar research. Capsules with architectures {PSS/PAH} 4 ,
{PSS/PDDA}4, {PVS/PAH}4 + {PSS/PAH}4 , and {PVS/PAH}4 +{PSS/CHT}4 were
fabricated using MF template. Among these, internal matrices were formed in the case o f
{PVS/PAH}4 +{PSS/CHT}4 capsules during the capsule fabrication process, due to the
interaction o f CHT and PVS with the MF. In the case o f {PSS/PAH}4 capsules fabricated
using MC templates, internal matrices were fabricated by polymerizing amino acids using
zero-length crosslinkers EDC and NHS. {PSS-PDDA}4(MF) and {PVS-CHTU + {PSSPAH} 2 (MF) capsules retained a significant portion o f encapsulated enzyme at the end o f
the four-week study (59% and 79%, respectively). While the enzyme was entrapped in
the walls and there was no internal matrix in the case o f (PSS-PDDA) 4(MF) capsules, in
the case o f {PVS-CHTU + (PSS-PAHUCMF)

capsules it was encapsulated in the

internal charged matrix. This may be the reason why a higher percentage o f GOx leached
out in the former case.
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FRAP was used to compare the effect o f capsule wall architecture on mobility o f
labeled GOx. Average diffusion coefficients for GOx were three times higher for {P8SPDDA} 4 (MF) capsules than for (PSS-PAH} 4 (MF) capsules indicating that {PSSPDDA} 4 (MF) capsule walls are more permeable than (PSS-PAH} 4 (MF) capsule walls.
Though {PSS-PDDA} 4 (MF) are highly permeable to GOx by simple diffusion, they
entrap and retain GOx more efficiently in the walls than (PSS-PAH} 4 (MF) capsules.
Diffusion coefficients o f GOx for (PSS-PDDA}4(MF) and {PVS-PAH}2 + {P8SPAH} 2 (MF) capsules were comparable. Diffusion coefficients o f GOx were higher in the
case o f {PVS-CHT } 2 + {PSS-PAH}2(MF) capsules compared with the other three types
o f capsules. A possible reason for this result is that the internal charged matrix o f the
capsules played an important role in attracting and hence rapidly drawing the enzyme
into the capsule interior, whereas in the other three cases, the enzyme entered the
capsules by simple diffusion. For capsules with higher mobile fractions, diffusion
coefficients for GOx were higher, except for {PVS-CHT}2 + {PSS-PAH}2(MF) capsules.
A possible reason is that while the presence o f a matrix reduces the mobile fraction, the
inward movement o f the labeled enzyme is faster because o f electrochemical attraction
by the charged matrix.
Finally, experiments were performed to demonstrate glucose sensitivity o f
HPTS-GOx both in solution and after encapsulation. Capsules with an internal charged
matrix o f chitosan, PVS, and melamine formaldehyde oligomers were fabricated by
LbL assembly o f {PVS-CHT}2 + {PSS-PAH}2 on MF templates. They were loaded
with TRITC-GOx for visualization with confocal microscopy. M orphology o f unloaded
capsules was studied using AFM. A pH-sensitive dye (HPTS), was used to label GOx,
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and HPTS-GOx was loaded into the capsules. Since HPTS has dual excitation peaks
and shows ratiometric variation in response to changes in pH, no reference dye was
required to account for variation o f sensor response from fluctuations in instrument
parameters or environmental changes. In order to study the effect o f labeling on the pH
response o f HPTS, pH sensitivities o f both conjugated and free HPTS were studied.
The sensors were evaluated for glucose sensitivity. The response o f sensors was linear
in the physiological range o f interest, both when the sensitivity experiments were
performed in DI water and in buffer. Since most regions o f the human body are
buffered at approximately pH 7.34, the results o f the glucose sensitivity experiment in
PBS buffer are more appropriate for in vivo applications.
For future work, a number o f steps need to be taken in order to alleviate the
effects o f instrumental noise in order to improve the response o f the sensors in the
physiological region o f interest, especially for experiments performed in PBS. These
include optimization o f stirring speed o f sample during measurement, using higher
concentrations o f sample to minimize the effects o f the inherent noise contributed by the
electronics (PMT), and using a dual emission channel fluorometer (the two excitation
peaks (400nm and 454nm) are not measured at the same time and hence the contribution
o f instrumental noise at each peak may vary). The sensitivity o f HPTS-GOx is 10 times
less in PBS than in DI water because o f which the effects o f noise are more pronounced
when experiments are peformed in buffer. In order to improve the sensitivity o f HPTSGOx in buffer, the labeling ratio can be optimized.

Also, experiments need to be

performed to demonstrate measurement o f unknown glucose values by using the
sensitivity curves obtained in the experiments as calibration curves.
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APPENDIX A

ATTRACTION AND ENCAPSULATION OF H E P BY
POLYMERIZING ACRYLIC ACID MONOMERS
BY POLYELECTROLYTE
MICROCAPSULES

In the process o f exploring various possibilities for encapsulation o f GOx, a novel
method o f encapsulation o f HRP was developed. This method is unsuitable for
encapsulation o f GOx for reasons explained later in the chapter. The procedure was
developed and studied to demonstrate new and uncomplicated methods to encapsulate
macromolecules. The following section describes the results o f this short study.
Polyelectrolyte

microcapsules

with

shell

architecture

{PAH/PSS } 4

were

fabricated by LbL assembly o f polyelectrolytes on MnCOs, followed by dissolution o f
the core. After free-radical polymerization o f acrylic acid inside the capsules using
initiator (NTL^SaOg, which created a negatively charged matrix inside the capsule, the
spontaneous loading o f cationic HRP into the capsules was visualized with CLSM, and
the effect o f using increasing quantities o f monomer and initiator on percentage
encapsulation o f HRP and activity was evaluated.
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A l.l Visualization of Spontaneous Loading
of HRP Inside Capsules Using CLSM
The spontaneous loading o f TRITC-HRP (1 mg/ml) was followed by
CLSM as shown in Figure 2. The terra “spontaneous” has been used to emphasize the
fact that the internal charge o f the capsule matrix is responsible for loading o f enzyme;
the properties o f the wall are not altered in any way (by changing pH, salt composition o f
loading solution etc) to facilitate loading. It can be observed from the first confocal image
at t=0 seconds that the capsule interior had zero intensity prior to addition o f cationic
TRITC-HRP (pl=8). After addition o f the labeled enzyme, the intensity in the capsule
interior increased increased rapidly and reached a high intensity within 90 seconds as the
TRITC-HRP diffused inside the capsule. Thus, the process o f loading was simple and the
capsules were loaded quickly, and with high efficiency. It can be observed from Figure
65 that the fluorescence intensity inside the capsule reached steady state within 120
seconds. The charge o f the capsule matrix is responsible for loading o f enzyme; the
properties o f the wall are not altered in any w ay (by changing pH, salt composition o f
loading solution etc) to facilitate loading.
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Figure 65. Loading o f microcapsules with TRITC-POx. Images: Left to right:
microcapsule imaged at 0s, 30s , 60s, 90s, 120s and 150s after addition o f
loading solution. Data points on the graph represent change in the averaged
intensity in a fixed region o f interest (ROI, Area=1.2/nn2) inside in the imaged
capsule.

A1.2 Microcapsules at Various Stages Studied
Using Confocal Imaging and AFM
The process o f polymerization was not precisely controlled and limited to the
capsule interior only. Hence, the monomers polymerized even on the surface o f the
capsules. However, the fact that there is sufficient polymerization occurring in the
capsule interior can be indirectly verified by confocal microscopy imaging o f the
capsules. Figure 66 contains a capsule with an internal PAA matrix, which was loaded
with HRP and rinsed with DI water after loading.
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Figure 66. Confocal image and corresponding line scan o f capsule with
polymerized acrylic acid matrix in loading solution o f HRP

From the image, it is apparent that the capsule interior is filled with the labeled
enzyme. The acrylic acid polymerized in the surrounding solution was previously
removed by rinsing and dialyzing against DI water. For comparison, capsule without the
internal matrix is shown in Figure 68. A linescan o f the capsule in a loading solution o f
TRITC-GOx indicates equilibrium loading, with the intensity being approximately the
same inside the capsule as in the loading solution. Further, when these capsules were
rinsed, only TRITC-GOx entrapped in the walls was retained and the enzyme in the
capsule interior was removed during the rinsing process, indicating that the presence o f a
charged internal matrix helps encapsulate and retain a larger quantity o f enzyme.
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Figure 67. Confocal image and corresponding line scan o f capsule without
polymerized acrylic acid matrix in loading solution o f HRP
AFM imaging was used in order to compare the topographic features o f capsules
before and after formation o f the acrylic acid matrix, and after encapsulation o f HRP.
Figure 69(a) contains an image o f a dried capsule prior to polymerization o f PAA internal
matrix.

wrnrnm

mm

IIP
(a)
Figure 68. AFM images o f microcapsules. Left to right (a) capsules after dissolution o f
core and before polymerization o f PAA matrix ;(B) after polymerization (c) after loading
with HRP
The capsule is flat with folds and invaginations. After polymerization o f acrylic
acid and loading with enzyme, it can be seen from Figures 69(b) and 69(c) that the
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capsule is no longer flat and has a “bean bag” structure. An estimate o f the average height
o f capsules in each o f the three cases was calculated by averaging the heights at 20
random points on the imaged capsules. The average heights o f the capsules (N -3) before
and after formation o f the PAA matrix and after loading were calculated to be 163±2.4,
292±0.98 and 757±4.34nm, respectively. Thus, polymerization o f acrylic acid inside the
capsule interior caused an increase in the average height to approximately twice that o f an
empty dried capsule. Loading the capsules with HRP increased the average height to five
times its original height. The additional increase in the average height after incubation in
loading solution and rinsing, as compared to capsules after polymerization but before
loading o f HRP can thus be attributed to loading o f HRP inside the capsules.

A.I.3 Effect of (Acrylic Acid
Volumes on Efficiency of Enzyme
Encapsulation and
Enzyme Activity
Several groups have reported detrimental effects o f free radicals (peroxides,
reactive oxides, free radical sulfates, etc.) on enzyme activity224. Most free radicals are
known to inactivate enzymes by oxidizing the enzymes, whereas some act as both
oxidizing and reducing substrates, e.g. H 2 O 2 225 Based on this consideration, it was
hypothesized that use o f higher quantities o f initiator may be detrimental to enzyme
activity due to higher quantities o f residual initiator, post termination o f the
polymerization reaction, despite careful rinsing o f the capsules and dialysis. It has also
been shown that larger quantities o f monomers produce higher quantities o f the
polymerized end product and thus, higher internal ionic strength o f the capsules226.
Therefore, it was also hypothesized that a stronger internal charge will attract and retain
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more enzyme into the capsule matrix. Hence, though higher monomer volumes are
necessary to encapsulate more enzyme, if the initiator is not efficiently removed from the
capsule suspension after the reaction, it is detrimental to enzyme activity. To test these
hypotheses, the effect o f using three different volumes o f monomers and initiators (1:1 by
volume) on the enzyme encapsulation efficiency and activity was studied.
Table 2 contains a comparison o f mass encapsulated per capsule and the
activity/unit mass in the three cases. From Table 2, it can be seen that there was a
correlation between the quantities o f the monomer and initiator used and the percentage
o f HRP in the loading solution encapsulated in the polymerized capsules.

Table 2. Enzyme encapsulation efficiency and activity for loaded capsules with three
different volumes (10/d, 50/d and 100/d each) o f initiator: monomer (1:1 ratio by
volume) used in the polymerization o f acrlylic acid to form the internal matrix. Number
o f capsules=2050000, estimated by Coulter counter
Characteristic

10fjL(1:1)

50fjL(1:1)

1Q0/j L(1:1)

% Encapsulated

45%

49%

59%

Mass/capsule (ng)

0.18

0.2

0.24

Activity/unit mass
(au/mg.s)

0.007

0.025

0.51

The capsules with 100/d o f monomer and initiator encapsulated 59% o f the total
mass o f enzyme in the loading solution, whereas the others encapsulated 45% and 49% o f
HRP. The estimated mass o f HRP encapsulated per capsule was 0.18, 0.2, and 0.24ng,
respectively, for capsules with increasing reactant volumes. These data support the
hypothesis that higher volumes o f reactants attract and entrap higher quantities o f
oppositely-charged enzyme. There is an approximately linear relationship (R2=97%)
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between the increase in the volumes o f the reactants and the mass o f enzyme
encapsulated.
The activity o f the encapsulated enzyme increased exponentially with the increase
in volumes o f reactants. The sample having capsules with the highest volumes o f
monomers and initiator and correspondingly the highest percentage o f encapsulated
enzyme was nearly 70 times as active as one with the lowest volumes o f the reactants and
a lower percentage o f encapsulation o f enzyme. Since the activity is normalized to mass,
it is independent o f the mass o f encapsulated jenzyme and indicates the effect o f other
factors, such as effect of material used to create the internal matrix as well as favorability
o f the internal matrix structure to enzyme conformation, availability o f enzyme to
substrate and assay. Since the materials used for fabrication o f the matrix are the same in
all the three cases, the effect o f this factor on activity can be ruled out. According to the
kinetics o f free-radical polymerization, increasing the monomer or initiator concentration
increases the rate o f polymerization; higher initiator concentrations however produce
numerous lower molecular weight polymeric units. Hence, it is possible that some o f
these may diffuse out over time because o f which the internal matrix is not very stable
causing the encapsulated enzyme to also leach out. Hence, the effective activity is the
activity o f two populations o f enzymes- free enzyme in the solution and encapsulated
enzyme.
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Figure 69. Activity/unit mass/unit capsule o f encapsulated POx for for capsules
with three different volumes (10/d, 50/d and 100/d each) o f initiator and monomer.
Presence o f residual initiator due to inefficient separation o f capsules from the
initiator after the polymerization reaction can also inactivate the enzyme. However, in
this case, apparently, the quantity o f the free radical initiator used for the polymerization
reaction did not affect the activity, as is evident from the high activity o f the sample using
the highest volume o f initiator. This is because all samples were dialyzed overnight,
which removed the unreacted initiator from the capsule solution. Hence, an important
consideration for the maintenance o f activity o f the encapsulated enzyme is an efficient
separation o f the initiator from the capsules prior to loading o f the enzyme.
In this study, a monomer: initiator volume ratio (and hence concentration ratio)
has been maintained constant, though the volumes have been changed to study the effect
o f increasing quantities o f the reactants on the encapsulated enzyme. Hence, future work
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will involve studying the effect o f factors such as initiator to monomer ratio, and the
reaction incubation time on the formation o f PAA and activity o f the encapsulated
enzyme. Also, long-term effects o f encapsulation on the enzyme stability and activity
(activity/unit mass) will have to be studied. Such a study is important to understand if the
entire encapsulated enzyme is equally active or if there are different populations o f
enzymes with different conformations depending on their position in the matrix. If the
enzyme is bound too tightly in the matrix, it may not be able to move or change its
conformation during catalysis, and is hence inefficient.

A1.4 Attempt to Load GOx Into Capsules
With Polvacrvlic Acid Matrix in
the Capsule Interior
W ith the successful encapsulation o f HRP, the method was tested for the
encapsulation o f GOx. Various methods, such as varying the pH o f the loading solution
o f FITC-GOx (pH 5 and pH 9), were attempted in order to study the effect o f varying the
charge o f FITC-GOx and the PAA matrix on loading. Figure 71 shows the typical results
in each case. The attempts to load FITC-GOx using this method were unsuccessful. The
successful loading o f HRP and the failure to load GOx can be explained by the fact that
GOx(pI=4.2) has an acidic isoelectric point whereas that o f HRP is basic (pl=8.1). Also,
the isoelectric point o f PAA is at a low acidic pH.
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Figure 70. {PSS/PAH} capsules with poly(acrylic acid) matrices in the core in (a)
acidic (pH 5) loading solution, and (b) basic (pH 9) loading solution

So, at basic pHs o f loading solution, TRITC-GOx is negative and PAA matrix is
also strongly negative. Therefore, the internal matrix electrostatically repels the likecharged enzyme molecules. At acidic pHs, TRITC-GOx is positively charged, and the
PAA matrix is close to its p i and hence weakly negatively charged. The results concluded
that in both cases GOx is repelled by the capsule interior and cannot be encapsulated by
this method.
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APPENDIX B

STUDY O F PM M A AS AN A LTERNA TIVE
TEM PLA TE TO M.F

This work was aimed at developing a novel and repeatable method for fabrication
o f microcapsules using LbL assembly o f polyions on PMMA templates, followed by
dissolution o f the PMMA core using acetone. The main challenge was to have the
appropriate number and types o f polyions (wall composition and thickness) and most
appropriate procedure for titrating water into the suspension o f capsules (after dissolution
with acetone) in order to counter the tremendous osmotic pressure that resulted during
dissolution o f the core. As described in the chapter IV, three different methods were used
to fabricate the capsules, which were then qualitatively assessed using the confocal
microscope to assess the quality o f the yield.
The zeta-potential measurements o f the assembly o f PAH and PSS are shown in
Figure 71. The assembly o f polyions was confirmed by the alternation o f zeta-potential
values with the assembly o f each consecutive layer.
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Figure 71. Zeta-potential measurement o f coating o f {PAH/PSSjs + {PAHFITC/PSS}3
It was observed from confocal images, that approximately 40-50% o f capsules
produced by the first method (involving overnight immersion in acetone followed by
rinses with acetone and DI water) described in chapter IV were ruptured. It was
speculated that the overnight immersion in acetone might have damaged the capsules
because the acetone may have a detrimental effect on capsule wall materials. Figure 72
contains images o f various stages o f this method.
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Figure 72. Confocal images o f capsules with architecture {PAH /PSS }3 + {PAHFITC /PSS}3 ,(a) acetone overnight, (b) acetone rinse 1, (c) acetone rinse2, (d) DI
water rinse 1, (e) DI water rinse2, (f) DI water rinseS, (g) DI water rinse4
Since the first method involving immersion o f coated particles in acetone for a
prolonged period o f time, in second method the capsules were imaged after varying the
acetone immersion time. This method did not improve the yield o f capsules for all times
o f immersion (Figure 73).
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Figure 73. Confocal images o f capsules with architecture {PAH /PSS } 3 + {PAH-FITC
/PSS}3 ,(a) undissolved coated PM M A particles, (b)after five-hour immersion in
acetone, (c) afterl 7-hour immersion in acetone, (d) after 24-hour immersion in acetone.
Increasing the wall thickness and titrating DI water into the sample after acetone
Immersion for an hour resulted in damage to approximately 30-40% o f the capsules
(Figure 74). Hence, the yields were comparable in all three cases.
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Figure 74. Confocal images o f capsules with architecture {PAH /PSS}s + {PAH-FITC
fPSSh

In the case o f MF template, it was previously cited that during the core dissolution
process, there is a possibility o f the rupture o f the walls o f capsules, if the MF oligomers
do not diffuse out o f the interior sufficiently fast227. From Figure 75, it can be seen from
the indicated areas in the capsule walls that PMMA dissociated into chunks that were too
big to diffuse out o f the capsule wall. This effect has two main consequences: first, it
increases the osmotic pressure so much so that it causes the capsules to burst; second,
large pieces o f PMMA are always present in the capsules or capsule walls.
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Figure 75. Confocal and transmission images o f capsules with architecture {PAH
/PSS}8 + {PAH-FITC /PSS}3 in loading solution o f G O x-TRITC. The dark regions in
(a) and the indicated regions in (b) are undissolved pieces o f PMMA
The integrity o f the capsules with architecture {PAH /PSS}s + {PAH-FITC
/PSS}3 was evaluated by a “salt test.” Three pL o f a capsule sample was applied to the
surface o f a bare slide after which five juL o f 1M NaCl salt solution were added to the
capsule sample. Figure 76(a) contains the initial images o f the capsules before the
addition o f salt. It can be seen that the capsules are spherical and show no signs o f
collapsing. Figures 76(b) and 76(c) contain images o f capsules after addition o f salt
solution. It can clearly be seen that the capsules collapsed after salt addition. This
collapse confirms the integrity o f capsules; that is, if the capsules were ruptured, they
would be unaffected by the large osmotic forces exerted by the salt solution.
Approximately 70% o f the capsules collapsed, while the rest remained intact, suggesting
that the latter were ruptured.

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

189

a.

b.

c.

Figure 76. “Salt test” for confirmation o f integrity o f {PAH /PSSjs + {PAH-FITC
/PSS}3 capsules
This study demonstrated that though PMMA proves to be an alternative to MF,
much work still needs to be done in order to improve the overall yield o f capsules. Other
organic solvents such as toluene can also dissolve PMMA, however, they are difficult to
handle when compared with acetone. For future work, choices o f alternative solvents for
PMMA may be considered. Recently, the use o f alternative templates that can be simply
and inexpensively mass—produced in the lab, and which can be dissolved using acid or
non-acid solvents producing a high yield o f microcapsules, has been demonstrated44,176.
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APPENDIX C

CHEMICALS

Polyelectrolvtes. buffers and microspheres
•

FDD A (Cat number: 40,903-0, Sigma)

•

PSS (Cat number: 43,457-4, Sigma)

•

PVS (Cat number: 27,196-9, Sigma)

•

PAH (Cat number: 283215, Sigma)

•

Chitosan (448869, Sigma)

•

PEI (P-3143, Sigma)

Enzymes /amino acids
•

Glucose Oxidase (G-2133, Sigma)

•

Peroxidase (P-8250, Sigma)

•

FITC (F7250, Sigma)

•

TRITC (T-490, Molecular Probes)

•

HPTS (M0535, Marker Gene Technologies)

Dyes

Other chemicals
•
•

O-dianisidine (D-3252, Sigma)
Glucose (G5250, Sigma)
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•

PBS buffer (Cat number: 79382, Fluka)

•

Sodium bicarbonate bu£fer(S-8875, Sigma)

•

Acrylic acid (Cat number: 147230)

•

Ammonium Persulfate (A9164, Sigma)

•

Pyrogallol (P0381, Sigma)

•

EDC (03450, Fluka)

•

NHS (56485, Fluka)

•

DMF - N,N-Dimethylformamide (DMF) (D4551, Sigma)

•

Hydrogen Peroxide (349887, Sigma)
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APPENDIX D

EQUIPMENT/MATERIALS

1.
2.
3.
4.
5.
6.
7.
8.

Scanning fluorescence spectrometer (QMI, Photon Technology International)
UV-Vis spectrophotometer (Perkin Elmer, Lambda 45)
Scanning Probe Microscope (Atomic Force Microscope Quesant, Model 250)
Zeta potential- Zeta Potential Analyzer (Zeta Plus, Brookhaven Instruments
Corp.)
Gel-filtration columns (Amersham Pharmacia Biotech PD-10 desalting column)
pH-meter (Thermo Orion, Model A -2 1 0 )
Sonicator (Branson, 1510)
Micro cover glass for imaging with confocal and FRAP experiments (VWR
Scientific, Cat number: 48395 252
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APPENDIX E

MATLAB PROGRAM FOR DETERMINATION OF
DIFFUSION COEFFICIENTS USING
FRAP PROCEDURE

%removes stored information about variables
clear all
close all
%These parameters must be properly identified for file to function
%properly. Make sure the current directory contains the files to be
%imported
%Make sure that the first 2 time/fluorescence data points reflect
%the pre-bleach lapse
%These are the ONLY parameters that need to be adjusted
m olecularjw eight-160kDa';
%file_name:=(['matlab input for pss pah 70 diffusion studies 3 19 04']);
file_name=(['mcdar81ine3']);
sheet_name=([’mcdar81ine3']);
capsule_structure-MF-(PSS/PVS)_2+(PSS/PAH)_2!;
% Data importing commands
a=xlsread(file_name,sheet_name);
%defines the intensity values before and after
%bleaching
Iprebleach=a(2,2);
Ipostbleach=a(3,2);
%Put fluorescence recovery data in fractional form
f_fractionai_form=(a( 1: end,2)-a(3,2))/(a(end,2)-a(3,2));
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%Since data contains info about prebleach,
%that data is ignored, by defining time t=0
%as the first recovery point with the corresponding%intensity value.
trecovery=a(3 :end, 1)-a(3,1);
ffecovery=f_fractional_form(3:end, 1);
processed_time_and_recov_data=[trecovery,frecovery];
%Calculation o f k
syms ratio;
Ipre=num2str(Iprebleach);
Ipost=num2str(Ipostbleach);
ratio=[Ipost'/' Ipre -exp(-k)'];
x=solve(ratio,'k');
k_calc-eval(x( 1));

%FRAP model from Blonk et. a ll
%Note: m odel_parm(l)=k
%
model_parm(2)=tau
k_guess=5;
tau_guess=50;
modelparmO=[k_guess,tau_guess];
t=trecovery';
N=50;
n=[0:N];
%LSQ curve fitting using a calsulated k value, then fitting tau
f_string=['sum( ( ( ( - ' num2str(k_calc) ').A (transpose^' num2str(n) '])* o n es(l,'
num2str(length(frecovery)) ')) )./ (transpose(factorialarray([' num2str(n) ']))*ones(l,'
num2str(length(frecovery))')) * l./(l+(transpose([' num2str(n) '])*one$(l,'
num2str(length(frecovery)) ')).*(l+2*(ones((' num2str(N) '+1), 1)*t)/tau_k_calc) ) ) ) '] ;
f=inline(f_string,'tau_k_calcVt');
[tau_k_calc,resid] = lsqcurvefit(f,tau_guess,trecovery’,frecovery');
model_k_calc=eval(f_string);
%LSQ curve fitting tau first, then fitting for k
f_string-['sum( ( ( (-' num2str(k_guess) ').A (transpose([' num2str(n) ’])* o n es(l,'
num2str(length(frecovery)) ’)))./ (transpose(factorialarray([’ num2str(n) ']))*ones(l,'
num2str(length(frecovery)) ')) * l./(l+(transpose([' num2str(n) '])*ones(l,'
num2str(length(frecovery)) ')).*(l+2*(ones((' num2str(N) '+ l),l)* t)/ta u )) ))'];
f=inline(f_string,'tauVt');
[tau,resid] = lsqcurvefit(f,tau_guess,trecovery',frecovery');
f_string=['sum( ( ( (-k).A (transpose([' num2str(n) '])* o n e s(l,'
num2str(length(frecovery)) ')) )./ (transpose(factorialarray(['num2str(n) ']))*ones(l,’
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num2str(length(frecovery))')) * 1„/(l+(transpose([' num2str(n) '])*ones(l,'
num2str(length(frecovery)) ')).*(l+2*(ones((' num2str(N) '+ l),l)* t)/ ’ num 2str(tau)' ) ) )

)’];
f=inline(f_string,'kVt');
[k,resid] = lsqcurvefit(f,k_guess,trecovery',frecovery');
model 1=e val(f_string);
%LSQ curve fitting using for k anf tau simultaneously
f_string=['sum( ( ( (-model_parm( 1)).A (transpose([' num2str(n) '])* o n e s(l,'
num2str(length(frecovery))')))./ (transpose(factorialarray([! num2str(n) ']))*ones(l,'
num2str(length(frecovery)) ')) * l./(l+(transpose([’ num2str(n) '])*ones(l,'
num2str(length(frecovery)) ')).*(l+2*(ones((' num2str(N) '+1), 1)*t)/model_parm(2)) ) )

)’];
f=inline(f_string,'model_parmVt’);
[model_parm,resid] = lsqcurvefit(f,modelparmO,trecovery',frecovery');
model2=eval(f_string);

%delete first recovery point, since it is 0
mpe_model0=mean(abs(ffecovery(2:end)-model_k_calc(2:end)')./freco very(2:end))* 100;
m p e m o d e l 1=mean(abs(ffecovery(2:end)-model 1(2: end)')./frecovery(2:end))* 100;
mpe_model2=mean(abs(ffecovery(2:end)-model2(2:end)')./frecovery(2:end))*100;
%solving for diffusion coefficient
%w_squared was wxperimentally determined
w_squared=!(.0000557)A2;
D0==w_squared/(4*tau_k_calc);
D 1=w_squared/(4*tau);
D2=w_squared/(4*model_parm(2));

%spreadsheet information
[file_type, sheet_names]=xlsfinfo(file_name);
%plotting analysis
textplace_x=. 1*max(trecovery);
textplace_ymain=. 6*max(model 1);
textplace_ysub=.45 *max(model 1);
textplace_ysub2=. 3 *max(model 1);
textplace_ysub3=. 15*max(model 1);
figure(l)
subplot(2,l,l)
plotO jm odelJ^calc/rg’jtjmodelljTj'jtjmodelS,'--r',trecovery,frecovery, !k ’s'LineWidth',2)
title([capsule_structure,', FITC-GOx Mw=', molecular w eig h t,' (', sheet_nam e,')' ])
xlabel(Time (sec)')
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ylabel(Tluorescence Intensity (A.U.)')
legend((['ModelO Output (tau)']),(['Modell Output (tau then k)']),([’Mode!2 Output
(simul)’]) , 'Exp. Data’,4)
legend('boxoff)
text(textplace_x,textplace_ymain,['M_0: {\tau}JD-,num2str(tau_k_calc),'s;
D=',num2str(DQ),'cmA2 /s',K -,n u m 2 str(k _ c a lc )])
text(textplace_x,textplace_ysub,['M__l: {\tau}_D=',num2str(tau),'s;
D=',num2str(D 1),'cmA2 /s',K -',n u m 2 str(k )])
text(textplace_x,textplace_ysub2,['M_2: {\tau}_D-,num2str(model_parm(2)),'s;
D=',num2str(D2),'cmA2/s’,K =',num 2str(m odel_parm (2))])
text(textplace_x,textplace_ysub3,['MPE_0-,num2str(mpe_model0),';
MPE l =',num2str(mpe_model 1 ) , MPE_2-',num2str(mpe_model2)])
subplot(2,l,2)
p!ot(a(l :end,l),a(l:end,2), ’kVLinewidth',2)
title([TJnprocessed FRAP Data'])
xlabel('Time (sec)')
ylabel('Fluorescence Intensity (A.U.)')
legend('Unprocessed Data',0)
legend('boxoff)
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